FedInvent™ Patents

Patent Details for Tuesday, February 01, 2022 

This page was updated on Thursday, February 03, 2022 at 01:47 AM GMT

Department of Health and Human Services (HHS) 

US 11234607 Barlow et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Deafness and Other Communication Disorders (NIDCD)
APPLICANT(S) Steven M. Barlow (Lawrence, Kansas);  David L. Stalling (Shawnee, Kansas);  Kenneth Aron (Shawnee, Kansas)
ASSIGNEE(S) Innara Health, Inc. (Olathe, Kansas);  University of Kansas (Lawrence, Kansas)
INVENTOR(S) Steven M. Barlow (Lawrence, Kansas);  David L. Stalling (Shawnee, Kansas);  Kenneth Aron (Shawnee, Kansas)
ABSTRACT The present invention relates to methods of using a therapeutic system. In particular, the present invention relates to procedures and methods of using a system having hardware, software, and appliance components for assessing and entraining a non-nutritive suck (NNS) pattern in a patient. The methods include configuring the hardware and software systems to receive data from an orofacial stimulation appliance and to generate a precise therapeutic pulse profile that is actuated as a tactile stimulus. The methods also include collecting data using the orofacial stimulation appliance and delivering the tactile stimulus via the orofacial stimulation appliance to entrain an organized NNS pattern.
FILED Thursday, April 26, 2012
APPL NO 13/457154
ART UNIT 3791 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/038 (20130101) Original (OR) Class
A61B 5/486 (20130101)
A61B 5/682 (20130101)
A61B 5/6896 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11234627 Seymour et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) NeuroNexus Technologies, Inc. (Ann Arbor, Michigan)
ASSIGNEE(S) NeuroNexus Technologies, Inc. (Ann Arbor, Michigan)
INVENTOR(S) John P. Seymour (Ann Arbor, Michigan);  Jongeun Jeon (Ann Arbor, Michigan);  Nicholas Hewitt (Chelsea, Michigan);  Abeer Khurram (Ypsilanti, Michigan)
ABSTRACT An optical electrode having a plurality of electrodes, including a recording electrode having a roughened surface and an optical light source configured to emit light, wherein at least a portion of the light impinges on the recording electrode. Also disclosed are methods of producing an optical electrode and an opto-electronic neural interface system.
FILED Friday, February 15, 2019
APPL NO 16/277334
ART UNIT 3794 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/24 (20210101) Original (OR) Class
A61B 5/6847 (20130101)
A61B 5/6868 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 1/0534 (20130101)
A61N 5/0622 (20130101)
A61N 2005/0612 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 29/49826 (20150115)
Y10T 29/49886 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11234637 Kayyali et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) Cleveland Medical Devices Inc. (Cleveland, Ohio)
ASSIGNEE(S) Cleveland Medical Devices Inc. (Cleveland, Ohio)
INVENTOR(S) Hani Kayyali (Shaker Heights, Ohio);  Craig A. Frederick (Solon, Ohio);  Christian Martin (Eden, North Carolina);  Robert N. Schmidt (Ft. Myers, Florida);  Brian Kolkowski (Leroy, Ohio)
ABSTRACT The present invention provides a method of conducting a sleep analysis by collecting physiologic and kinetic data from a subject, preferably via a wireless in-home data acquisition system, while the subject attempts to sleep at home. The sleep analysis, including clinical and research sleep studies and cardiorespiratory studies, can be used in the diagnosis of sleeping disorders and other diseases or conditions with sleep signatures, such as Parkinson's, epilepsy, chronic heart failure, chronic obstructive pulmonary disorder, or other neurological, cardiac, pulmonary, or muscular disorders. The method of the present invention can also be used to determine if environmental factors at the subject's home are preventing restorative sleep.
FILED Monday, June 14, 2021
APPL NO 17/346640
ART UNIT 3792 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0022 (20130101)
A61B 5/0077 (20130101)
A61B 5/085 (20130101)
A61B 5/087 (20130101)
A61B 5/0205 (20130101)
A61B 5/318 (20210101)
A61B 5/369 (20210101)
A61B 5/389 (20210101)
A61B 5/398 (20210101)
A61B 5/1135 (20130101)
A61B 5/4815 (20130101) Original (OR) Class
A61B 5/6814 (20130101)
A61B 5/6828 (20130101)
A61B 5/14552 (20130101)
A61B 2505/07 (20130101)
A61B 2560/0242 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11234657 Fleming et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
APPLICANT(S) Rhode Island Hospital (Providence, Rhode Island);  Children's Medical Center Corporation (Boston, Massachusetts)
ASSIGNEE(S) Rhode Island Hospital (Providence, Rhode Island);  Children's Medical Center Corporation (Boston, Massachusetts)
INVENTOR(S) Braden C. Fleming (East Greenwich, Rhode Island);  Martha M. Murray (Sherborn, Massachusetts)
ABSTRACT The current subject matter provides a tool for evaluating the risk of failure or the likelihood of success of surgery of healing ligaments and tendons in the body. In some embodiments, a region of a scan comprising one or more of an anterior cruciate ligament (ACL) or an ACL graft can be defined. A magnetic resonance (MR) imaging data set can be obtained. MR parameters characterizing a size and a quality of the ACL or ACL graft can be derived using the MR data. The MR parameters can be used as inputs to a predictive model. A score characterizing a likelihood of failure of the ACL or ACL graft in a human patient can be generated using the predictive model.
FILED Tuesday, May 01, 2018
APPL NO 16/609737
ART UNIT 2664 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/055 (20130101)
A61B 5/4533 (20130101)
A61B 5/4585 (20130101)
A61B 5/4851 (20130101)
A61B 5/7275 (20130101) Original (OR) Class

Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/5608 (20130101)

Image Data Processing or Generation, in General
G06T 7/0016 (20130101)
G06T 7/62 (20170101)
G06T 7/174 (20170101)
G06T 11/005 (20130101)
G06T 11/008 (20130101)
G06T 2207/10088 (20130101)
G06T 2207/30052 (20130101)

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 30/20 (20180101)
G16H 50/30 (20180101)
G16H 50/50 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11234673 Fatemi et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Mayo Foundation for Medical Education and Research (Rochester, Minnesota)
ASSIGNEE(S) Mayo Foundation for Medical Education and Research (Rochester, Minnesota)
INVENTOR(S) Mostafa Fatemi (Rochester, Minnesota);  Mahdi Bayat (Rochester, Minnesota);  Alireza Nabavizadehrafsanjani (Bronx, New York);  Azra Alizad (Rochester, Minnesota)
ABSTRACT Methodology, with a programmable-processor imaging system, for control and determination of breast lesion viscoelastic properties with the use of a creep-like test. Two dimensional reconstruction maps are used for different parameters of a linear viscoelastic model. Description of different aspects of the test used on live subjects and suitability of a 1-D inversion model in capturing different viscoelasticity parameters. An automated methodology for the selection of a region of interest derived only from the appearance of the breast lesion on pre-compressed B-mode images. Based on the ROI and estimated viscoelasticity parameters, contrast values are determined that facilitate the enhanced differentiation of breast mass. Employing the methodology in a large group of patients provides better understanding of variations of different viscoelasticity parameters in different types of breast lesion and helps to identify new biomarkers for enhanced differentiation of benign from malignant cases.
FILED Tuesday, October 23, 2018
APPL NO 16/167791
ART UNIT 3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 8/085 (20130101) Original (OR) Class
A61B 8/403 (20130101)
A61B 8/463 (20130101)
A61B 8/466 (20130101)
A61B 8/485 (20130101)
A61B 8/0825 (20130101)
A61B 8/4209 (20130101)
A61B 8/4281 (20130101)
A61B 8/5223 (20130101)
A61B 8/5253 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11234681 Jay-Russell et al.
FUNDED BY
Department of Health and Human Services (HHS)
Food and Drug Administration (FDA)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Michele T. Jay-Russell (Davis, California);  Esteban Soto Martinez (Davis, California);  Elizabeth Antaki-Zukoski (Davis, California);  Christopher Zukoski (Davis, California)
ABSTRACT Provided are fish tank effluent sampling systems, e.g., for use in recirculating aquaponics systems, methods of using same for sampling effluent, and kits for assembling such an effluent sampling system.
FILED Thursday, February 14, 2019
APPL NO 16/276071
ART UNIT 1773 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Horticulture; Cultivation of Vegetables, Flowers, Rice, Fruit, Vines, Hops or Seaweed; Forestry; Watering
A01G 31/02 (20130101)
A01G 2031/006 (20130101)

Animal Husbandry; Care of Birds, Fishes, Insects; Fishing; Rearing or Breeding Animals, Not Otherwise Provided For; New Breeds of Animals
A01K 63/10 (20170101)
A01K 63/045 (20130101)

Diagnosis; Surgery; Identification
A61B 10/0038 (20130101) Original (OR) Class
A61B 2503/40 (20130101)

Treatment of Water, Waste Water, Sewage, or Sludge
C02F 3/327 (20130101)
C02F 2001/007 (20130101)
C02F 2103/20 (20130101)
C02F 2201/005 (20130101)
C02F 2203/006 (20130101)
C02F 2301/046 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11234751 Rollins et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Case Western Reserve University (Cleveland, Ohio)
ASSIGNEE(S) CASE WESTERN RESERVE UNIVERSITY (Cleveland, Ohio)
INVENTOR(S) Andrew M. Rollins (Cleveland Heights, Ohio);  Christine P. Fleming (Bronx, New York)
ABSTRACT Systems, methods, and other embodiments associated with characterizing Radio Frequency Ablation (RFA) lesions using Optical Coherence Tomography (OCT) are described. One example method includes acquiring an OCT signal from a Region Of Interest (ROI) in an ablated material. The example method may also include determining whether a lesion was formed by the ablation by analyzing optical properties of the ROI as recorded in the OCT signal.
FILED Wednesday, January 31, 2018
APPL NO 15/884604
ART UNIT 3792 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0066 (20130101)
A61B 5/6852 (20130101)
A61B 18/02 (20130101)
A61B 18/12 (20130101) Original (OR) Class
A61B 18/20 (20130101)
A61B 18/1492 (20130101)
A61B 2017/00243 (20130101)
A61B 2018/00351 (20130101)
A61B 2018/00702 (20130101)
A61B 2090/3735 (20160201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11234896 Lampe et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
ASSIGNEE(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
INVENTOR(S) Joshua Lampe (Jenkintown, Pennsylvania);  Lance Becker (Philadelphia, Pennsylvania)
ABSTRACT Devices and methods for blood flow enhancement and hemodynamic power monitoring are provided. A blood flow enhancement device includes a pump system configured to be coupled to a central vasculature of a subject during cardiopulmonary resuscitation (CPR). The pump system includes a pumping mechanism configured to increase forward blood flow generated during the CPR while substantially limiting backward blood flow generated during the CPR. The pumping mechanism being operated concurrently with the CPR. The hemodynamic power monitor is configured to control a chest compression device and an active valve.
FILED Thursday, October 17, 2013
APPL NO 14/436250
ART UNIT 3791 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/026 (20130101)
A61B 5/0215 (20130101)
A61B 5/02028 (20130101)
A61B 5/02158 (20130101)

Physical Therapy Apparatus, e.g Devices for Locating or Stimulating Reflex Points in the Body; Artificial Respiration; Massage; Bathing Devices for Special Therapeutic or Hygienic Purposes or Specific Parts of the Body
A61H 31/005 (20130101) Original (OR) Class
A61H 31/006 (20130101)
A61H 2230/04 (20130101)
A61H 2230/255 (20130101)
A61H 2230/305 (20130101)

Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 60/40 (20210101)
A61M 60/50 (20210101)
A61M 60/122 (20210101)
A61M 60/135 (20210101)
A61M 60/148 (20210101)
A61M 60/205 (20210101)
A61M 60/274 (20210101)
A61M 60/414 (20210101)
A61M 60/892 (20210101)
A61M 60/894 (20210101)
A61M 2205/3334 (20130101)
A61M 2205/3358 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 7/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11234953 Veech et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) TDELTAS LIMITED (Thame, United Kingdom);  THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (Bethesda, Maryland)
ASSIGNEE(S) TDELTAS LIMITED (Thame, United Kingdom);  THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (Bethesda, Maryland)
INVENTOR(S) Richard Lewis Veech (Rockville, Maryland);  Kieran Clarke (Oxford, United Kingdom)
ABSTRACT Described herein is the surprising discovery that ketone bodies protect cell and tissues from ionizing radiation. Based on this finding, methods of protecting animal tissue and cells from damage caused by radiation exposure are disclosed which include, contacting the tissue with a therapeutically effective amount of an agent including at least one ketone ester, thereby protecting the tissue from radiation damage. Ketone esters can be used to minimize, reduce and/or prevent tissue damage following intentional and accidental radiation exposure, as well as increasing the therapeutic efficacy of radiation therapies by protecting non-target tissue from incidental radiation damage.
FILED Monday, October 07, 2019
APPL NO 16/594431
ART UNIT 1625 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/22 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11234966 Buynak et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Southern Methodist University (Dallas, Texas);  University of Central Florida Research Foundation, Inc. (Orlando, Florida)
ASSIGNEE(S) Southern Methodist University (Dallas, Texas);  University of Central Florida Research Foundation, Inc. (Orlando, Florida)
INVENTOR(S) John D. Buynak (Dallas, Texas);  Noora M. S. A. Al-Kharji (Richardson, Texas);  Weirui Chai (Chicago, Illinois);  Thu Q. Nguyen (North Richland Hills, Texas);  Maha Alqurafi (Dallas, Texas);  Kyle Rohde (Orlando, Florida);  Rashmi Gupta (Lake Mary, Florida)
ABSTRACT The present invention includes a composition, method of making and method of using a novel C5-substituted carbapenem antibiotic of formula 1: R1 is H or CH3 R2 is not H, and is CH3, or C1-C6 straight chain, or branched alkyl, or C3-C6 cycloalkyl group, or unsaturated alkenyl, including C═CH2; R3 is H, CH3, or a C1-C6 alkyl or cycloalkyl group, a heteroatom-substituted alkyl; and R4 is a C1 to C6 alkyl, or substituted alkyl group, especially including substituents which possess positive charge, or a hydroxyl group; or R4 is an SRa, where Ra is an unsubstituted C1 to C6 alkyl group, a substituted C1 to C6 alkyl group, or a functional group that is positively charged, or which bears a positive charge when in aqueous solution at pH 7; or R4 is a CH2ORb, where Rb=C1 to C6 alkyl or substituted alkyl groups, substituted or unsubstituted aryl, or a heteroaryl groups.
FILED Thursday, May 21, 2020
APPL NO 16/879892
ART UNIT 1624 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/407 (20130101) Original (OR) Class
A61K 45/06 (20130101)

Heterocyclic Compounds
C07D 477/00 (20130101)
C07D 477/04 (20130101)
C07D 477/06 (20130101)
C07D 477/20 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11234978 Wise et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Southern Methodist University (Dallas, Texas)
ASSIGNEE(S) Southern Methodist University (Dallas, Texas)
INVENTOR(S) John G. Wise (Dallas, Texas);  Pia D. Vogel (Dallas, Texas);  Frances K. Brewer (Waxahachie, Texas);  Courtney A. Follit (Dallas, Texas)
ABSTRACT The present disclosure provides a method of treating a subject that is resistant to one or more drugs by identifying a subject having one or more drug resistant cells; administering to the subject a pharmaceutically effective amount of an inhibitor compound, and contacting one or more drug resistant cells with the inhibitor compound to reduce the export of the inhibitor compound from the one or more drug resistant tumor cells and to block the transport of drug(s) from the one or more drug resistant cells.
FILED Thursday, September 26, 2019
APPL NO 16/584121
ART UNIT 1623 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/352 (20130101)
A61K 31/353 (20130101)
A61K 31/4196 (20130101)
A61K 31/4525 (20130101)
A61K 31/5025 (20130101) Original (OR) Class
A61K 45/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11234990 Pan et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The University of Chicago (Chicago, Illinois)
ASSIGNEE(S) The University of Chicago (Chicago, Illinois)
INVENTOR(S) Deng Pan (Chicago, Illinois);  Masha Kocherginsky (Chicago, Illinois);  Suzanne D. Conzen (Park Ridge, Illinois)
ABSTRACT Embodiments of the invention are directed to methods of determining the prognosis of a breast cancer patient by evaluating the activity of the glucocorticoid receptor in tumor cells. Other embodiment include methods of treating breast cancer cells, particularly, chemo-resistant cells, with a glucocorticoid receptor antagonist and an anticancer agent or compound.
FILED Tuesday, October 08, 2019
APPL NO 16/596342
ART UNIT 1615 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Containers Specially Adapted for Medical or Pharmaceutical Purposes; Devices or Methods Specially Adapted for Bringing Pharmaceutical Products into Particular Physical or Administering Forms; Devices for Administering Food or Medicines Orally; Baby Comforters; Devices for Receiving Spittle
A61J 1/00 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 31/58 (20130101)
A61K 31/282 (20130101)
A61K 31/337 (20130101)
A61K 31/357 (20130101)
A61K 31/567 (20130101)
A61K 31/575 (20130101) Original (OR) Class
A61K 31/575 (20130101)
A61K 31/4745 (20130101)
A61K 31/7068 (20130101)
A61K 33/243 (20190101)
A61K 39/3955 (20130101)
A61K 45/06 (20130101)
A61K 2300/00 (20130101)

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 5/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11234992 Gordts et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Philip Gordts (San Diego, California);  Ariane Pessentheiner (San Diego, California);  Lars Bode (San Diego, California)
ABSTRACT The disclosure provides for therapies and methods to treat atherosclerosis and/or hyperlipidemia, and complications resulting therefrom, with compositions that comprise therapeutically effective amounts of one or more human milk oligosaccharides.
FILED Thursday, February 28, 2019
APPL NO 16/289288
ART UNIT 1623 — Organic Chemistry
CURRENT CPC
Foods, Foodstuffs, or Non-alcoholic Beverages, Not Covered by Subclasses A23B - A23J; Their Preparation or Treatment, e.g Cooking, Modification of Nutritive Qualities, Physical Treatment; Preservation of Foods or Foodstuffs, in General
A23L 33/125 (20160801)

Indexing Scheme Relating to Foods, Foodstuffs or Non-alcoholic Beverages
A23V 2002/00 (20130101)
A23V 2200/326 (20130101)
A23V 2200/3262 (20130101)

Preparations for Medical, Dental, or Toilet Purposes
A61K 9/14 (20130101)
A61K 9/20 (20130101)
A61K 9/0095 (20130101)
A61K 9/4808 (20130101)
A61K 31/702 (20130101)
A61K 31/7016 (20130101) Original (OR) Class
A61K 35/20 (20130101)
A61K 45/06 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 3/06 (20180101)
A61P 9/10 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11234996 Vaidya et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Environmental Health Sciences (NIEHS)
APPLICANT(S) The Brigham and Women's Hospital, Inc. (Boston, Massachusetts)
ASSIGNEE(S) The Brigham and Women's Hospital, Inc. (Boston, Massachusetts)
INVENTOR(S) Vishal S. Vaidya (Cambridge, Massachusetts);  Casimiro Gerarduzzi (Boston, Massachusetts)
ABSTRACT Described herein are methods for treating fibrosis, e.g., kidney fibrosis, using agents that target Secreted Modular Calcium-binding protein 2 (SMOC2).
FILED Tuesday, February 21, 2017
APPL NO 16/079002
ART UNIT 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/712 (20130101) Original (OR) Class

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 13/12 (20180101)
A61P 43/00 (20180101)

Peptides
C07K 16/18 (20130101)
C07K 16/2842 (20130101)
C07K 2317/76 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101)
C12N 2310/14 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235005 Halum
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Deafness and Other Communication Disorders (NIDCD)
APPLICANT(S) Purdue Research Foundation (West Lafayette, Indiana)
ASSIGNEE(S) Purdue Research Foundation (West Lafayette, Indiana)
INVENTOR(S) Stacey L. Halum (Indianapolis, Indiana)
ABSTRACT This invention relates to a method for repairing and reconstructing a damaged or non-functional muscle, in particular to a method and a tool kit using in vitro primed motor endplate-expressing muscle progenitor cells (MPCs) to promote innervation of the damaged or non-functional muscle using an agent without any genetic manipulation. This method is particularly useful for repairing or reconstructing damaged or non-functional head and neck muscles, and urinary detrusor bladder muscle.
FILED Friday, April 27, 2018
APPL NO 15/964784
ART UNIT 1633 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/221 (20130101)
A61K 35/30 (20130101)
A61K 35/34 (20130101) Original (OR) Class
A61K 38/1883 (20130101)
A61K 2300/00 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 21/00 (20180101)
A61P 25/00 (20180101)
A61P 43/00 (20180101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0658 (20130101)
C12N 2501/805 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235029 Cannavo et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Temple University-Of The Commonwealth System of Higher Education (Philadelphia, Pennsylvania);  Johns Hopkins Technology Ventures (Baltimore, Maryland);  Universita di Napoli Federico II (Naples, Italy)
ASSIGNEE(S) Temple University-Of The Commonwealth System of Higher (Philadelphia, Pennsylvania);  Education Johns Hopkins Technology Ventures (Baltimore, Maryland);  Universita di Napoli Federico II (Naples, Italy)
INVENTOR(S) Alessandro Cannavo (Naples, Italy);  Ning Feng (Wexford, Pennsylvania);  Giuseppe Rengo (Naples, Italy);  Nazareno Paolocci (Baltimore, Maryland);  Walter J. Koch (Malvern, Pennsylvania)
ABSTRACT The present invention relates to compositions and methods for the treatment of heart failure.
FILED Friday, March 09, 2018
APPL NO 15/916494
ART UNIT 1646 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/138 (20130101)
A61K 31/166 (20130101)
A61K 31/353 (20130101)
A61K 31/404 (20130101)
A61K 38/185 (20130101) Original (OR) Class
A61K 2039/505 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 9/04 (20180101)

Peptides
C07K 14/71 (20130101)
C07K 14/475 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235032 Wang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Chensu Wang (Allston, Massachusetts);  Karl Dane Wittrup (Boston, Massachusetts);  Darrell J. Irvine (Arlington, Massachusetts)
ABSTRACT The present disclosure provides a method of treating cancer with a priming dose of combination immunotherapy comprising IL-2 (e.g., extended-PK IL-2), an immune checkpoint inhibitor, a tumor targeting antibody or integrin-binding polypeptide, and optional cancer vaccine, administered prior to maintenance doses of immune checkpoint inhibitor therapy. The methods of the disclosure can be used to treat a broad range of cancer types.
FILED Friday, November 22, 2019
APPL NO 16/692892
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/2013 (20130101) Original (OR) Class
A61K 39/0011 (20130101)
A61K 39/39 (20130101)
A61K 39/3955 (20130101)
A61K 39/39558 (20130101)
A61K 2039/507 (20130101)
A61K 2039/545 (20130101)
A61K 2039/55561 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235043 Lyerly et al.
FUNDED BY
Department of Defense (DOD)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Duke University (Durham, North Carolina)
ASSIGNEE(S) Duke University (Durham, North Carolina)
INVENTOR(S) Herbert K. Lyerly (Durham, North Carolina);  Michael A. Morse (Durham, North Carolina);  Takuya Osada (Durham, North Carolina);  Timothy M. Clay (Waterloo, Belgium);  Zachary C. Hartman (Durham, North Carolina)
ABSTRACT Methods of reducing, the likelihood of a cancer or precancer developing resistance to a cancer therapeutic or prevention agent are provided herein. The methods include administering the cancer therapeutic or prevention agent and a vaccine comprising a polynucleotide encoding a polypeptide whose expression or activation is correlated with development of resistance of the cancer or precancer to the cancer therapeutic or prevention agent to a subject. The vaccine may include a polynucleotide encoding a HER3 polypeptide. Methods of using the vaccine including the polynucleotide encoding the HER3 polypeptide to treat a cancer or precancer are also provided.
FILED Wednesday, April 25, 2018
APPL NO 15/962824
ART UNIT 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/517 (20130101)
A61K 31/517 (20130101)
A61K 39/001106 (20180801) Original (OR) Class
A61K 39/3955 (20130101)
A61K 45/06 (20130101)
A61K 2039/53 (20130101)
A61K 2039/505 (20130101)
A61K 2039/507 (20130101)
A61K 2039/585 (20130101)
A61K 2039/5256 (20130101)
A61K 2300/00 (20130101)

Peptides
C07K 16/32 (20130101)
C07K 2317/73 (20130101)
C07K 2317/76 (20130101)
C07K 2317/77 (20130101)
C07K 2317/734 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235045 Milich et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) VLP Biotech, Inc. (San Diego, California)
ASSIGNEE(S) VLP Biotech, Inc. (San Diego, California)
INVENTOR(S) David R. Milich (Escondido, California);  David C. Whitacre (San Diego, California)
ABSTRACT The present disclosure relates to rodent hepadnavirus core antigens including one or more B cell and T cell epitopes of a malaria parasite antigen. More specifically, the present disclosure relates to hybrid woodchuck hepadnavirus core antigens that have been modified to diminish the antibody response to the core antigen so as to enhance the antibody response to fragments of malaria antigen(s) included therein.
FILED Tuesday, October 30, 2018
APPL NO 16/175681
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/015 (20130101) Original (OR) Class
A61K 39/29 (20130101)
A61K 39/295 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 33/06 (20180101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/701 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235047 Malley et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Children's Medical Center Corporation (Boston, Massachusetts)
ASSIGNEE(S) CHILDREN'S MEDICAL CENTER CORPORATION (Boston, Massachusetts)
INVENTOR(S) Richard Malley (Beverly, Massachusetts);  Yingjie Lu (West Roxbury, Massachusetts);  Kristin L. Moffitt (Woburn, Massachusetts)
ABSTRACT The present application is generally directed to methods for identifying immunogens from organisms and pathogens, and in particular for identifying immunogens which when administered as vaccines elicit a cellular and/or humoral immune response. The present application is also directed to pneumococcal T-cell immunogens, and vaccine compositions comprising one or a combination of pneumococcal immunogens and methods for treating or preventing pneumococcal infections using the vaccines thereof. The present invention also encompasses use of the pneumococcal immunogens for diagnostic purposes to identify a subject with a pneumococcal infection.
FILED Tuesday, June 28, 2016
APPL NO 15/195099
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/092 (20130101) Original (OR) Class
A61K 2039/70 (20130101)
A61K 2039/55544 (20130101)
A61K 2039/55583 (20130101)

Peptides
C07K 14/3156 (20130101)
C07K 2319/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235054 Dhere et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) Serum Institute of India Private Limited (Pune Maharashtra, India);  The United States of America, as Represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland)
ASSIGNEE(S) Serum Institute of India Private Limited (Pune Maharashtra, India);  The United States of America, as Represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland)
INVENTOR(S) Rajeev Mhalasakant Dhere (Pune Maharashtra, India);  Sambhaji Shankar Pisal (Pune Maharashtra, India);  Jagdish Kamalaji Zade (Pune Maharashtra, India);  Rajendra Narayan Sabale (Pune Maharashtra, India);  Ravindra Bapurao Kadam (Pune Maharashtra, India);  Abhijeet Sanjeev Kamble (Pune Maharashtra, India);  Baoming Jiang (Bethesda, Maryland);  Roger Glass (Bethesda, Maryland)
ABSTRACT Stable, immunogenic combination vaccine(s) comprising a mixture of antigens for prevention and prophylaxis of infections caused by Rotavirus, Poliomyelitis virus, Haemophilus influenzae, Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis and Hepatitis B virus. A multivalent combination vaccine comprises i) significantly dose-reduced Salk-IPV or Sabin-IPV (IPV) antigens prepared by methods of formaldehyde inactivation and alum hydroxide adsorption resulting in maximum D-antigen recovery; ii) Injectable heat inactivated Rotavirus antigen(s) providing broad cross-protective immunity among human rotavirus strains; iii) Hib PRP-carrier protein conjugate having improved stability and immunogenicity; iv) whole cell pertussis antigen with improved immunogenicity and stability; and v) Homogenous fractions of Diphtheria and Tetanus toxoids. Such stable and immunogenic vaccine compositions are made by i) individually adsorbing dose reduced IPV, IRV antigens on alum hydroxide and keeping other antigen(s) unadsorbed or adsorbed on alum phosphate, alum hydroxide, or a combination thereof; and ii) using an order of addition of antigens during blending.
FILED Thursday, August 24, 2017
APPL NO 16/327513
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/12 (20130101)
A61K 39/13 (20130101)
A61K 39/15 (20130101) Original (OR) Class
A61K 39/099 (20130101)
A61K 2039/545 (20130101)
A61K 2039/5252 (20130101)
A61K 2039/55505 (20130101)
A61K 2039/55544 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 2720/12334 (20130101)
C12N 2770/32634 (20130101)

Technologies for Adaptation to Climate Change
Y02A 50/466 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235055 Korber et al.
FUNDED BY
Department of Energy (DOE)
Los Alamos National Laboratory (LANL)
Los Alamos National Security, LLC (LANS)
National Nuclear Security Administration (NNSA)
Triad National Security, LLC (Triad)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Los Alamos National Security, LLC (Los Alamos, New Mexico);  Oxford University Innovation Limited (Oxford, United Kingdom)
ASSIGNEE(S) Triad National Security, LLC (Los Alamos, New Mexico);  Isis Innovation Limited (Oxford, United Kingdom)
INVENTOR(S) Bette T. M. Korber (Los Alamos, New Mexico);  Tomas Hanke (Oxford, United Kingdom);  Andrew McMichael (Oxford, United Kingdom)
ABSTRACT Disclosed herein are mosaic conserved region HIV polypeptides and immunogenic polypeptides including one or more of the mosaic conserved region polypeptides. In some embodiments, the immunogenic polypeptides are included in an immunogenic composition, such as a polyvalent immunogenic composition. Also disclosed herein are methods for treating or inhibiting HIV in a subject including administering one or more of the disclosed immunogenic polypeptides or compositions to a subject having or at risk of HIV infection. In some embodiments, the methods include inducing an immune response in a subject comprising administering to the subject at least one of the disclosed immunogenic polypeptides or a nucleic acid encoding at least one of the immunogenic polypeptides.
FILED Friday, June 29, 2018
APPL NO 16/023871
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/12 (20130101)
A61K 39/21 (20130101) Original (OR) Class

Peptides
C07K 14/005 (20130101)
C07K 14/161 (20130101)
C07K 14/162 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 2740/16034 (20130101)
C12N 2740/16122 (20130101)
C12N 2740/16222 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235056 Chen et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland)
INVENTOR(S) Xuejun Chen (Clarksburg, Maryland);  Jeffrey Boyington (Clarksburg, Maryland);  Hongying Duan Holdsworth (McLean, Virginia);  Cheng Cheng (Bethesda, Maryland);  John R. Mascola (Rockville, Maryland)
ABSTRACT Embodiments of immunogens based on the outer domain of HIV-1 gp120 and methods of their use and production are disclosed. Nucleic acid molecules encoding the immunogens are also provided. In several embodiments, the immunogens can be used to prime an immune response to gp120 in a subject, for example, to treat or prevent an HIV-1 infection in the subject.
FILED Monday, March 26, 2018
APPL NO 16/496912
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/21 (20130101) Original (OR) Class
A61K 2039/5258 (20130101)
A61K 2039/55555 (20130101)

Peptides
C07K 14/005 (20130101)
C07K 14/162 (20130101)
C07K 2319/00 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 2740/16023 (20130101)
C12N 2740/16043 (20130101)
C12N 2740/16111 (20130101)
C12N 2740/16122 (20130101)
C12N 2740/16134 (20130101)
C12N 2740/16171 (20130101)

Enzymes
C12Y 205/01078 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235058 Yantasee et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
National Cancer Institute (NCI)
APPLICANT(S) PDX Pharmaceuticals, Inc. (Portland, Oregon);  Oregon Health and Science University (Portland, Oregon)
ASSIGNEE(S) Oregon Health and Science University (Portland, Oregon);  PDX Pharmaceuticals, Inc. (Portland, Oregon)
INVENTOR(S) Wassana Yantasee (Lake Oswego, Oregon);  Amanda Lund (Portland, Oregon);  Worapol Ngamcherdtrakul (Portland, Oregon);  Moataz Reda (Portland, Oregon)
ABSTRACT Disclosed herein are immunotherapeutic constructs comprising a delivery particle, at least one adjuvant, and one or more therapeutic agents/compounds that cause antigen release and/or modulate immunosuppressive tumor microenvironment. These immunotherapeutic constructs create adaptive immunity or anti-cancer immune response(s) that can be used, for instance, to prevent and treat broad types of cancer. Further disclosed are uses of the immunotherapeutic constructs, including to prevent and treat cancer in humans and animals.
FILED Friday, August 21, 2020
APPL NO 16/999948
ART UNIT 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0014 (20130101)
A61K 9/0021 (20130101)
A61K 9/1676 (20130101)
A61K 31/519 (20130101)
A61K 31/7105 (20130101)
A61K 39/39 (20130101) Original (OR) Class
A61K 2039/55561 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101)
C12N 15/1135 (20130101)
C12N 2310/141 (20130101)
C12N 2320/31 (20130101)
C12N 2320/35 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235066 Wang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Michigan)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Michigan)
INVENTOR(S) Thomas D. Wang (Ann Arbor, Michigan);  Supang Khondee (Phayao, Thailand)
ABSTRACT The present invention relates to micelle drug carriers and methods of using the micelles to deliver drugs to target cells. The micelles are useful, for example, for carrying and targeting drugs for the treatment of cancer to cancer cells. As one example, the disclosure provides pegylated octadecyl lithocholate micelles that are labeled with a peptide ligand for colorectal neo-plasia and that carry the small molecule mTOR inhibitor rapamycin to colorectal cancer cells.
FILED Thursday, December 01, 2016
APPL NO 15/780277
ART UNIT 1658 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/1075 (20130101)
A61K 31/436 (20130101)
A61K 47/60 (20170801)
A61K 47/62 (20170801)
A61K 47/554 (20170801)
A61K 47/6907 (20170801) Original (OR) Class

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 65/3348 (20130101)
C08G 69/10 (20130101)
C08G 69/40 (20130101)
C08G 81/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235071 Mao et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) THE JOHNS HOPKINS UNIVERSITY (Baltimore, Maryland)
ASSIGNEE(S) The Johns Hopkins University (Baltimore, Maryland)
INVENTOR(S) Hai-Quan Mao (Baltimore, Maryland);  John Michael Williford (Chicago, Illinois);  Maani Archang (Baltimore, Maryland);  Il Minn (Ellicott City, Maryland);  Yong Ren (Baltimore, Maryland);  Jose Luis Santos (Rockville, Maryland);  Martin G. Pomper (Baltimore, Maryland)
ABSTRACT Compositions comprising a polymeric micellar nanoparticle composition comprising a block or graft copolymer comprising at least one polycationic polymer and at least one polyethylene glycol (PEG) polymer having an average molecular weight less than 1 kDa, and at least one nucleic acid, wherein the graft or block copolymer and at least one nucleic acid are complexed and condensed into a shaped micellar nanoparticle that is stable in biological media are disclosed. The presently disclosed subject matter also provides a method for preparing the presently disclosed polymeric micellar nanoparticle compositions, a method for targeting at least one metastatic cancer cell in a subject, and a method for treating a disease or condition using the presently disclosed polymeric micellar nanoparticle compositions.
FILED Wednesday, February 07, 2018
APPL NO 15/890771
ART UNIT 1633 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 45/06 (20130101)
A61K 47/59 (20170801)
A61K 47/60 (20170801)
A61K 47/62 (20170801)
A61K 47/64 (20170801)
A61K 47/6803 (20170801)
A61K 47/6935 (20170801)
A61K 48/0041 (20130101) Original (OR) Class

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/88 (20130101)
C12N 2810/855 (20130101)
C12N 2810/856 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235075 McMahon et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) THE JOHNS HOPKINS UNIVERSITY (Baltimore, Maryland);  KENNEDY KRIEGER INSTITUTE, INC. (Baltimore, Maryland);  NATIONAL INSTITUTES OF HEALTH (Bethesda, Maryland)
ASSIGNEE(S) THE JOHNS HOPKINS UNIVERSITY (Baltimore, Maryland);  KENNEDY KRIEGER INSTITUTE, INC. (Baltimore, Maryland);  NATIONAL INSTITUTES OF HEALTH (Bethesda, Maryland)
INVENTOR(S) Michael T. McMahon (Columbia, Maryland);  Kannie Wai-Yan Chan (Baltimore, Maryland);  Michael Christopher Giano (Frederick, Maryland);  Nikita Oskolkov (Reisterstown, Maryland);  Joel Patrick Schneider (Frederick, Maryland);  Xiaolei Song (Lutherville, Maryland)
ABSTRACT The present invention provides novel hydrogels through peptides, which are designed to self-assemble and produce magnetic resonance (MR) contrast through chemical exchange saturation transfer (CEST). The location and integrity of these gels could consequently be tracked using MR imaging. The self-assembly of the peptides into hydrogels can be brought about by a change in pH, ionic strength, temperature, and concentration of ions.
FILED Monday, April 28, 2014
APPL NO 14/787039
ART UNIT 1618 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 49/14 (20130101)
A61K 49/1803 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235076 Strong et al.
FUNDED BY
Department of Energy (DOE)
Lawrence Berkeley National Laboratory (LBNL)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Fred Hutchinson Cancer Research Center (Seattle, Washington);  The Regents of the University of California (Oakland, California)
ASSIGNEE(S) Fred Hutchinson Cancer Research Center (Seattle, Washington);  The Regents of the Universitv of California (Oakland, California)
INVENTOR(S) Roland K. Strong (Seattle, Washington);  Peter Rupert (Seattle, Washington);  Rebecca J. Abergel (Berkeley, California);  Ilya Captain (Moraga, California);  Gauthier J P Deblonde (Berkeley, California)
ABSTRACT Siderocalin-metal chelator combinations that bind metallic radioisotopes used in nuclear medicine with high affinity are described. The high affinity siderocalin-metal chelator combinations include a number of chelator backbone arrangements with functional groups that coordinate with metals. The siderocalin-metal chelator combinations can be used to deliver radionuclides for imaging and therapeutic purposes.
FILED Monday, August 28, 2017
APPL NO 16/329178
ART UNIT 1618 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 51/0478 (20130101)
A61K 51/0482 (20130101) Original (OR) Class

Separation
B01D 15/34 (20130101)
B01D 15/3804 (20130101)

Peptides
C07K 14/47 (20130101)

Production and Refining of Metals; Pretreatment of Raw Materials
C22B 60/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235141 Lucke et al.
FUNDED BY
Department of Health and Human Services (HHS)
U.S. Public Health Service (USPHS)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Minnetronix, Inc. (St. Paul, Minnesota)
ASSIGNEE(S) Minnetronix, Inc. (St. Paul, Minnesota)
INVENTOR(S) Lori Lucke (Rosemount, Minnesota);  Vlad Bluvshtein (Plymouth, Minnesota);  James Kurkowski (Roseville, Minnesota);  William Weiss (Mechanicsburg, Pennsylvania)
ABSTRACT Disclosed are systems and methods for use of an inductive link for a communication channel in a transcutaneous energy transfer system. An example system may include a resonant circuit associated with an external primary, a power transistor connected to the resonant circuit and configured to drive the resonant circuit with a first time-varying electrical signal having a frequency, and a power driver connected to the power transistor that is configured to set the frequency of the first time-varying electrical signal to a resonant frequency to enable power transfer from the external primary to an implanted secondary. The example system may further include a communication driver operatively connected to the power transistor and configured to encode the first time-varying electrical signal with a data signal by modulating an attribute of the time-varying electrical signal as electrical power is transferred from the external primary to the implanted secondary.
FILED Monday, September 09, 2019
APPL NO 16/564210
ART UNIT 3792 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 60/148 (20210101)
A61M 60/205 (20210101)
A61M 60/871 (20210101) Original (OR) Class

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 1/3727 (20130101)
A61N 1/3787 (20130101)
A61N 1/37223 (20130101)

Transmission
H04B 3/54 (20130101)
H04B 3/548 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235152 Beauchamp et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) Baylor College of Medicine (Houston, Texas)
ASSIGNEE(S) Baylor College of Medicine (Houston, Texas)
INVENTOR(S) Michael S. Beauchamp (Houston, Texas);  Daniel Yoshor (Houston, Texas);  William H. Bosking, III (Austin, Texas)
ABSTRACT One aspect of the invention provides a computer-implemented method of conveying a visual image to a blind subject fitted with a visual prosthesis. The computer-implemented method includes: mapping a representation of a visual image onto a two-dimensional array of points having a resolution greater than or equal to an electrode resolution of the visual prosthesis; identifying one or more continuous paths along the mapped representation; and controlling the visual prosthesis to sequentially actuate electrodes along the one or more paths. Another aspect of the invention provides a system including: a visual prosthesis comprising multiple electrodes; and an imaging processing device in communication with the visual prosthesis. The imaging processing device can be programmed to receive an image and perform any of the methods described herein.
FILED Tuesday, March 05, 2019
APPL NO 16/970804
ART UNIT 3792 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 1/0543 (20130101)
A61N 1/3787 (20130101)
A61N 1/36046 (20130101) Original (OR) Class
A61N 1/36167 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235177 Krishnaswamy et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) DOSEOPTICS LLC (Lebanon, New Hampshire);  Venkataramanan Krishnaswamy (Lebanon, New Hampshire);  Brian W. Pogue (Hanover, New Hampshire)
ASSIGNEE(S) DoseOptics LLC (Lebanon, New Hampshire)
INVENTOR(S) Venkataramanan Krishnaswamy (Lebanon, New Hampshire);  Brian W. Pogue (Hanover, New Hampshire)
ABSTRACT The present invention relates to advanced Cherenkov-based imaging systems, tools, and methods of feedback control, temporal control sequence image capture, and quantification in high resolution dose images. In particular, the present invention provides a system and method for simple, accurate, quick, robust, real-time, water-equivalent characterization of beams from LINACs and other systems producing external-therapy radiation for purposes including optimization, commissioning, routine quality auditing, R&D, and manufacture. The present invention also provides a system and method for rapid and economic characterization of complex radiation treatment plans prior to patient exposure. Further, the present invention also provides a system and method of economically detecting Cherenkov radiation emitted by tissue and other media in real-world clinical settings (e.g., settings illuminated by visible light).
FILED Monday, October 23, 2017
APPL NO 16/344139
ART UNIT 2881 — Optics
CURRENT CPC
Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 5/1067 (20130101)
A61N 5/1071 (20130101)
A61N 5/1075 (20130101) Original (OR) Class

Measurement of Nuclear or X-radiation
G01T 1/22 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235972 Gopalkrishnan et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Science Foundation (NSF)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
INVENTOR(S) Nikhil Gopalkrishnan (Jamaica Plain, Massachusetts);  Thomas E. Schaus (Arlington, Massachusetts);  Peng Yin (Brookline, Massachusetts)
ABSTRACT The present disclosure provides, in some aspects, methods and compositions for producing nucleic acid nanostructures having little to no kinetic barriers to self-assembly.
FILED Tuesday, April 11, 2017
APPL NO 16/092802
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Nanostructures Formed by Manipulation of Individual Atoms, Molecules, or Limited Collections of Atoms or Molecules as Discrete Units; Manufacture or Treatment Thereof
B82B 3/0042 (20130101) Original (OR) Class

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 40/00 (20130101)

Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids
C07H 21/04 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/10 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6811 (20130101)
C12Q 1/6811 (20130101)
C12Q 2563/155 (20130101)
C12Q 2563/155 (20130101)
C12Q 2563/157 (20130101)
C12Q 2563/157 (20130101)
C12Q 2565/133 (20130101)
C12Q 2565/133 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236051 Crew et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Arvinas Operations, Inc. (New Haven, Connecticut)
ASSIGNEE(S) Arvinas Operations, Inc. (New Haven, Connecticut)
INVENTOR(S) Andrew P. Crew (Guilford, Connecticut);  Kurt Zimmermann (Durham, Connecticut);  Hanqing Dong (Madison, Connecticut);  Lawrence B. Snyder (Killingworth, Connecticut)
ABSTRACT The present disclosure relates to bifunctional compounds, which find utility to degrade (and inhibit) Androgen Receptor. In particular, the present disclosure is directed to compounds, which contain on one end a cereblon ligand which binds to the E3 ubiquitin ligase and on the other end a moiety which binds Androgen Receptor, such that Androgen Receptor is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of Androgen Receptor. The present disclosure exhibits a broad range of pharmacological activities associated with compounds according to the present disclosure, consistent with the degradation/inhibition of Androgen Receptor.
FILED Friday, July 24, 2020
APPL NO 16/938864
ART UNIT 1626 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/02 (20130101)
A61K 31/166 (20130101)
A61K 31/277 (20130101)
A61K 31/496 (20130101)
A61K 31/497 (20130101)
A61K 31/501 (20130101)
A61K 31/506 (20130101)
A61K 45/06 (20130101)
A61K 47/10 (20130101)

Heterocyclic Compounds
C07D 205/04 (20130101)
C07D 209/48 (20130101)
C07D 211/76 (20130101)
C07D 213/72 (20130101)
C07D 221/20 (20130101)
C07D 231/12 (20130101)
C07D 233/42 (20130101) Original (OR) Class
C07D 237/08 (20130101)
C07D 239/24 (20130101)
C07D 241/04 (20130101)
C07D 401/04 (20130101)
C07D 401/14 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236053 Güner et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Emory University (Atlanta, Georgia);  Mercer University (Atlanta, Georgia);  Howard University (Washington, District of Columbia);  Union University (Jackson, Tennessee)
ASSIGNEE(S) Emory University (Atlanta, Georgia);  Mercer University (Atlanta, Georgia);  Howard University (Washington, District of Columbia);  Union University (Jackson, Tennessee)
INVENTOR(S) Osman Güner (Rohnert Park, California);  Bernard Lassegue (Decatur, Georgia);  Kathy Griendling (Stone Mountain, Georgia);  Qian Xu (Changsha, China PRC);  David Brown (Durham, North Carolina);  J. Phillip Bowen (Atlanta, Georgia);  Amol Kulkarni (Silver Spring, Maryland);  E. Blake Watkins (Jackson, Tennessee)
ABSTRACT This disclosure relates to compounds and methods of treating or preventing a Nox related disease or condition comprising administering to a subject in need thereof a Nox inhibitor or pharmaceutical compositions comprising a Nox inhibitor disclosed herein, derivatives, or compounds disclosed herein optionally substituted with one or more substitutes including optional salt and prodrug forms. In certain embodiments, this disclosure relates to sulfonylurea compounds and uses reported herein.
FILED Thursday, July 26, 2018
APPL NO 16/634567
ART UNIT 1626 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 213/50 (20130101)
C07D 213/65 (20130101)
C07D 215/14 (20130101)
C07D 239/26 (20130101) Original (OR) Class
C07D 307/54 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236074 Ridky et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (Philadelphia, Pennsylvania)
ASSIGNEE(S) THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (Philadelphia, Pennsylvania)
INVENTOR(S) Todd Ridky (Bryn Mawr, Pennsylvania);  Christopher Natale (Philadelphia, Pennsylvania)
ABSTRACT The present invention includes compounds, compositions comprising the same, and methods using the compounds and/or compositions therein, for modulating skin pigmentation in a mammalian subject. In certain embodiments, the compounds of the invention treat or prevent skin disorders or diseases associated with hyperpigmentation in the subject. In other embodiments, the compounds of the invention act as antagonist to the non-canonical sex steroid hormone receptor GPRE1 and do not bind to a canonical nuclear estrogen receptor (ER). In yet other embodiments, the compounds of the invention comprise acts as agonists to the non-canonical sex steroid hormone receptor PAQR7 and do not bind to a canonical nuclear progesterone receptor (PR).
FILED Wednesday, April 06, 2016
APPL NO 15/562725
ART UNIT 1615 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 8/49 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 17/00 (20180101)
A61P 17/06 (20180101)
A61P 17/14 (20180101)
A61P 17/16 (20180101)
A61P 17/18 (20180101)

Specific Use of Cosmetics or Similar Toilet Preparations
A61Q 17/04 (20130101)
A61Q 19/02 (20130101)

Heterocyclic Compounds
C07D 221/16 (20130101)
C07D 405/04 (20130101) Original (OR) Class
C07D 491/048 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236082 Bradner et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
ASSIGNEE(S) Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
INVENTOR(S) James E. Bradner (Weston, Massachusetts);  Jun Qi (Sharon, Massachusetts);  Kwok-kin Wong (Arlington, Massachusetts)
ABSTRACT The present disclosure provides compounds of any one of Formulae (I) and (II). The compounds described herein are inhibitors of histone methyltransferases (e.g., enhancer of zeste homolog 1 (EZH1) and enhancer of zeste homolog 2 (EZH2)) and are useful in treating and/or preventing a broad range of diseases (e.g., proliferative diseases). Also provided in the present disclosure are pharmaceutical compositions, kits, methods, and uses including or using a compound described herein. Further provided in the present disclosure are methods of identifying EZH1 and/or EZH2 inhibitors.
FILED Friday, November 06, 2015
APPL NO 15/524679
ART UNIT 1625 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 471/04 (20130101) Original (OR) Class
C07D 519/00 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5008 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236097 Mulcahy et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) SITEONE THERAPEUTICS, INC. (Bozeman, Montana);  THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford, California)
ASSIGNEE(S) SITEONE THERAPEUTICS, INC. (Bozeman, Montana);  THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford, California)
INVENTOR(S) John Mulcahy (Redwood City, California);  Hassan Pajouhesh (Mountain View, California);  George Miljanich (Redwood City, California);  Anton Delwig (Albany, California);  Jacob Beckley (Bozeman, Montana);  Grant Masaaki Shibuya (South San Francisco, California);  Justin Du Bois (Menlo Park, California)
ABSTRACT Provided herein are compounds, pharmaceutical compositions comprising the compounds, methods of preparing the compounds, and methods of using the compounds and compositions in treating conditions associated with voltage-gated sodium channel function where the compounds are 11,13-modified saxitoxins according to Formula (I): where R4, R4a, R7, R7a, and X2 are as described herein.
FILED Thursday, March 29, 2018
APPL NO 16/499205
ART UNIT 1626 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 487/14 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236122 Nitz et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) DFH THERAPEUTICS (Gaithersburg, Maryland);  The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland)
ASSIGNEE(S) DFH THERAPEUTICS (Gaithersburg, Maryland);  The United States Of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland)
INVENTOR(S) Theodore J. Nitz (Boyds, Maryland);  Carl T. Wild (Gaithersburg, Maryland);  David E. Martin (Shawnee, Oklahoma);  Eric O. Freed (Frederick, Maryland)
ABSTRACT The present invention concerns novel pharmaceutically active triterpene amine derivatives, pharmaceutical compositions containing the same, their use as medicaments, and the use of the compounds for the manufacture of specific medicaments. The present invention also concerns a method of treatment involving administration of the triterpene amine compounds. Specifically, the compounds are derivatives of betulinic acid having substitutions at one or more of the C-3, C-28 and C-19 positions as further described herein. The novel compounds are useful as antiretroviral agents. In particular, the novel compounds are useful for the treatment of Human Immunodeficiency Virus-1 (HIV-1).
FILED Friday, June 28, 2019
APPL NO 17/254189
ART UNIT 1625 — Organic Chemistry
CURRENT CPC
Steroids
C07J 63/008 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236134 Kong et al.
FUNDED BY
Department of Energy (DOE)
Argonne National Laboratory (ANL)
UChicago Argonne, LLC (UCHICAGO)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) The Scripps Research Institute (La Jolla, California)
ASSIGNEE(S) The Scripps Research Institute (La Jolla, California)
INVENTOR(S) Leopold Kong (Bethesda, Maryland);  Ian A. Wilson (La Jolla, California);  Natalia De Val (San Diego, California);  Andrew B. Ward (San Diego, California);  Dennis Burton (La Jolla, California);  Linling He (San Diego, California);  Jiang Zhu (San Diego, California)
ABSTRACT The present invention provides HIV-1 vaccine immunogens. Some of the immunogens contain a soluble gp140-derived protein that harbors a modified N-terminus of the HR1 region in gp41. Some of the immunogens contain an HIV-1 Env-derived trimer protein that is presented on a nanoparticle platform. The invention also provides methods of using the HIV-1 vaccine immunogens for eliciting an immune response or treating HIV infections.
FILED Monday, February 03, 2020
APPL NO 16/780495
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/12 (20130101)
A61K 39/21 (20130101)
A61K 47/64 (20170801)
A61K 47/6929 (20170801)
A61K 2039/645 (20130101)
A61K 2039/5258 (20130101)
A61K 2039/6031 (20130101)

Peptides
C07K 14/005 (20130101)
C07K 14/162 (20130101) Original (OR) Class

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 2740/16122 (20130101)
C12N 2740/16134 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236147 Ingber et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) CHILDREN'S MEDICAL CENTER CORPORATION (Boston, Massachusetts)
ASSIGNEE(S) CHILDREN'S MEDICAL CENTER CORPORATION (Boston, Massachusetts)
INVENTOR(S) Donald E. Ingber (Boston, Massachusetts);  Mariko Kobayashi (Brookline, Massachusetts)
ABSTRACT TRPV4 activation increases vascular permeability and can be triggered by both chemical and mechanical cues. This activation of TRPV4 can contribute to a number of pathological conditions, e.g., edema, inflammation, hypertension, and/or hyperalgesia. Described herein are methods and compositions relating to inhibition of mechanically-induced TRPV4 activation, e.g., for the treatment of pulmonary edema, edema, inflammation, hypertension, and/or hyperalgesia.
FILED Friday, July 13, 2018
APPL NO 16/034894
ART UNIT 1699 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Peptides
C07K 14/705 (20130101)
C07K 14/70596 (20130101) Original (OR) Class
C07K 2319/10 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236148 Raines et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
ASSIGNEE(S) WISCONSIN ALUMNI RESEARCH FOUNDATION (Madison, Wisconsin)
INVENTOR(S) Ronald T. Raines (Madison, Wisconsin);  Ismet Tanrikulu (Madison, Wisconsin)
ABSTRACT Novel synthetic human scale collagen triple helices assemblies are disclosed. Methods of making self-assembling collagen mimetic peptides that self-assemble into human scale collagen are also disclosed.
FILED Wednesday, June 14, 2017
APPL NO 15/622966
ART UNIT 1654 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Peptides
C07K 14/78 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236151 Bu et al.
FUNDED BY
Department of Defense (DOD)
Uniformed Services University of the Health Sciences (USUHS)
Henry M Jackson Foundation for the Advancement of Military Medicine, Inc (HJF)
Department of Health and Human Services (HHS)
APPLICANT(S) THE USA, as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland);  THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. (Bethesda, Maryland)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland);  The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (Bethesda, Maryland)
INVENTOR(S) Wei Bu (Potomac, North Dakota);  Masaru Kanekiyo (Chevy Chase, Maryland);  Michael Gordon Joyce (Washington, District of Columbia);  Jeffrey I. Cohen (Silver Spring, Maryland)
ABSTRACT Antibodies and compositions of matter useful for the detection, diagnosis and treatment of Epstein Barr Virus infection in mammals, and to methods of using those compositions of matter for the same. Also disclosed are proteins, referred to as anti-gp350 antibody probes, and anti-gp350 B-cell probes, that maintain the epitope structure of the CR2-binding region of gp350, but do not bind CR2.
FILED Wednesday, April 25, 2018
APPL NO 16/608386
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Peptides
C07K 14/05 (20130101)
C07K 16/085 (20130101) Original (OR) Class
C07K 2317/10 (20130101)
C07K 2317/21 (20130101)
C07K 2317/565 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236152 Kwong et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland);  The Trustees of Columbia University in the City of New York (New York, New York)
ASSIGNEE(S) The United States of America, as represented by the Sectetary, Department of Health and Human Services (Bethesda, Maryland);  The Trustees of Columbia University in the City of New York (New York, New York)
INVENTOR(S) Peter Kwong (Washington, District of Columbia);  Young Do Kwon (Kensington, Maryland);  Ivelin Georgiev (Nashville, Tennessee);  Gilad Ofek (Gaithersburg, Maryland);  Baoshan Zhang (Bethesda, Maryland);  Krisha McKee (Columbia, Maryland);  John Mascola (Rockville, Maryland);  Mark Connors (Bethesda, Maryland);  Gwo-Yu Chuang (Rockville, Maryland);  Sijy O'Dell (Silver Spring, Maryland);  Robert Bailer (Adamstown, Maryland);  Mark Louder (Mt. Airy, Maryland);  Mangaiarkarasi Asokan (Rockville, Maryland);  Richard Schwartz (Bethesda, Maryland);  Jonathan Cooper (Arlington, Virginia);  Kevin Carlton (Gaithersburg, Maryland);  Michael Bender (Washington, District of Columbia);  Amarendra Pegu (Potomac, Maryland);  Lawrence Shapiro (New York, New York);  Tatyana Gindin (New York, New York);  Lisa Kueltzo (Gaithersburg, Maryland)
ABSTRACT Neutralizing antibodies that specifically bind to HIV-1 Env and antigen binding fragments of these antibodies are disclosed. Nucleic acids encoding these antibodies, vectors and host cells are also provided. Methods for detecting HIV-1 using these antibodies are disclosed. In addition, the use of these antibodies, antigen binding fragment, nucleic acids and vectors to prevent and/or treat an HIV-1 infection is disclosed.
FILED Thursday, November 03, 2016
APPL NO 15/772443
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/18 (20180101)

Peptides
C07K 16/1063 (20130101) Original (OR) Class
C07K 2317/21 (20130101)
C07K 2317/31 (20130101)
C07K 2317/33 (20130101)
C07K 2317/52 (20130101)
C07K 2317/76 (20130101)
C07K 2317/92 (20130101)
C07K 2317/94 (20130101)
C07K 2317/565 (20130101)
C07K 2317/567 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236153 Grakoui et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Emory University (Atlanta, Georgia);  Rutgers, The State University of New Jersey (New Brunswick, New Jersey)
ASSIGNEE(S) Emory University (Atlanta, Georgia);  Rutgers, the State University of New Jersey (New Brunswick, New Jersey)
INVENTOR(S) Arash Grakoui (Decatur, Georgia);  Joseph Marcotrigiano (New Brunswick, New Jersey)
ABSTRACT The present disclosure relates to constructs useful in expressing biotinylated monomers and tetramers produced from these monomers. Specifically, the disclosure provides a construct useful in expressing biotinylated antigen monomers, said construct comprising a viral protein of an ectodomain of Hepatitis C Virus (HCV) envelope glycoprotein E2 or Human Immunodeficiency Virus (HIV) gp140. Further disclosed are methods for production and use of these tetramers in identifying and isolating antigen specific B cells and cloning antibodies thereto.
FILED Friday, September 22, 2017
APPL NO 16/335891
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Peptides
C07K 16/109 (20130101) Original (OR) Class
C07K 16/1063 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1006 (20130101)
C12N 2740/16122 (20130101)
C12N 2770/24222 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/686 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236161 Kochenderfer
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland)
INVENTOR(S) James N. Kochenderfer (Bethesda, Maryland)
ABSTRACT The invention is directed to a chimeric antigen receptor (CAR) directed against CD19, which comprises an amino acid sequence of any one of SEQ ID NO: 1-SEQ ID NO: 13. The invention also provides T-cells expressing the CAR and methods for destroying malignant B-cells.
FILED Thursday, March 21, 2019
APPL NO 16/360281
ART UNIT 1633 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 35/17 (20130101)

Peptides
C07K 14/705 (20130101)
C07K 14/7051 (20130101)
C07K 14/70517 (20130101)
C07K 14/70521 (20130101)
C07K 14/70535 (20130101)
C07K 14/70578 (20130101)
C07K 16/2803 (20130101) Original (OR) Class
C07K 16/3061 (20130101)
C07K 2317/21 (20130101)
C07K 2317/70 (20130101)
C07K 2317/622 (20130101)
C07K 2319/00 (20130101)
C07K 2319/02 (20130101)
C07K 2319/03 (20130101)
C07K 2319/33 (20130101)
C07K 2319/74 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 5/0636 (20130101)
C12N 2510/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236169 Ruiz-Opazo et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute on Aging (NIA)
APPLICANT(S) TRUSTEES OF BOSTON UNIVERSITY (Boston, Massachusetts)
ASSIGNEE(S) TRUSTEES OF BOSTON UNIVERSITY (Boston, Massachusetts)
INVENTOR(S) Nelson Ruiz-Opazo (Westwood, Massachusetts);  Victoria L. M. Herrera (Westwood, Massachusetts);  Francis Joseph Carr (Balmedie, United Kingdom)
ABSTRACT Provided herein are novel compositions comprising anti-DEspR antibodies and fragments thereof derived from 6G8G7 and 7C5B2 anti-DEspR variant antibodies, including fully human, composite engineered human, humanized, monoclonal, and polyclonal anti-DEspR antibodies and fragments thereof, and methods of their use in a variety of therapeutic applications. The compositions comprising the anti-DEspR antibodies and fragments thereof described herein are useful in diagnostic and imaging methods, such as DEspR-targeted molecular imaging of angiogenesis, and for companion diagnostic and/or in vivo non-invasive imaging and/or assessments.
FILED Thursday, January 31, 2019
APPL NO 16/263202
ART UNIT 1646 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 2039/505 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Peptides
C07K 16/2863 (20130101) Original (OR) Class
C07K 2317/21 (20130101)
C07K 2317/24 (20130101)
C07K 2317/34 (20130101)
C07K 2317/52 (20130101)
C07K 2317/53 (20130101)
C07K 2317/56 (20130101)
C07K 2317/76 (20130101)
C07K 2317/92 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236171 Dimitrov et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) The U.S.A., as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland)
INVENTOR(S) Dimiter S. Dimitrov (Frederick, Maryland);  Weizao Chen (Frederick, Maryland);  Terry J. Fry (Aurora, Colorado);  Christopher Chien (Falls Church, Virginia);  Haiying Qin (Bethesda, Maryland)
ABSTRACT Human monoclonal antibodies that specifically bind Fms-like tyrosine kinase 3 (FLT3) are described. Chimeric antigen receptors (CARs) and other antibody conjugates that include the FLT3-specific monoclonal antibodies are also described. Methods for the diagnosis and treatment of FLT3-associated cancer, such as acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML), are further described.
FILED Thursday, December 21, 2017
APPL NO 16/471485
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 47/6849 (20170801)
A61K 47/6929 (20170801)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)
A61P 35/02 (20180101)
A61P 35/04 (20180101)

Peptides
C07K 14/7051 (20130101)
C07K 14/70517 (20130101)
C07K 14/70578 (20130101)
C07K 16/468 (20130101)
C07K 16/2863 (20130101) Original (OR) Class
C07K 2317/21 (20130101)
C07K 2317/31 (20130101)
C07K 2317/76 (20130101)
C07K 2317/565 (20130101)
C07K 2317/622 (20130101)
C07K 2319/02 (20130101)
C07K 2319/03 (20130101)
C07K 2319/30 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/577 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236176 Reed
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) Translational Sciences Inc. (Memphis, Tennessee)
ASSIGNEE(S) Translational Sciences Inc. (Memphis, Tennessee)
INVENTOR(S) Guy L. Reed (Memphis, Tennessee)
ABSTRACT Compositions and methods of using SerpinF2-binding molecules for preventing and/or reducing organ damage, functional disability or mortality in a patient at risk due to the activity of SerpinF2 and/or plasminogen activators on tissue injury. Also provided are compositions and methods of using SerpinF2-binding molecules for inhibiting hemorrhage, edema, and apoptosis. Methods for the preparation of medicaments for such methods of treatment and prevention are provided.
FILED Thursday, March 06, 2014
APPL NO 14/198804
ART UNIT 1646 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 2039/505 (20130101)

Peptides
C07K 16/18 (20130101)
C07K 16/38 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236177 Tsourkas et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (Philadelphia, Pennsylvania)
ASSIGNEE(S) THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (Philadelphia, Pennsylvania)
INVENTOR(S) Andrew Tsourkas (Bryn Mawr, Pennsylvania);  Burcin Altun (Philadelphia, Pennsylvania);  Hejia Henry Wang (Philadelphia, Pennsylvania);  Feifan Yu (Aberdeen, New Jersey)
ABSTRACT The invention relates to proximity-based sortase-mediated protein purification and ligation. Specifically, the invention relates to techniques that links protein expression/purification with conjugation to therapeutic agents, imaging agents, or linkers.
FILED Thursday, September 14, 2017
APPL NO 16/333196
ART UNIT 1644 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Peptides
C07K 1/14 (20130101)
C07K 7/06 (20130101)
C07K 16/40 (20130101) Original (OR) Class
C07K 2317/622 (20130101)
C07K 2319/20 (20130101)
C07K 2319/21 (20130101)
C07K 2319/22 (20130101)
C07K 2319/70 (20130101)
C07K 2319/73 (20130101)
C07K 2319/92 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236326 McKnight
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) University of Oregon (Eugene, Oregon)
ASSIGNEE(S) University of Oregon (Eugene, Oregon)
INVENTOR(S) Jeffrey McKnight (Eugene, Oregon)
ABSTRACT Compositions and methods for assessing protein function are provided. A modified SpyCatcher protein that can include a tag is provided. Modified SpyCatcher proteins linked to a protein of interest, such as a nuclease are also provided. The methods include contacting a SpyCatcher protein and a SpyTagged protein to form a complex that may further include a protein of interest, one or more nucleic acids, and/or a nuclease. The methods can be used to purify a protein of interest or identify or target a protein binding site in a nucleic acid.
FILED Wednesday, June 24, 2020
APPL NO 16/910507
ART UNIT 1636 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Peptides
C07K 14/315 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/22 (20130101)
C12N 15/63 (20130101)
C12N 15/102 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236327 Konermann et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
APPLICANT(S) The Broad Institute, Inc. (Cambridge, Massachusetts);  Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) The Broad Institute, Inc. (Cambridge, Massachusetts);  Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Silvana Konermann (Cambridge, Massachusetts);  David Feldman (Cambridge, Massachusetts);  Feng Zhang (Cambridge, Massachusetts);  Paul Blainey (Cambridge, Massachusetts)
ABSTRACT The invention provides for use of CRISPR-Cas systems to sort barcoded cells or molecules. Cells or nucleic acid molecules may be sorted from a heterogenous population by targeting a barcode of interest specific for a cell or cell progeny or nucleic acid molecule of interest.
FILED Thursday, December 14, 2017
APPL NO 15/842315
ART UNIT 1636 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 9/22 (20130101)
C12N 9/96 (20130101)
C12N 15/11 (20130101)
C12N 15/907 (20130101)
C12N 15/1065 (20130101) Original (OR) Class
C12N 15/1065 (20130101)
C12N 15/1082 (20130101)
C12N 2310/20 (20170501)
C12N 2310/531 (20130101)
C12N 2740/15043 (20130101)
C12N 2750/14143 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 2563/179 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236330 Rigo et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Ionis Pharmaceuticals, Inc. (Carlsbad, California);  Cold Spring Harbor Laboratory (Cold Spring Harbor, New York)
ASSIGNEE(S) Ionis Pharmaceuticals, Inc. (Carlsbad, California);  Cold Spring Harbor Laboratory (Cold Spring Harbor, New York)
INVENTOR(S) Frank Rigo (Carlsbad, California);  C. Frank Bennett (Carlsbad, California);  Adrian R. Krainer (Huntington Station, New York);  Zhenxun Wang (Singapore, Singapore)
ABSTRACT The present invention provides compounds comprising oligonucleotides complementary to a pyruvate kinase M transcript. Certain such compounds are useful for hybridizing to a pyruvate kinase M transcript, including but not limited to a pyruvate kinase M transcript in a cell. In certain embodiments, such hybridization results in modulation of splicing of the pyruvate kinase M transcript. In certain embodiments, such compounds are used to treat one or more symptoms associated with cancer.
FILED Tuesday, October 02, 2018
APPL NO 16/149941
ART UNIT 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101) Original (OR) Class
C12N 15/1137 (20130101)
C12N 2310/11 (20130101)
C12N 2310/14 (20130101)

Enzymes
C12Y 207/0104 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236337 Ju et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) The Research Foundation for The State University of New York (Albany, New York)
ASSIGNEE(S) The Research Foundation for The State University of New York (Albany, New York)
INVENTOR(S) Jingfang Ju (East Setauket, New York);  Andrew Fesler (Sound Beach, New York);  Younghwa Song (Port Jefferson Station, New York);  Jun Chung (Setauket, New York)
ABSTRACT The present disclosure provides nucleic acid compositions that incorporate one or more halouracil molecules. More specifically, the present disclosure reveals that the replacement of uracil nucleotides within a microRNA nucleotide sequence with a 5-halouracil increases the ability of the micro-RNA to inhibit cancer progression and tumorigenesis. As such, the present disclosure provides various nucleic acid (e.g., microRNA) compositions having 5-halouracil molecules incorporated in their nucleic acid sequences and methods for using the same. The present disclosure further provides pharmaceutical compositions comprising the modified nucleic acid compositions, and methods for treating cancers using the same.
FILED Friday, June 26, 2020
APPL NO 16/912932
ART UNIT 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/04 (20180101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/113 (20130101) Original (OR) Class
C12N 2310/141 (20130101)
C12N 2310/335 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236340 Wyss-Coray et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Aging (NIA)
NIH Office of the Director (NIHOD)
APPLICANT(S) THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford, California);  THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (Washington, District of Columbia)
ASSIGNEE(S) THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford, California);  THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (Washington, District of Columbia)
INVENTOR(S) Anton Wyss-Coray (Palo Alto, California);  Thomas A. Rando (Stanford, California);  Markus Britschgi (Allscwil, Switzerland);  Kaspar Rufibach (Basel, Switzerland);  Saul A. Villeda (Lancaster, California)
ABSTRACT Methods of treating an adult mammal for an aging-associated impairment are provided. Aspects of the methods include modulating CCR3, e.g., by modulating eotaxin-1/CCR3 interaction, in the mammal in a manner sufficient to treat the mammal for the aging-associated impairment. A variety of aging-associated impairments may be treated by practice of the methods, which impairments include cognitive impairments.
FILED Tuesday, April 07, 2020
APPL NO 16/842054
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/00 (20130101)
A61K 31/7088 (20130101)
A61K 38/19 (20130101)
A61K 38/45 (20130101)
A61K 2039/505 (20130101)

Peptides
C07K 16/24 (20130101)
C07K 16/28 (20130101)
C07K 2317/76 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1138 (20130101) Original (OR) Class
C12N 2310/14 (20130101)
C12N 2799/06 (20130101)
C12N 2799/022 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6883 (20130101)
C12Q 2600/136 (20130101)
C12Q 2600/158 (20130101)

Enzymes
C12Y 207/10001 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236345 Coller et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) CASE WESTERN RESERVE UNIVERSITY (Cleveland, Ohio)
ASSIGNEE(S) CASE WESTERN RESERVE UNIVERSITY (Cleveland, Ohio)
INVENTOR(S) Jeffery M. Coller (Novelty, Ohio);  Kristian E. Baker (Novelty, Ohio)
ABSTRACT A synthetic nucleic acid which encodes a protein wherein at least one optimal or non-optimal codon in a wild type nucleic acid encoding the protein has been replaced respectively with one or more non-optimal codons or optimal codons encoding the same amino acid.
FILED Wednesday, March 09, 2016
APPL NO 15/557412
ART UNIT 1636 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/67 (20130101)
C12N 15/68 (20130101) Original (OR) Class
C12N 15/81 (20130101)
C12N 15/85 (20130101)
C12N 2800/22 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 21/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236359 Mali et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Human Genome Research Institute (NHGRI)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
INVENTOR(S) Prashant G. Mali (Somerville, Massachusetts);  George M. Church (Brookline, Massachusetts);  Luhan Yang (Somerville, Massachusetts)
ABSTRACT A method of altering a eukaryotic cell is provided including transfecting the eukaryotic cell with a nucleic acid encoding RNA complementary to genomic DNA of the eukaryotic cell, transfecting the eukaryotic cell with a nucleic acid encoding an enzyme that interacts with the RNA and cleaves the genomic DNA in a site specific manner, wherein the cell expresses the RNA and the enzyme, the RNA binds to complementary genomic DNA and the enzyme cleaves the genomic DNA in a site specific manner.
FILED Friday, February 12, 2016
APPL NO 15/042573
ART UNIT 1658 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/22 (20130101)
C12N 15/01 (20130101)
C12N 15/10 (20130101)
C12N 15/63 (20130101)
C12N 15/81 (20130101)
C12N 15/85 (20130101) Original (OR) Class
C12N 15/87 (20130101)
C12N 15/90 (20130101)
C12N 15/102 (20130101)
C12N 15/907 (20130101)
C12N 15/1024 (20130101)
C12N 15/8201 (20130101)
C12N 2310/20 (20170501)
C12N 2800/80 (20130101)
C12N 2810/55 (20130101)

Enzymes
C12Y 301/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236360 Schmidt
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
APPLICANT(S) Regents of the University of Minnesota (Minneapolis, Minnesota)
ASSIGNEE(S) Regents of the University of Minnesota (Minneapolis, Minnesota)
INVENTOR(S) Daniel Schmidt (Minneapolis, Minnesota)
ABSTRACT Methods to prepare recombinant adeno-associated virus (AAV) capsids with altered tropism and compositions having AAVs with altered tropism are provided.
FILED Friday, December 08, 2017
APPL NO 15/836345
ART UNIT 1633 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 48/0008 (20130101)

Peptides
C07K 14/00 (20130101)
C07K 14/005 (20130101)
C07K 14/46 (20130101)
C07K 14/43518 (20130101)
C07K 2319/02 (20130101)
C07K 2319/20 (20130101)
C07K 2319/21 (20130101)
C07K 2319/42 (20130101)
C07K 2319/55 (20130101)
C07K 2319/60 (20130101)
C07K 2319/70 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/86 (20130101) Original (OR) Class
C12N 15/1082 (20130101)
C12N 15/1093 (20130101)
C12N 2750/14122 (20130101)
C12N 2750/14145 (20130101)
C12N 2750/14151 (20130101)
C12N 2750/14171 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236383 Berman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Bio-Rad Laboratories, Inc. (Hercules, California);  J. David Gladstone Institutes (San Francisco, California)
ASSIGNEE(S) Bio-Rad Laboratories, Inc. (Hercules, California);  J. David Gladstone Institute (San Francisco, California)
INVENTOR(S) Jennifer Berman (San Carlos, California);  Samantha Cooper (Berkeley, California);  George Karlin-Neumann (Palo Alto, California);  Yuichiro Miyaoka (San Francisco, California);  Bruce Conklin (San Francisco, California);  Josh Shinoff (Emeryville, California)
ABSTRACT Methods, compositions, and kits are provided for quantification of genome editing.
FILED Wednesday, March 13, 2019
APPL NO 16/352600
ART UNIT 1637 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/63 (20130101)
C12N 15/102 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6809 (20130101)
C12Q 1/6809 (20130101)
C12Q 1/6827 (20130101) Original (OR) Class
C12Q 2537/143 (20130101)
C12Q 2563/159 (20130101)
C12Q 2565/101 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236389 Feldman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Temple University of the Commonwealth System of Higher Education (Philadelphia, Pennsylvania)
ASSIGNEE(S) TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (Philadelphia, Pennsylvania)
INVENTOR(S) Arthur M. Feldman (Wynnewood, Pennsylvania);  Douglas G. Tilley (Bryn Mawr, Pennsylvania);  Weizhong Zhu (Cockeysville, Maryland);  Kamel Khalili (Bala Cynwyd, Pennsylvania);  Walter J. Koch (Broomall, Pennsylvania)
ABSTRACT Compositions are directed to BCL2-associated athanogene 3 (BAG3) molecules and agents which modulate expression of BAG3 molecules. Pharmaceutical composition for administration to patients, for example, patients with heart failure, comprise one or more BAG3 molecules or agents which modulate expression of BAG3. Methods of treatment and identifying candidate therapeutic agents are also provided.
FILED Friday, January 30, 2015
APPL NO 15/115807
ART UNIT 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 48/00 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6883 (20130101) Original (OR) Class
C12Q 2600/106 (20130101)
C12Q 2600/156 (20130101)
C12Q 2600/158 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/6887 (20130101)
G01N 33/6893 (20130101)
G01N 2500/04 (20130101)
G01N 2500/10 (20130101)
G01N 2800/50 (20130101)
G01N 2800/325 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236393 Rotter et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) CEDARS-SINAI MEDICAL CENTER (Los Angeles, California)
ASSIGNEE(S) CEDARS-SINAI MEDICAL CENTER (Los Angeles, California)
INVENTOR(S) Jerome I. Rotter (Los Angeles, California);  Marla Dubinsky (Los Angeles, California);  Stephan R. Targan (Santa Monica, California);  Kent D. Taylor (Ventura, California)
ABSTRACT The present invention relates to methods of prognosing responsiveness to anti-TNFα therapy by determining the presence or absence of risk factors in the individual. In one embodiment, the risk factors are genetic markers, serological markers and/or clinical phenotypes associated with non-responsiveness to treatment with anti-TNFα therapy in an individual diagnosed with IBD.
FILED Monday, July 02, 2018
APPL NO 16/025769
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6883 (20130101) Original (OR) Class
C12Q 2600/106 (20130101)
C12Q 2600/156 (20130101)
C12Q 2600/172 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236395 Petrovics et al.
FUNDED BY
Department of Defense (DOD)
Uniformed Services University of the Health Sciences (USUHS)
Henry M Jackson Foundation for the Advancement of Military Medicine, Inc (HJF)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (Bethesda, Maryland)
ASSIGNEE(S) The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (Bethesda, Maryland)
INVENTOR(S) Gyorgy Petrovics (Bethesda, Maryland);  Shiv Srivastava (Potomac, Maryland)
ABSTRACT The present invention relates to oncogenes or tumor suppressor genes, as well as other genes, involved in prostate cancer and their expression products, as well as derivatives and analogs thereof. Provided are therapeutic compositions and methods of detecting and treating cancer, including prostate and other related cancers. Also provided are methods of diagnosing and/or prognosing prostate cancer by determining the expression level of at least one prostate cancer-cell-specific gene, including, for example, the ERG gene or the LTF gene alone, or in combination with at least one of the AMACR gene and the DD3 gene.
FILED Friday, May 11, 2018
APPL NO 15/977443
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Peptides
C07K 16/30 (20130101)
C07K 16/32 (20130101)
C07K 2317/33 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101) Original (OR) Class
C12Q 2600/112 (20130101)
C12Q 2600/118 (20130101)
C12Q 2600/158 (20130101)

Printed Circuits; Casings or Constructional Details of Electric Apparatus; Manufacture of Assemblages of Electrical Components
H05K 999/99 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236398 Glazko et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) BioVentures, LLC (Little Rock, Arkansas);  The United States As Represented By The Department of Veterans Affairs (Washington, District of Columbia)
ASSIGNEE(S) BioVentures, LLC (Little Rock, Arkansas);  The United States As Represented By The Department of Veterans Affairs (Washington, District of Columbia)
INVENTOR(S) Galina Glazko (Little Rock, Arkansas);  Curt H. Hagedorn (Little Rock, Arkansas);  Yasir Rahmatallah (Little Rock, Arkansas)
ABSTRACT The disclosure provides a method to detect sessile serrated adenomas/polyps (SSA/Ps) and to differentiate SSA/Ps from hyperplastic polyps (HPs). The method uses a molecular signature that is platform-independent and could be used with multiple platforms such as microarray, RNA-seq or real-time quantitative platforms.
FILED Thursday, March 01, 2018
APPL NO 16/489604
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101) Original (OR) Class
C12Q 2600/112 (20130101)
C12Q 2600/118 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 2800/7028 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236402 Schaffer et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) David V. Schaffer (Danville, California);  Ryan R. Klimczak (San Francisco, California);  James T. Koerber (San Francisco, California);  John G. Flannery (Berkeley, California);  Deniz Dalkara Mourot (Berkeley, California);  Meike Visel (El Cerrito, California);  Leah C. T. Byrne (Berkeley, California)
ABSTRACT The present disclosure provides adeno-associated virus (AAV) virions with altered capsid protein, where the AAV virions exhibit greater infectivity of retinal cells, when administered via intravitreal injection, compared to wild-type AAV. The present disclosure further provides methods of delivering a gene product to a retinal cell in an individual, and methods of treating ocular disease.
FILED Friday, December 21, 2018
APPL NO 16/230080
ART UNIT 1632 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 9/0048 (20130101)
A61K 38/1709 (20130101)
A61K 48/0008 (20130101)
A61K 48/0025 (20130101)
A61K 48/0075 (20130101)

Peptides
C07K 14/005 (20130101)
C07K 2319/33 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 15/86 (20130101)
C12N 15/113 (20130101)
C12N 15/115 (20130101)
C12N 2310/14 (20130101)
C12N 2310/16 (20130101)
C12N 2320/32 (20130101)
C12N 2750/14021 (20130101)
C12N 2750/14121 (20130101)
C12N 2750/14122 (20130101)
C12N 2750/14142 (20130101)
C12N 2750/14143 (20130101)
C12N 2750/14145 (20130101)
C12N 2750/14152 (20130101)
C12N 2810/40 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/70 (20130101)
C12Q 1/701 (20130101) Original (OR) Class
C12Q 2600/16 (20130101)
C12Q 2600/158 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5008 (20130101)
G01N 33/5058 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237111 Cheng et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Trustees of Boston University (Boston, Massachusetts)
ASSIGNEE(S) TRUSTEES OF BOSTON UNIVERSITY (Boston, Massachusetts)
INVENTOR(S) Ji-Xin Cheng (Newton, Massachusetts);  Haonan Lin (Allston, Massachusetts)
ABSTRACT Systems and methods implement of high-speed delay scanning for spectroscopic SRS imaging characterized by scanning a first pulsed beam across a stepwise reflective surface (such as a stepwise mirror or a reflective blazed grating) in a Littrow configuration to generate near continuous temporal delays relative to a second pulsed beam. Systems and methods also implement deep learning techniques for image restoration of spectroscopic SRS images using a trained encoder-decoder convolution neural network (CNN) which in some embodiments may be designed as a spatial-spectral residual net (SS-ResNet) characterized by two parallel filters including a first convolution filter on the spatial domain and a second convolution filter on the spectral domain.
FILED Friday, January 29, 2021
APPL NO 17/162455
ART UNIT 2664 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0075 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/65 (20130101) Original (OR) Class
G01N 2021/655 (20130101)

Computer Systems Based on Specific Computational Models
G06N 3/04 (20130101)
G06N 3/08 (20130101)

Image Data Processing or Generation, in General
G06T 5/001 (20130101)
G06T 2207/20081 (20130101)
G06T 2207/20084 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237131 Molho et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) ProteinSimple (Santa Clara, California)
ASSIGNEE(S) ProteinSimple (Santa Clara, California)
INVENTOR(S) Joshua I. Molho (Oakland, California);  Kelly Gardner (Berkeley, California);  Danh C. Tran (Hayward, California);  Eric Jabart (Berkeley, California);  David Nilson (Walnut Creek, California);  Yuri Kouchnir (Sunnyvale, California);  Michael Huston (San Jose, California);  Colin B. Kennedy (Greenbrae, California);  David John Roach (Los Gatos, California)
ABSTRACT A system for assaying a biological sample for a presence of a target analyte includes an assaying device and a computer controller. The assaying device includes a housing, a receptacle disposed in the housing, and a source of activation energy. The receptacle is configured to accept an electrophoresis cell. The electrophoresis cell has a recess area configured to accept a chip configured to accept the biological sample. The chip includes a polymeric separation medium with activatable functional groups that covalently bond to the target analyte when activated. The source of activation energy is configured to supply activation energy to activate the activatable functional groups. The computer controller is operably coupled to the source of activation energy and is configured to activate the source of activation energy to direct an application of activation energy to the polymeric separation medium to activate the activatable functional groups.
FILED Friday, May 20, 2016
APPL NO 15/160636
ART UNIT 1795 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/44704 (20130101)
G01N 27/44726 (20130101)
G01N 27/44739 (20130101)
G01N 27/44752 (20130101)
G01N 27/44756 (20130101)
G01N 27/44782 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237169 Hewitt et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) The United States of America, as represented by the Secretary, Dept. of Health and Human Services (Bethesda, Maryland)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland)
INVENTOR(S) Stephen M. Hewitt (Potomac, Maryland);  Joon-Yong Chung (Rockville, Maryland)
ABSTRACT Compositions, methods and kits are described for identifying biomolecules (e.g., proteins and nucleic acids) expressed in a biological sample that are associated with the presence, development, or progression of a disease (such as cancer), or more generally determination of the etiology or risk factors associated with a disease. Sample types analyzed by the disclosed methods include but are not limited to archival tissue blocks that have been preserved in a fixative, tissue biopsy samples, tissue microarrays, and so forth. The methods disclosed herein correlate expression profiles of biomolecules with various disease types, and allow for the determination of relative survival rates; in some embodiments, the methods permit determination of survival rates for a subject with cancer. In other embodiments, the disclosure relates to methods for evaluating therapeutic regimes for the treatment, such as treatment of cancer.
FILED Wednesday, December 12, 2018
APPL NO 16/217540
ART UNIT 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/582 (20130101)
G01N 33/57484 (20130101) Original (OR) Class
G01N 2800/60 (20130101)

Bioinformatics, i.e Information and Communication Technology [ICT] Specially Adapted for Genetic or Protein-related Data Processing in Computational Molecular Biology
G16B 25/10 (20190201)
G16B 99/00 (20190201)

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 50/20 (20180101)

Information and Communication Technology [ICT] Specially Adapted for Specific Application Fields, Not Otherwise Provided for
G16Z 99/00 (20190201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237233 Yan et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) VANDERBILT UNIVERSITY (Nashville, Tennessee)
ASSIGNEE(S) Vanderbilt University (Nashville, Tennessee)
INVENTOR(S) Xinqiang Yan (Nashville, Tennessee);  John C. Gore (Nashville, Tennessee);  William A. Grissom (Nashville, Tennessee)
ABSTRACT A self-decoupled RF coil and method for adjusting the same is disclosed. The RF coil is an array of elements including at least one loop. Electromagnetic coupling between elements in the array causes an induced current in the at least one loop. The induced current has two modes. A reactance inserted in the at least one loop balances the two modes. The balanced current modes cancel. This cancelation results in self-decoupling of at the least one loop from the other elements in the RF coil array.
FILED Wednesday, March 21, 2018
APPL NO 16/495135
ART UNIT 2866 — Printing/Measuring and Testing
CURRENT CPC
Measuring Electric Variables; Measuring Magnetic Variables
G01R 33/365 (20130101) Original (OR) Class
G01R 33/3415 (20130101)
G01R 33/3635 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11238956 Gilbert et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Florida State University Research Foundation, Inc. (Tallahassee, Florida)
ASSIGNEE(S) FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (Tallahassee, Florida)
INVENTOR(S) David M. Gilbert (Tallahassee, Florida);  Juan Carlos Rivera-Mulia (Tallahassee, Florida)
ABSTRACT Methods for identifying and classifying differences between biological samples are based on replication timing (RT) data. By comparing RT data for a test sample(s) to RT data for already characterized samples, one can identify differences and profile any new cell type or disease. These new methods allow for the detection of all the changes between distinct samples, many of which would escape detection by previous methods that discard any features showing any intra-sample variation.
FILED Tuesday, June 06, 2017
APPL NO 15/615069
ART UNIT 1631 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Bioinformatics, i.e Information and Communication Technology [ICT] Specially Adapted for Genetic or Protein-related Data Processing in Computational Molecular Biology
G16B 20/00 (20190201)
G16B 20/20 (20190201) Original (OR) Class
G16B 25/00 (20190201)
G16B 25/10 (20190201)
G16B 30/00 (20190201)
G16B 40/00 (20190201)
G16B 40/30 (20190201)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11238975 El-Baz et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) University of Louisville Research Foundation, Inc. (Louisville, Kentucky)
ASSIGNEE(S) University of Louisville Research Foundation, Inc. (Louisville, Kentucky)
INVENTOR(S) Ayman S. El-Baz (Louisville, Kentucky);  Amy Dwyer (Goshen, Kentucky);  Ahmed Soliman (Louisville, Kentucky);  Mohamed Shehata (Louisville, Kentucky);  Hisham Abdeltawab (Louisville, Kentucky);  Fahmi Khalifa (Louisville, Kentucky)
ABSTRACT A computer aided diagnostic system and automated method to classify a kidney utilizes medical image data and clinical biomarkers in evaluation of kidney function pre- and post-transplantation. The system receives image data from a medical scan that includes image data of a kidney, then segments kidney image data from other image data of the medical scan. The kidney is then classified by analyzing at least one feature determined from the kidney image data and the at least one clinical biomarker.
FILED Friday, February 22, 2019
APPL NO 16/282753
ART UNIT 2661 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/201 (20130101)
A61B 5/0261 (20130101)
A61B 5/0295 (20130101)
A61B 5/4848 (20130101)
A61B 5/7264 (20130101)
A61B 5/14546 (20130101)
A61B 2505/05 (20130101)
A61B 2576/02 (20130101)

Image Data Processing or Generation, in General
G06T 7/0012 (20130101)
G06T 7/12 (20170101)
G06T 7/33 (20170101)
G06T 7/143 (20170101)
G06T 2207/10088 (20130101)
G06T 2207/10096 (20130101)
G06T 2207/20081 (20130101)
G06T 2207/30084 (20130101)

Healthcare Informatics, i.e Information and Communication Technology [ICT] Specially Adapted for the Handling or Processing of Medical or Healthcare Data
G16H 30/20 (20180101)
G16H 30/40 (20180101) Original (OR) Class
G16H 50/20 (20180101)
G16H 50/30 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239065 Eberlin et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas)
ASSIGNEE(S) BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas)
INVENTOR(S) Livia Schiavinato Eberlin (Austin, Texas);  Thomas Milner (Austin, Texas);  Jialing Zhang (Austin, Texas);  John Lin (Austin, Texas);  John Rector (Austin, Texas);  Nitesh Katta (Austin, Texas);  Aydin Zahedivash (Austin, Texas)
ABSTRACT Method and devices are provided for assessing tissue samples from a plurality of tissue sites in a subject using molecular analysis. In certain aspects, devices of the embodiments allow for the collection of liquid tissue samples and delivery of the samples for mass spectrometry analysis.
FILED Monday, November 30, 2020
APPL NO 17/106445
ART UNIT 2881 — Optics
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 10/0045 (20130101)

Chemical or Physical Laboratory Apparatus for General Use
B01L 3/0293 (20130101)
B01L 3/502 (20130101)
B01L 2200/0605 (20130101)
B01L 2400/0655 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 1/02 (20130101)
G01N 30/72 (20130101)
G01N 33/487 (20130101)
G01N 33/574 (20130101)
G01N 33/6848 (20130101)
G01N 2001/028 (20130101)
G01N 2001/4061 (20130101)
G01N 2560/00 (20130101)

Electric Discharge Tubes or Discharge Lamps
H01J 49/04 (20130101)
H01J 49/0031 (20130101)
H01J 49/0431 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Defense (DOD) 

US 11234678 Huang et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Congressionally Directed Medical Research Programs (CDMRP)
Department of Energy (DOE)
Los Alamos National Laboratory (LANL)
Los Alamos National Security, LLC (LANS)
National Nuclear Security Administration (NNSA)
Triad National Security, LLC (Triad)
APPLICANT(S) Los Alamos National Security, LLC (Los Alamos, New Mexico)
ASSIGNEE(S) TRIAD NATIONAL SECURITY, LLC (Los Alamos, New Mexico)
INVENTOR(S) Lianjie Huang (Los Alamos, New Mexico);  Zhigang Zhang (Los Alamos, New Mexico)
ABSTRACT Ultrasound tomography imaging methods for imaging a tissue medium with one or more ultrasound transducer arrays comprising a plurality of transducers, wherein said transducers comprise source transducers, receiving transducers. The methods include assigning a phase value or time delay to source transducers, exciting the transducers and calculating a search direction based on data relating to the excited transducers.
FILED Wednesday, July 25, 2018
APPL NO 16/045279
ART UNIT 3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0073 (20130101)
A61B 5/7275 (20130101)
A61B 8/13 (20130101)
A61B 8/14 (20130101)
A61B 8/15 (20130101)
A61B 8/085 (20130101)
A61B 8/145 (20130101)
A61B 8/406 (20130101)
A61B 8/483 (20130101)
A61B 8/0825 (20130101)
A61B 8/4477 (20130101)
A61B 8/4488 (20130101)
A61B 8/4494 (20130101)
A61B 8/5207 (20130101) Original (OR) Class

Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 15/8915 (20130101)
G01S 15/8929 (20130101)
G01S 15/8997 (20130101)

Image Data Processing or Generation, in General
G06T 5/001 (20130101)
G06T 11/005 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11234998 McCarthy et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army
U.S. Army Medical Research and Development Command (USAMRDC)
U.S. Army Medical Materiel Development Activity (USAMMDA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
APPLICANT(S) Tricol Biomedical, Inc. (Portland, Oregon)
ASSIGNEE(S) Tricol Biomedical, Inc. (Portland, Oregon)
INVENTOR(S) Simon McCarthy (Portland, Oregon);  Barbara McGrath (Portland, Oregon);  Sam Kuhn (Portland, Oregon);  Jess Kimball (Portland, Oregon);  Michael Stolten (New Orleans, Louisiana);  Amanda Bennett (New Orleans, Louisiana)
ABSTRACT The present invention comprises chitosan materials and methods of using carbonic acid for aqueous solubilization of neutralized or pre-treated chitosan gels and provides, among other things, substantially acid salt free composition native final forms without requiring subsequent acid salt elution. The invention includes chitosan-based solid and semi-solid material forms, optionally reinforced with chitosan fibers, such as powders, fibers, films, matrices, sponges, implants, scaffolds, fillers, and hydrogels. Native final forms are produced from chitosan powder solubilized in an aqueous acidic solution, processed to form a high pH hydrated chitosan gel precipitate material that is then neutralized by water washing and re-solubilized substantially to chitosan solution using carbonic acid. Chitosan materials can be mixed in solution with one or more of other hydrophilic polymers to create compositional heterogeneity and pharmaceutical agents to achieve controlled release of the agent(s) from the final forms at the site of application.
FILED Tuesday, March 17, 2020
APPL NO 16/821459
ART UNIT 1623 — Organic Chemistry
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/19 (20130101)
A61K 9/70 (20130101)
A61K 9/1652 (20130101)
A61K 9/1694 (20130101)
A61K 31/722 (20130101) Original (OR) Class
A61K 47/12 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235043 Lyerly et al.
FUNDED BY
Department of Defense (DOD)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Duke University (Durham, North Carolina)
ASSIGNEE(S) Duke University (Durham, North Carolina)
INVENTOR(S) Herbert K. Lyerly (Durham, North Carolina);  Michael A. Morse (Durham, North Carolina);  Takuya Osada (Durham, North Carolina);  Timothy M. Clay (Waterloo, Belgium);  Zachary C. Hartman (Durham, North Carolina)
ABSTRACT Methods of reducing, the likelihood of a cancer or precancer developing resistance to a cancer therapeutic or prevention agent are provided herein. The methods include administering the cancer therapeutic or prevention agent and a vaccine comprising a polynucleotide encoding a polypeptide whose expression or activation is correlated with development of resistance of the cancer or precancer to the cancer therapeutic or prevention agent to a subject. The vaccine may include a polynucleotide encoding a HER3 polypeptide. Methods of using the vaccine including the polynucleotide encoding the HER3 polypeptide to treat a cancer or precancer are also provided.
FILED Wednesday, April 25, 2018
APPL NO 15/962824
ART UNIT 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/517 (20130101)
A61K 31/517 (20130101)
A61K 39/001106 (20180801) Original (OR) Class
A61K 39/3955 (20130101)
A61K 45/06 (20130101)
A61K 2039/53 (20130101)
A61K 2039/505 (20130101)
A61K 2039/507 (20130101)
A61K 2039/585 (20130101)
A61K 2039/5256 (20130101)
A61K 2300/00 (20130101)

Peptides
C07K 16/32 (20130101)
C07K 2317/73 (20130101)
C07K 2317/76 (20130101)
C07K 2317/77 (20130101)
C07K 2317/734 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235046 Brett et al.
FUNDED BY
Department of Defense (DOD)
Defense Threat Reduction Agency (DTRA)
APPLICANT(S) BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON BEHALF OF THE UNIVERSITY OF NEVADA (Reno, Nevada)
ASSIGNEE(S) Nevada Research and Innovation Corporation (Reno, Nevada)
INVENTOR(S) Paul J. Brett (Reno, Nevada);  Mary N. Burtnick (Reno, Nevada)
ABSTRACT Disclosed are capsular polysaccharide (CPS)-protein immunogenic conjugates useful for providing protection against any condition or disease associated with Burkholderia pseudomallei or Burkholderia mallei, such as melioidosis or glanders, respectively. For example, a disclosed CPS-protein immunogenic conjugate includes purified 6-deoxyheptan capsular polysaccharide (CPS) from B. pseudomallei chemically activated and covalently linked to recombinant CRM 197 diphtheria toxin mutant (CRM197) to produce CPS-CRM197. Methods of inducing an immune response are disclosed. The methods include the use of a CPS-protein immunogenic conjugate, alone or in conjunction with other agents, such as Hcp1 and TssM, to prevent infection with B. pseudomallei or B. mallei. Also disclosed are methods for treating a subject having melioidosis or glanders.
FILED Friday, November 02, 2018
APPL NO 16/760418
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/02 (20130101) Original (OR) Class
A61K 47/646 (20170801)
A61K 47/6415 (20170801)
A61K 2039/6037 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/04 (20180101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235183 Dashevsky et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Air Systems Command (NAVAIR)
APPLICANT(S) Orbital Research Inc. (Cleveland, Ohio)
ASSIGNEE(S) Orbital Research Inc. (Cleveland, Ohio)
INVENTOR(S) David Dashevsky (Cupertino, California);  Matthew Birch (Madison, Alabama);  Aaron T. Rood (Rocky River, Ohio);  Frederick J. Lisy (Euclid, Ohio)
ABSTRACT A wearable device for comprehensive bio-monitoring of physiologic metrics to determine metabolic, pulmonary and cardiac function and oxygen saturation measurements from breathing mask apparatuses. The device non-invasively monitors the physiologic profile of the subject, and is capable of detecting physiologic changes, predicting onset of symptoms, and alerting the wearer or another person or system. In some embodiments, the device comprises both a wearable sensor suite and a portable gas composition and flow analysis system. In preferred embodiments, it comprises a miniaturized non-invasive sensor suite for detecting physiologic changes to detect dangerous breathing or other health conditions. The acquired physiologic profile is used to generate alarms or warnings based on detectable physiological changes, to adjust gas delivery to the subject, alter mission profiles, or to transfer control of the craft or other duties away from a debilitated subject. The device is compact, portable, vehicle independent and non-encumbering to the subject.
FILED Tuesday, April 09, 2019
APPL NO 16/379173
ART UNIT 3785 — Body Treatment, Kinestherapy, and Exercising
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/486 (20130101)
A61B 5/0833 (20130101)
A61B 5/0836 (20130101)
A61B 5/6803 (20130101)
A61B 5/7225 (20130101)
A61B 5/7275 (20130101)
A61B 5/7278 (20130101)

Devices, Apparatus or Methods for Life-saving
A62B 7/14 (20130101)
A62B 9/006 (20130101) Original (OR) Class
A62B 18/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235291 Medina et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Secretary of the Army (SECARMY)
APPLICANT(S) United States of America as Represented by The Secretary of The Army (Alexandria, Virginia)
ASSIGNEE(S) UNITED STATES of AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (Alexandria, Virginia)
INVENTOR(S) Victor F Medina (Clinton, Mississippi);  Christopher S Griggs (Vicksburg, Mississippi);  Jose Mattei-Sosa (Vicksburg, Mississippi);  Brooke Petery (Schwenksville, Pennsylvania);  Luke Gurtowski (Vicksburg, Mississippi)
ABSTRACT A composition of five parts by mass of chitosan and one part graphene oxide is suspended in water. The composition may be used to form filtration layers of any size or shape and may be reinforced by additional layers. The composition may be used to construct a large filtration apparatus of any size or shape and may be used to form highly resilient, antimicrobial structures and surfaces for a variety of applications.
FILED Monday, March 23, 2020
APPL NO 16/826296
ART UNIT 1777 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Separation
B01D 63/10 (20130101)
B01D 67/0079 (20130101)
B01D 69/02 (20130101)
B01D 69/10 (20130101)
B01D 69/12 (20130101)
B01D 69/148 (20130101) Original (OR) Class
B01D 71/08 (20130101)
B01D 71/021 (20130101)
B01D 71/024 (20130101)
B01D 71/74 (20130101)
B01D 2319/06 (20130101)
B01D 2323/12 (20130101)
B01D 2323/30 (20130101)
B01D 2325/04 (20130101)

Treatment of Water, Waste Water, Sewage, or Sludge
C02F 1/44 (20130101)
C02F 1/441 (20130101)
C02F 2303/04 (20130101)
C02F 2303/20 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235894 Nevarez et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) THE BOEING COMPANY (Chicago, Illinois)
ASSIGNEE(S) THE BOEING COMPANY (Chicago, Illinois)
INVENTOR(S) Moises Nevarez (Long Beach, California);  Robert J. Perez (Huntington Beach, California);  Stephanie C. Klimczak (St. Louis, Missouri);  Jonathan D. Embler (Tustin, California)
ABSTRACT A method for building an aerodynamic structure, an aerodynamic structure, and a vehicle that includes the aerodynamic structure are provided. The method includes providing a structure with at least one substantially-flat exterior surface. The method also includes attaching blocks of rigid fibrous insulation to the at least one substantially-flat outer surface of the structure. Outward-facing surfaces of the blocks of rigid fibrous insulation extend past a target outer mold line of a final aerodynamic shape. The method also includes machining the outward-facing surfaces of the attached blocks to the outer mold line.
FILED Monday, December 16, 2019
APPL NO 16/715346
ART UNIT 3642 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Aeroplanes; Helicopters
B64C 1/12 (20130101)
B64C 1/40 (20130101)
B64C 3/26 (20130101)

Cosmonautics; Vehicles or Equipment Therefor
B64G 1/14 (20130101)
B64G 1/58 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235972 Gopalkrishnan et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Science Foundation (NSF)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
INVENTOR(S) Nikhil Gopalkrishnan (Jamaica Plain, Massachusetts);  Thomas E. Schaus (Arlington, Massachusetts);  Peng Yin (Brookline, Massachusetts)
ABSTRACT The present disclosure provides, in some aspects, methods and compositions for producing nucleic acid nanostructures having little to no kinetic barriers to self-assembly.
FILED Tuesday, April 11, 2017
APPL NO 16/092802
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Nanostructures Formed by Manipulation of Individual Atoms, Molecules, or Limited Collections of Atoms or Molecules as Discrete Units; Manufacture or Treatment Thereof
B82B 3/0042 (20130101) Original (OR) Class

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 40/00 (20130101)

Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids
C07H 21/04 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/10 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6811 (20130101)
C12Q 1/6811 (20130101)
C12Q 2563/155 (20130101)
C12Q 2563/155 (20130101)
C12Q 2563/157 (20130101)
C12Q 2563/157 (20130101)
C12Q 2565/133 (20130101)
C12Q 2565/133 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235977 Tse et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
APPLICANT(S) Rutgers, The State University of New Jersey (New Brunswick, New Jersey)
ASSIGNEE(S) RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (New Brunswick, New Jersey)
INVENTOR(S) Stephen D. Tse (Warren, New Jersey);  Hua Hong (Weehawken, New Jersey);  Bernard H. Kear (Whitehouse Station, New Jersey)
ABSTRACT Methods for the production of carbon-based and other nanostructures are provided.
FILED Friday, December 21, 2018
APPL NO 16/229055
ART UNIT 1736 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 40/00 (20130101)

Non-metallic Elements; Compounds Thereof;
C01B 32/184 (20170801) Original (OR) Class

Indexing Scheme Relating to Structural and Physical Aspects of Solid Inorganic Compounds
C01P 2002/52 (20130101)
C01P 2002/82 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236023 Whalen et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
United States Army (USA)
APPLICANT(S) HONEYWELL INTERNATIONAL INC. (Morris Plains, New Jersey)
ASSIGNEE(S) HONEYWELL INTERNATIONAL INC. (Charlotte, North Carolina)
INVENTOR(S) Terence Whalen (Morristown, New Jersey);  Bahram Jadidian (Watchung, New Jersey);  Reza Oboodi (Morris Plains, New Jersey)
ABSTRACT A method for forming a protective coating on a surface of a ceramic substrate includes combining a rare-earth oxide, alumina, and silica to form a powder, etching the surface of the ceramic substrate, applying the powder on the etched surface in an amount of from about 0.001 to about 0.1 g/cm2 to reduce capture of bubbles from off-gassing of the ceramic substrate, heating the powder for a time of from about 5 to about 60 minutes to a temperature at or above the melting point such that the powder melts and forms a molten coating on the surface that has a minimized number of bubbles, and cooling the molten coating to ambient temperature to form the protective coating disposed on and in direct contact with the surface of the ceramic substrate such that the protective coating has a thickness of less than about 1 mil.
FILED Wednesday, November 07, 2018
APPL NO 16/183276
ART UNIT 1796 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Chemical Composition of Glasses, Glazes or Vitreous Enamels; Surface Treatment of Glass; Surface Treatment of Fibres or Filaments Made From Glass, Minerals or Slags; Joining Glass to Glass or Other Materials
C03C 8/02 (20130101)
C03C 8/16 (20130101)
C03C 2209/00 (20130101)

Lime, Magnesia; Slag; Cements; Compositions Thereof, e.g Mortars, Concrete or Like Building Materials; Artificial Stone; Ceramics; Refractories; Treatment of Natural Stone
C04B 35/584 (20130101)
C04B 41/009 (20130101)
C04B 41/86 (20130101)
C04B 41/89 (20130101)
C04B 41/91 (20130101)
C04B 41/522 (20130101)
C04B 41/4523 (20130101)
C04B 41/5022 (20130101) Original (OR) Class
C04B 41/5353 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236149 Watters et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
APPLICANT(S) PRESIDENT AND FELLOWS OF HARVARD COLLEGE (Cambridge, Massachusetts)
ASSIGNEE(S) PRESIDENT AND FALLOWS OF HARVARD COLLEGE (Cambridge, Massachusetts)
INVENTOR(S) Alexander Watters (North Andover, Massachusetts);  Brendon Dusel (West Roxbury, Massachusetts);  Michael Super (Lexington, Massachusetts);  Mark Cartwright (West Newton, Massachusetts);  Donald E. Ingber (Boston, Massachusetts)
ABSTRACT Described herein are engineered microbe-targeting molecules, microbe-targeting articles, kits comprising the same, and uses thereof. Such microbe-targeting molecules, microbe-targeting articles, or the kits comprising the same can not only bind or capture of a microbe or microbial matter thereof, but they also have improved capability (e.g., enhanced sensitivity or signal intensity) of detecting a microbe or microbial matter. Thus, the microbe-targeting molecules, microbe-targeting articles, and/or the kit described herein can be used in various applications, e.g., but not limited to assays for detection of a microbe or microbial matter, diagnostic and/or therapeutic agents for diagnosis and/or treatment of an infection caused by microbes in a subject or any environmental surface, and/or devices for removal of a microbe or microbial matter from a fluid.
FILED Wednesday, May 20, 2020
APPL NO 16/879015
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Peptides
C07K 14/00 (20130101)
C07K 14/78 (20130101) Original (OR) Class
C07K 14/4726 (20130101)
C07K 19/00 (20130101)
C07K 2319/30 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/569 (20130101)
G01N 2333/78 (20130101)
G01N 2400/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236151 Bu et al.
FUNDED BY
Department of Defense (DOD)
Uniformed Services University of the Health Sciences (USUHS)
Henry M Jackson Foundation for the Advancement of Military Medicine, Inc (HJF)
Department of Health and Human Services (HHS)
APPLICANT(S) THE USA, as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland);  THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. (Bethesda, Maryland)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Maryland);  The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (Bethesda, Maryland)
INVENTOR(S) Wei Bu (Potomac, North Dakota);  Masaru Kanekiyo (Chevy Chase, Maryland);  Michael Gordon Joyce (Washington, District of Columbia);  Jeffrey I. Cohen (Silver Spring, Maryland)
ABSTRACT Antibodies and compositions of matter useful for the detection, diagnosis and treatment of Epstein Barr Virus infection in mammals, and to methods of using those compositions of matter for the same. Also disclosed are proteins, referred to as anti-gp350 antibody probes, and anti-gp350 B-cell probes, that maintain the epitope structure of the CR2-binding region of gp350, but do not bind CR2.
FILED Wednesday, April 25, 2018
APPL NO 16/608386
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Peptides
C07K 14/05 (20130101)
C07K 16/085 (20130101) Original (OR) Class
C07K 2317/10 (20130101)
C07K 2317/21 (20130101)
C07K 2317/565 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236370 Lynch et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
Office of Naval Research (ONR)
National Science Foundation (NSF)
APPLICANT(S) DUKE UNIVERSITY (Durham, North Carolina)
ASSIGNEE(S) DUKE UNIVERSITY (Durham, North Carolina)
INVENTOR(S) Michael David Lynch (Durham, North Carolina);  Zhixia Ye (Raleigh, North Carolina)
ABSTRACT The present disclosure provides compositions and methods for rapid production of chemicals in genetically engineered microorganisms in a large scale. Also provided herein is a high-throughput metabolic engineering platform enabling the rapid optimization of microbial production strains. The platform, which bridges a gap between current in vivo and in vitro bio-production approaches, relies on dynamic minimization of the active metabolic network.
FILED Wednesday, October 23, 2019
APPL NO 16/661010
ART UNIT 1652 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/001 (20130101)
C12N 9/0006 (20130101)
C12N 9/0008 (20130101)
C12N 9/0016 (20130101)
C12N 9/0051 (20130101)
C12N 9/1025 (20130101)
C12N 15/746 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 7/42 (20130101) Original (OR) Class
C12P 13/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236382 Connolly et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Research, Development and Engineering Command (RDECOM)
U.S. Army Medical Research and Materiel Command (USAMRMC)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Design, Manufacture, and Industrial Innovation (DMII)
Division of Industrial Innovation and Partnerships (IIP)
APPLICANT(S) Integrated Nano-Technologies, Inc. (Henrietta, New York)
ASSIGNEE(S) Integrated Nano-Technologies, LLC (Henrietta, New York)
INVENTOR(S) Dennis M. Connolly (Rochester, New York);  Tara Holz (Henrietta, New York);  Vera Tannous (Penfield, New York);  Christopher Kilcoin (Boulder Creek, California);  Konstantin Aptekarev (Santa Cruz, California);  David B. Bailey (Webster, New York);  Richard S. Murante (Henrietta, New York);  Nathaniel E. Wescott (West Henrietta, New York)
ABSTRACT A method for preparing a sample by utilizing a shearing force in the presence of a size stabilizer to break apart the sample to obtain nucleic acid molecules in a usable size range. Once nucleic acid molecules are obtained, magnetic nanoparticles are used to concentrate and clean the nucleic acid molecules for further testing.
FILED Friday, June 28, 2019
APPL NO 16/457602
ART UNIT 1798 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Chemical or Physical Laboratory Apparatus for General Use
B01L 3/502 (20130101)
B01L 2200/0631 (20130101)
B01L 2300/0681 (20130101)

Apparatus for Enzymology or Microbiology;
C12M 47/06 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 1/066 (20130101)
C12N 15/10 (20130101)
C12N 15/1013 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/02 (20130101)
C12Q 1/6806 (20130101)
C12Q 1/6825 (20130101) Original (OR) Class
C12Q 2531/113 (20130101)
C12Q 2563/107 (20130101)
C12Q 2563/143 (20130101)
C12Q 2565/629 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 1/286 (20130101)
G01N 2001/2866 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236395 Petrovics et al.
FUNDED BY
Department of Defense (DOD)
Uniformed Services University of the Health Sciences (USUHS)
Henry M Jackson Foundation for the Advancement of Military Medicine, Inc (HJF)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (Bethesda, Maryland)
ASSIGNEE(S) The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (Bethesda, Maryland)
INVENTOR(S) Gyorgy Petrovics (Bethesda, Maryland);  Shiv Srivastava (Potomac, Maryland)
ABSTRACT The present invention relates to oncogenes or tumor suppressor genes, as well as other genes, involved in prostate cancer and their expression products, as well as derivatives and analogs thereof. Provided are therapeutic compositions and methods of detecting and treating cancer, including prostate and other related cancers. Also provided are methods of diagnosing and/or prognosing prostate cancer by determining the expression level of at least one prostate cancer-cell-specific gene, including, for example, the ERG gene or the LTF gene alone, or in combination with at least one of the AMACR gene and the DD3 gene.
FILED Friday, May 11, 2018
APPL NO 15/977443
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Peptides
C07K 16/30 (20130101)
C07K 16/32 (20130101)
C07K 2317/33 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101) Original (OR) Class
C12Q 2600/112 (20130101)
C12Q 2600/118 (20130101)
C12Q 2600/158 (20130101)

Printed Circuits; Casings or Constructional Details of Electric Apparatus; Manufacture of Assemblages of Electrical Components
H05K 999/99 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236500 Peterson
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Civil Engineer Center (AFCEC)
APPLICANT(S) Folding Holdings, LLC (Bothell, Washington)
ASSIGNEE(S) Folding Holdings, LLC (Bothell, Washington)
INVENTOR(S) Elliot Peterson (Bothell, Washington)
ABSTRACT A built-up beam includes a pair of I-beams each having opposing flanges, a web that extends between the opposing flanges, a plurality of flange openings in each of the opposing flanges, a plurality of web openings in the web, and a plurality of bolt holes in one of the opposing flanges. The I-beams are stacked together flange-to-flange in a stacked beam configuration and a plurality of bolts extend through the plurality of bolt holes and secure the pair of I-beams together in the stacked beam configuration.
FILED Wednesday, April 29, 2020
APPL NO 16/862411
ART UNIT 3726 — Manufacturing Devices & Processes, Machine Tools & Hand Tools Group Art Units
CURRENT CPC
Metal-working Not Otherwise Provided For; Combined Operations; Universal Machine Tools
B23P 13/02 (20130101)
B23P 15/00 (20130101)

General Building Constructions; Walls, e.g Partitions; Roofs; Floors; Ceilings; Insulation or Other Protection of Buildings
E04B 1/19 (20130101) Original (OR) Class

Structural Elements; Building Materials
E04C 3/04 (20130101)
E04C 3/14 (20130101)
E04C 2003/0413 (20130101)
E04C 2003/0452 (20130101)
E04C 2003/0465 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 29/49364 (20150115)
Y10T 29/49963 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236791 Nguyen et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Sea Systems Command (NAVSEA)
APPLICANT(S) Raytheon Company (Waltham, Massachusetts)
ASSIGNEE(S) Raytheon Company (Waltham, Massachusetts)
INVENTOR(S) Ly Dinh Nguyen (Cypress, Texas);  Stevie Alejandro (Sahuarita, Arizona)
ABSTRACT An energy damping and displacement control device is disclosed. The energy damping and displacement control device can include a contact protrusion and an energy damping pad constructed of a resilient material. The energy damping pad can have a first face oriented along a first plane. The energy damping pad can also have a second face oriented along a second plane transverse to the first plane, and toward the contact protrusion. In a static condition, the first and second faces of the energy damping pad can be separated from the contact protrusion. In a dynamic condition, displacement motion of the contact protrusion relative to the energy damping pad can be limited by contact with at least one of the first or second faces of the energy damping pad, which provides energy damping and motion displacement control of the contact protrusion in multiple axes.
FILED Friday, October 18, 2019
APPL NO 16/657859
ART UNIT 3657 — Material and Article Handling
CURRENT CPC
Springs; Shock-absorbers; Means for Damping Vibration
F16F 1/065 (20130101) Original (OR) Class
F16F 1/374 (20130101)
F16F 15/085 (20130101)
F16F 2230/007 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236955 Monacchio et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
United States Air Force (USAF)
APPLICANT(S) Hamilton Sundstrand Corporation (Charlotte, North Carolina)
ASSIGNEE(S) HAMILTON SUNDSTRAND CORPORATION (Charlotte, North Carolina)
INVENTOR(S) John D. Monacchio (Windsor Locks, Connecticut);  Eric Chrabascz (Longmeadow, Massachusetts);  Luke J. Mayo (Coventry, Connecticut);  John H. Whiton (South Windsor, Connecticut);  Robert H. Dold (Monson, Massachusetts);  Christopher Adriaan van Oss (Wethersfield, Connecticut);  Usman Khan (South Windsor, Connecticut)
ABSTRACT An outlet manifold is provided and includes an outlet portion having first and second sides and an inlet portion to which the outlet portion is fluidly coupled. The inlet portion has first and second sides corresponding to the first and second sides of the outlet portion. Each of the first and second sides of the inlet portion includes one or more tubular members connectable with corresponding tube joints and a mixing chamber fluidly interposed between each of the one or more tubular members and the outlet portion.
FILED Tuesday, December 29, 2020
APPL NO 17/136694
ART UNIT 3746 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Gas-flow Silencers or Exhaust Apparatus for Machines or Engines in General; Gas-flow Silencers or Exhaust Apparatus for Internal Combustion Engines
F01N 13/06 (20130101)
F01N 13/10 (20130101)
F01N 13/107 (20130101)

Details of Heat-exchange and Heat-transfer Apparatus, of General Application
F28F 9/0275 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237089 Lin et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Air Systems Command (NAVAIR)
U.S. Navy
APPLICANT(S) Hai Lin (Rancho Cucamonga, California);  Gregor Arthur Waldherr (Rancho Cucamonga, California)
ASSIGNEE(S) Hal Technology, LLC (Fontana, California)
INVENTOR(S) Hai Lin (Rancho Cucamonga, California);  Gregor Arthur Waldherr (Rancho Cucamonga, California)
ABSTRACT Disclosed herein is a novel, compact, real time optical particle identification and characterization system and method of use within both gaseous and liquid media. The system can implement elastic and/or inelastic light scattering techniques simultaneously and complimentarily under the same sensor platform. By separating the sensing components from the electro-optical unit and using optical fibers for interconnection, only the sensing components need to be exposed to the environmental conditions. This reduces the design constraints on the electro-optical unit and permits the incorporation of optical components into the sensor probe that can withstand high-temperature, high-pressure, and corrosive environments. Thus, the system can be used in benign, moderate, and harsh environments.
FILED Friday, February 08, 2019
APPL NO 16/271755
ART UNIT 2877 — Optics
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 15/0205 (20130101) Original (OR) Class
G01N 2015/1087 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237091 Hering et al.
FUNDED BY
Department of Defense (DOD)
Defense Threat Reduction Agency (DTRA)
APPLICANT(S) Aerosol Dynamics Inc. (Berkeley, California)
ASSIGNEE(S) Aerosol Dynamics Inc. (Berkeley, California)
INVENTOR(S) Susanne Vera Hering (Berkeley, California);  Arantzazu Eiguren Fernandez (Richmond, California);  Gregory Stephen Lewis (Berkeley, California);  Steven Russel Spielman (Oakland, California);  Philip Bourgeois (Woodside, California)
ABSTRACT A particle growth apparatus includes a temperature-controlled humidifier coupled to a water-based condensation growth system. The humidifier may include a tube of sulfonated tetrafluoroethylene-based fluoropolymer-copolymer and surrounded by a region containing water or water vapor. The apparatus includes a wetted wick and wick sensor in the condensation growth system, configured such that the gas sample flows through the sulfonated tetrafluoroethylene-based fluoropolymer-copolymer tube into the condensation growth system.
FILED Friday, November 01, 2019
APPL NO 16/671594
ART UNIT 1776 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Air-conditioning; Air-humidification; Ventilation; Use of Air Currents for Screening
F24F 6/043 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 15/065 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237143 Gregory et al.
FUNDED BY
Department of Homeland Security (DHS)
Science and Technology Directorate (DHS-S&T)
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Materiel Command (AFMC)
Air Force Office of Scientific Research (AFOSR)
MIT Lincoln Laboratory (MITLL)
Under Secretary of Defense for Research and Engineering (USDR&E)
APPLICANT(S) Massachusetts Institute Of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute Of Technology (Cambridge, Massachusetts)
INVENTOR(S) Kerin E. Gregory (Bolton, Massachusetts);  Roderick R. Kunz (Acton, Massachusetts);  Michael Sworin (Marlboro, Massachusetts)
ABSTRACT Reagents and methods are disclosed for detection of oxidizers and inorganic salts and other analytes of interest. The reagents can interact with their target analytes, especially oxidizer compositions or oxidizer-based explosives, to selectively enhance their ionization yield, interacting by chemical reaction or by forming an associative adduct which facilitates their detection. For example, the reagents can adduct with the counter-ion of the intended analyte for improved direct detection and/or react chemically via acid-base reactions to produce a new product for detection. In another aspect of the invention, reactive reagents and methods are also disclosed that facilitate indirect detection of the analyte at lower temperatures based on reduction-oxidation (redox) chemistry. These reagents are particularly useful in detecting oxidizer analytes.
FILED Friday, February 17, 2017
APPL NO 15/435733
ART UNIT 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/622 (20130101)
G01N 31/227 (20130101)
G01N 33/227 (20130101) Original (OR) Class
G01N 2001/028 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 436/19 (20150115)
Y10T 436/24 (20150115)
Y10T 436/141111 (20150115)
Y10T 436/143333 (20150115)
Y10T 436/173076 (20150115)
Y10T 436/206664 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237171 Walt et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) Trustees of Tufts College (Medford, Massachusetts)
ASSIGNEE(S) TRUSTEES OF TUFTS COLLEGE (Medford, Massachusetts)
INVENTOR(S) David R. Walt (Boston, Massachusetts);  David M. Rissin (Somerville, Massachusetts)
ABSTRACT Arrays of single molecules and methods of producing an array of single molecules are described. Arrays with defined volumes between 10 attoliters and 50 picoliters enable single molecule detection and quantitation.
FILED Wednesday, February 27, 2019
APPL NO 16/286811
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6837 (20130101)
C12Q 1/6837 (20130101)
C12Q 2527/143 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/543 (20130101)
G01N 33/581 (20130101) Original (OR) Class
G01N 33/54346 (20130101)
G01N 33/54366 (20130101)
G01N 33/54386 (20130101)
G01N 2333/938 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237327 Meade
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Micron Technology, Inc. (Boise, Idaho)
ASSIGNEE(S) Micron Technology, Inc. (Boise, Idaho)
INVENTOR(S) Roy E. Meade (Oakland, California)
ABSTRACT Disclosed are a method and structure providing a silicon-on-insulator substrate on which photonic devices are formed and in which a core material of a waveguide is optically decoupled from a support substrate by a shallow trench isolation region.
FILED Friday, August 16, 2019
APPL NO 16/543446
ART UNIT 2874 — Optics
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 6/122 (20130101)
G02B 6/136 (20130101) Original (OR) Class
G02B 2006/12061 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 21/84 (20130101)
H01L 21/76283 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237337 Ruffa
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Secretary of the Navy (SECNAV)
APPLICANT(S) The United States of America as represented by the Secretary of the Navy (Newport, Rhode Island)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Navy (, None)
INVENTOR(S) Anthony A Ruffa (Hope Valley, Rhode Island)
ABSTRACT A non-rotary joint for connecting a static component to a rotatable component includes an adapter on a rotatable part. A motor is joined to rotate the rotatable part. A connector is joined to the static component. The connector can be moved by an actuator from a first position joined with the adapter to a second position positioned away from the adapter. A controller is joined to control the motor and the actuator. The controller signals the actuator to move to the second position when the motor is activated and signals the actuator to move to the first position when said motor is deactivated. In a practical embodiment, the non-rotary joint makes a connection between a static signal carrier and a cable on a winch drum.
FILED Wednesday, October 21, 2020
APPL NO 17/075796
ART UNIT 2883 — Optics
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 6/3604 (20130101) Original (OR) Class
G02B 6/3825 (20130101)

Installation of Electric Cables or Lines, or of Combined Optical and Electric Cables or Lines
H02G 1/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237344 Vermeulen et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Analog Photonics LLC (Boston, Massachusetts)
ASSIGNEE(S) Analog Photonics LLC (Boston, Massachusetts)
INVENTOR(S) Diedrik Vermeulen (Boston, Massachusetts);  Ehsan Shah Hosseini (Milton, Massachusetts);  Michael J. Whitson (Salem, Massachusetts)
ABSTRACT A first photonic die has a first coupling edge and a first die surface, and comprises: a first waveguide extending in proximity to the first coupling edge; a portion of the first die surface forming an alignment edge substantially parallel to the first waveguide; and a first alignment feature etched into or formed adjacent to the first coupling edge. A second photonic die has a second coupling edge and a second die surface, and comprises: a second waveguide extending in proximity to the second coupling edge; a portion of the second die surface configured to form a receptacle sized to constrain a position of the alignment edge; and a second alignment feature etched into or formed adjacent to the second coupling edge and configured to enable alignment with the first alignment feature when the first photonic die and the second photonic die are substantially aligned with each other.
FILED Wednesday, March 11, 2020
APPL NO 16/815655
ART UNIT 2883 — Optics
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 6/4206 (20130101)
G02B 6/4214 (20130101)
G02B 6/4232 (20130101) Original (OR) Class
G02B 6/4238 (20130101)
G02B 6/4274 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237370 Han et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
National Science Foundation (NSF)
APPLICANT(S) University of Central Florida Research Foundation, Inc. (Orlando, Florida)
ASSIGNEE(S) UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (Orlando, Florida)
INVENTOR(S) Kyu Young Han (Orlando, Florida);  Jialei Tang (Oviedo, Florida)
ABSTRACT A dual inclined beam line-scanning confocal microscope apparatus, associated method, and applications thereof. An embodied dual-inclined beam line-scanning confocal microscope (2iLS) utilizes dual, parallel excitation beams each having a focused line shape that are scanned over a fluorescent sample. The emitted fluorescence from the sample is spatially filtered and detected by an array detector. 2iLS microscopy provides high resolution, ultrasensitivity, and deep optical sectioning capability. A reduced excitation intensity lowers photobleaching and photodamage.
FILED Tuesday, April 30, 2019
APPL NO 16/398630
ART UNIT 2884 — Optics
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/6458 (20130101)

Optical Elements, Systems, or Apparatus
G02B 21/02 (20130101)
G02B 21/008 (20130101)
G02B 21/0032 (20130101)
G02B 21/0036 (20130101)
G02B 21/36 (20130101)
G02B 21/0048 (20130101)
G02B 21/0076 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237454 Carolan et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
U.S. Air Force
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Jacques Johannes Carolan (Cambridge, Massachusetts);  Uttara Chakraborty (Cambridge, Massachusetts);  Nicholas C. Harris (Boston, Massachusetts);  Mihir Pant (Mountain View, California);  Dirk Robert Englund (Brookline, Massachusetts)
ABSTRACT Typically, quantum systems are very sensitive to environmental fluctuations, and diagnosing errors via measurements causes unavoidable perturbations. Here, an in situ frequency-locking technique monitors and corrects frequency variations in single-photon sources based on resonators. By using the classical laser fields used for photon generation as probes to diagnose variations in the resonator frequency, the system applies feedback control to correct photon frequency errors in parallel to the optical quantum computation without disturbing the physical qubit. Our technique can be implemented on a silicon photonic device and with sub 1 pm frequency stabilization in the presence of applied environmental noise, corresponding to a fractional frequency drift of <1% of a photon linewidth. These methods can be used for feedback-controlled quantum state engineering. By distributing a single local oscillator across a one or more chips, our approach enables frequency locking of many single photon sources for large-scale photonic quantum technologies.
FILED Tuesday, November 12, 2019
APPL NO 16/680908
ART UNIT 2828 — Semiconductors/Memory
CURRENT CPC
Devices or Arrangements, the Optical Operation of Which Is Modified by Changing the Optical Properties of the Medium of the Devices or Arrangements for the Control of the Intensity, Colour, Phase, Polarisation or Direction of Light, e.g Switching, Gating, Modulating or Demodulating; Techniques or Procedures for the Operation Thereof; Frequency-changing; Non-linear Optics; Optical Logic Elements; Optical Analogue/digital Converters
G02F 1/365 (20130101)
G02F 1/3501 (20130101) Original (OR) Class
G02F 1/3551 (20130101)
G02F 2201/06 (20130101)
G02F 2202/20 (20130101)
G02F 2202/101 (20130101)
G02F 2203/50 (20130101)

Devices Using the Process of Light Amplification by Stimulated Emission of Radiation [LASER] to Amplify or Generate Light; Devices Using Stimulated Emission of Electromagnetic Radiation in Wave Ranges Other Than Optical
H01S 3/13 (20130101)
H01S 3/23 (20130101)
H01S 3/083 (20130101)
H01S 3/1628 (20130101)
H01S 3/1671 (20130101)
H01S 3/06791 (20130101)
H01S 3/08018 (20130101)
H01S 3/094003 (20130101)
H01S 3/094096 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237551 Holden et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Secretary of the Navy (SECNAV)
APPLICANT(S) Daniel P. Holden (Fredericksburg, Virginia);  Sean R. Chapin (Richmond, Virginia);  Lynda R. Hester (Fredericksburg, Virginia);  Victoria Snyder (Fredericksburg, Virginia)
ASSIGNEE(S) United States of America, as represented by the Secretary of the Navy (Arlington, Virginia)
INVENTOR(S) Daniel P. Holden (Fredericksburg, Virginia);  Sean R. Chapin (Richmond, Virginia);  Lynda R. Hester (Fredericksburg, Virginia);  Victoria Snyder (Fredericksburg, Virginia)
ABSTRACT A computer-implemented system is provided for monitoring an electro-mechanical device. The system includes a sensor, a data acquisition receiver, and an analysis processor. The sensor measures a parameter of the device as an analog signal. The data acquisition receiver converts the analog signal into a digital signal. The analysis processor assigns the signal data to a condition state responsive to an action mode to control the device. The system is intended for automated implementation in real-time.
FILED Tuesday, February 12, 2019
APPL NO 16/273756
ART UNIT 2864 — Printing/Measuring and Testing
CURRENT CPC
Control or Regulating Systems in General; Functional Elements of Such Systems; Monitoring or Testing Arrangements for Such Systems or Elements
G05B 19/0428 (20130101)
G05B 23/0283 (20130101)
G05B 23/0291 (20130101) Original (OR) Class

Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/6265 (20130101)

Computer Systems Based on Specific Computational Models
G06N 7/005 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237616 Shah et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Parth Sanjaybhai Shah (Bangalore, India);  Ranjal Gautham Shenoy (Bangalore, India);  Vaidyanathan Srinivasan (Bangalore, India);  Alper Buyuktosunoglu (White Plains, New York);  Augusto Vega (Mount Vernon, New York);  Pradip Bose (Yorktown Heights, New York)
ABSTRACT A method, computer program product, and/or system associates a number of tokens with a plurality of frequency domains (for example, cores) of a central processing unit (CPU) computer chip. The number of tokens allotted to the CPU is based on the CPU power budget. Cores are organized as a ring topology. A token pool traverses the ring, picks up excess tokens from cores having excess tokens, and gives the tokens to cores that need additional tokens. Tokens acquired by a core allows the core to increase operating frequency by an increment represented by the tokens. Consequently, power usage is weighted toward heavily loaded cores and away from lightly loaded cores. Overall power usage of the CPU remains within a power budget. The method budgets power optimally to sustain turbo frequencies for longer durations by not allowing control units to increase frequency in absence of any useful high frequency benefiting workload.
FILED Monday, July 27, 2020
APPL NO 16/940171
ART UNIT 2186 — Computer Architecture and I/O
CURRENT CPC
Electric Digital Data Processing
G06F 1/263 (20130101)
G06F 1/324 (20130101) Original (OR) Class
G06F 1/3237 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237933 Riabov et al.
FUNDED BY
Department of Defense (DOD)
National Security Agency (NSA)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
INVENTOR(S) Anton V. Riabov (Ann Arbor, Michigan);  Shirin Sohrabi Araghi (Port Chester, New York);  Octavian Udrea (Ossining, New York)
ABSTRACT Techniques for solving a multi-agent plan recognition problem are provided. In one example, a computer-implemented method comprises transforming, by a device operatively coupled to a processor, a problem model and an at least partially ordered sequence of observations into an artificial intelligence planning problem through a transform algorithm. The problem model can comprises a domain description from a plurality of agents and a durative action. Furthermore, at least one of the observations of the at least partially ordered sequence of observations can be a condition that changes over time. The computer-implemented method further comprises determining, by the device, plan information using an artificial intelligence planner on the artificial intelligence planning problem. The computer-implemented method further comprises translating, by the device, the plan information into information indicative of a solution to the artificial intelligence planning problem.
FILED Thursday, December 14, 2017
APPL NO 15/842449
ART UNIT 2488 — Recording and Compression
CURRENT CPC
Electric Digital Data Processing
G06F 9/4862 (20130101)
G06F 11/302 (20130101) Original (OR) Class
G06F 11/3006 (20130101)
G06F 11/3438 (20130101)
G06F 16/951 (20190101)

Computer Systems Based on Specific Computational Models
G06N 5/043 (20130101)
G06N 20/00 (20190101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11238196 Bolander et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
United States Army (USA)
Department of the Navy (DON)
Naval Air Systems Command (NAVAIR)
United States Navy (USN)
National Aeronautics and Space Administration (NASA)
NASA Shared Services Center (NSSC)
APPLICANT(S) Sentient Science Corporation (Buffalo, New York)
ASSIGNEE(S) Sentient Science Corporation (Buffalo, New York)
INVENTOR(S) Nathan Bolander (Idaho Falls, Idaho);  Rajasekhar V. Pulikollu (Nashville, Tennessee);  Behrooz Jalalahmadi (Idaho Falls, Idaho)
ABSTRACT A system and method for determining surface contact fatigue life may use a finite element method to determine when components, such as a power transmission component, may fail in operation. The method may generate a finite element model based on the material parameters related to a power transmission component, generate a surface pressure time history for a loading event based on one or more loading parameters, determine, based on the surface pressure time history for a loading event, a finite element solution that describes stress in the grain structure, calculate damage in the finite element solution using a damage model, and determine whether a damage threshold is exceeded.
FILED Tuesday, November 12, 2019
APPL NO 16/680728
ART UNIT 2863 — Printing/Measuring and Testing
CURRENT CPC
Gearing
F16H 2057/0087 (20130101)

Testing Static or Dynamic Balance of Machines or Structures; Testing of Structures or Apparatus, Not Otherwise Provided for
G01M 13/022 (20130101)

Electric Digital Data Processing
G06F 17/18 (20130101)
G06F 30/23 (20200101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11238327 Paidimarri et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Arun Paidimarri (White Plains, New York);  Bodhisatwa Sadhu (Peekskill, New York);  Duixian Liu (Scarsdale, New York);  Alberto Valdes Garcia (Chappaqua, New York)
ABSTRACT A radio frequency identification (RFID) system. An RFID tag may include multiple antennas connected with associated circuitry. An RFID tag's multiple antennas and associated circuitry are connected in parallel, and output power of the multiple associated circuitry can be combined. Each of the multiple antennas can be tuned for a different operating property or region. An RFID reader can include multiple antennas connected with associated circuitry. RFID reader's multiple antenna interfaces connect with a baseband processor, which can integrate resources of the reader's multiple antennas and associated circuitry. RFID tag and/or reader can be configured to support wireless channel diversity in enhancing at least one of power delivery and communication link budget.
FILED Monday, December 28, 2020
APPL NO 17/134810
ART UNIT 2887 — Optics
CURRENT CPC
Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 7/0008 (20130101)
G06K 19/0773 (20130101)
G06K 19/0775 (20130101) Original (OR) Class
G06K 19/07796 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11238343 Arthur et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) John V. Arthur (Mountain View, California);  Steven K. Esser (San Jose, California);  Paul A. Merolla (Palo Alto, California);  Dharmendra S. Modha (San Jose, California)
ABSTRACT Embodiments of the invention relate to a scalable neural hardware for the noisy-OR model of Bayesian networks. One embodiment comprises a neural core circuit including a pseudo-random number generator for generating random numbers. The neural core circuit further comprises a plurality of incoming electronic axons, a plurality of neural modules, and a plurality of electronic synapses interconnecting the axons to the neural modules. Each synapse interconnects an axon with a neural module. Each neural module receives incoming spikes from interconnected axons. Each neural module represents a noisy-OR gate. Each neural module spikes probabilistically based on at least one random number generated by the pseudo-random number generator unit.
FILED Friday, November 30, 2018
APPL NO 16/206738
ART UNIT 2198 — Optics
CURRENT CPC
Electric Digital Data Processing
G06F 7/582 (20130101)

Computer Systems Based on Specific Computational Models
G06N 3/04 (20130101)
G06N 3/08 (20130101) Original (OR) Class
G06N 3/063 (20130101)
G06N 3/0472 (20130101)
G06N 7/005 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11238361 Wei et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
INVENTOR(S) Xuan Wei (White Plains, New York);  Sarah Elizabeth Sheldon (Tarrytown, New York);  Maika Takita (Hudson, New York);  Jay Michael Gambetta (Yorktown Heights, New York)
ABSTRACT An embodiment includes (CR) gate having a first control qubit coupled with a first target qubit, and a second CR gate having a second control qubit coupled with a second target qubit and the first control qubit. The embodiment also includes controller circuitry for performing operations including first and second iterations of: during a first time period, directing respective CR pulses to the first and second control qubits; during a second time period, directing respective single qubit pulses to the first control qubit and to the second target qubit; during a third time period, directing respective CR pulses to the first and second control qubits; and during a fourth time period, directing respective single qubit pulses to the second control qubit and to the first target qubit.
FILED Monday, December 21, 2020
APPL NO 17/128661
ART UNIT 2844 — Electrical Circuits and Systems
CURRENT CPC
Computer Systems Based on Specific Computational Models
G06N 10/00 (20190101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11238631 Sikka et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
APPLICANT(S) SRI International (Menlo Park, California)
ASSIGNEE(S) SRI International (Menlo Park, California)
INVENTOR(S) Karan Sikka (Lawrenceville, New Jersey);  Ajay Divakaran (Monmouth Junction, New Jersey);  Samyak Datta (Atlanta, Georgia)
ABSTRACT A method, apparatus and system for visual grounding of a caption in an image include projecting at least two parsed phrases of the caption into a trained semantic embedding space, projecting extracted region proposals of the image into the trained semantic embedding space, aligning the extracted region proposals and the at least two parsed phrases, aggregating the aligned region proposals and the at least two parsed phrases to determine a caption-conditioned image representation and projecting the caption-conditioned image representation and the caption into a semantic embedding space to align the caption-conditioned image representation and the caption. The method, apparatus and system can further include a parser for parsing the caption into the at least two parsed phrases and a region proposal module for extracting the region proposals from the image.
FILED Wednesday, April 22, 2020
APPL NO 16/855362
ART UNIT 2613 — Computer Graphic Processing, 3D Animation, Display Color Attribute, Object Processing, Hardware and Memory
CURRENT CPC
Electric Digital Data Processing
G06F 16/51 (20190101)
G06F 16/56 (20190101)

Image Data Processing or Generation, in General
G06T 11/60 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11238663 Guckenberger et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Natick Soldier Systems Center (NSSC)
APPLICANT(S) VR REHAB, INC. (Clermont, Florida)
ASSIGNEE(S) VR REHAB, INC. (Clermont, Florida)
INVENTOR(S) Elizabeth T. Guckenberger (Clermont, Florida);  Ronald J. Guckenberger (Clermont, Florida)
ABSTRACT Mini-Map with Gaze Guidance Line Visualization Module enables new types and classes of Human Computer Interface enhancements where the Humans can easily and simultaneously see where objects are relative within a 2D map in the foreground connected via intuitive gaze guidance lines to the same object with the Augmented Reality view. The Mini-Map is fully manipulatable position, zoom, display angle with defaults being relative to the user.
FILED Friday, October 02, 2020
APPL NO 17/062218
ART UNIT 2616 — Computer Graphic Processing, 3D Animation, Display Color Attribute, Object Processing, Hardware and Memory
CURRENT CPC
Image Data Processing or Generation, in General
G06T 11/00 (20130101)
G06T 19/006 (20130101) Original (OR) Class
G06T 2210/62 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239276 Roberts et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) CALIFORNIA INSTITUTE OF TECHNOLOGY (Pasadena, California)
ASSIGNEE(S) CALIFORNIA INSTITUTE OF TECHNOLOGY (Pasadena, California)
INVENTOR(S) Gregory Roberts (Pasadena, California);  Philip Camayd-Munoz (Pasadena, California);  Conner Ballew (Pasadena, California);  Andrei Faraon (Pasadena, California)
ABSTRACT Methods to build multi-functional scattering structures while respecting tight requirements imposed by manufacturing processes are described. The described methods and devices are based on etching away wire networks embedded in 3D structures to form voids in order to perform a target function. Optimization algorithms for designing binarized devices that meet manufacturing requirements are also disclosed.
FILED Friday, October 18, 2019
APPL NO 16/657640
ART UNIT 2891 — Semiconductors/Memory
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 5/0236 (20130101)
G02B 5/0247 (20130101)
G02B 27/0012 (20130101)
G02B 27/0025 (20130101)
G02B 27/0037 (20130101)
G02B 27/0056 (20130101)
G02B 27/0916 (20130101)
G02B 27/0938 (20130101)
G02B 27/0944 (20130101)
G02B 27/0977 (20130101)
G02B 27/4205 (20130101)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 27/14605 (20130101)
H01L 27/14607 (20130101)
H01L 27/14621 (20130101)
H01L 27/14625 (20130101)
H01L 27/14647 (20130101)
H01L 27/14685 (20130101)
H01L 27/14689 (20130101) Original (OR) Class
H01L 31/0232 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239422 McAlpine et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) The Trustees of Princeton University (Princeton, New Jersey)
ASSIGNEE(S) TRUSTEES OF PRINCETON UNIVERSITY (Princeton, New Jersey)
INVENTOR(S) Michael C. McAlpine (Minneapolis, Minnesota);  Yong Lin Kong (Cambridge, Massachusetts)
ABSTRACT Disclosed is a process whereby diverse classes of materials can be 3D printed and fully integrated into device components with active properties. An exemplary embodiment shows the seamless interweaving of five different materials, including (1) emissive semiconducting inorganic nanoparticles, (2) an elastomeric matrix, (3) organic polymers as charge transport layers, (4) solid and liquid metal leads, and (5) a UV-adhesive transparent substrate layer, demonstrating the integrated functionality of these materials. Further disclosed is a device for printing these fully integrated 3D devices.
FILED Monday, February 05, 2018
APPL NO 15/888616
ART UNIT 2894 — Semiconductors/Memory
CURRENT CPC
Shaping or Joining of Plastics; Shaping of Material in a Plastic State, Not Otherwise Provided For; After-treatment of the Shaped Products, e.g Repairing
B29C 64/112 (20170801)

Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 10/00 (20141201)

Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 51/0004 (20130101) Original (OR) Class
H01L 51/0022 (20130101)
H01L 51/502 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 10/549 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239429 Yu et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
U.S. Air Force
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Electrical, Communications and Cyber Systems (ECCS)
APPLICANT(S) The Florida State University Research Foundation, Inc. (Tallahassee, Florida)
ASSIGNEE(S) THE FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (Tallahassee, Florida)
INVENTOR(S) Zhibin Yu (Tallahassee, Florida);  Junqiang Li (Tallahassee, Florida);  Xin Shan (Tallahassee, Florida)
ABSTRACT An emissive perovskite ternary composite thin film comprising a perovskite material, an ionic-conducting polymer and an ionic-insulating polymer is provided. Additionally, a single-layer LEDs is described using a composite thin film of organometal halide perovskite (Pero), an ionic-conducting polymer (ICP) and an ionic-insulating polymer (IIP). The LEDs with Pero-ICP-IIP composite thin films exhibit a low turn-on voltage of about 1.9V (defined at 1 cd m−2 luminance) and a luminance of about 600,000 cd m−2.
FILED Monday, June 19, 2017
APPL NO 15/626759
ART UNIT 1786 — Miscellaneous Articles, Stock Material
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 51/004 (20130101)
H01L 51/0026 (20130101)
H01L 51/56 (20130101)
H01L 51/0077 (20130101) Original (OR) Class
H01L 51/5032 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239542 Vaisband et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Materiel Command (AFMC)
U.S. Air Force
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
INVENTOR(S) Boris Vaisband (Los Angeles, California);  Subramanian S. Iyer (Los Angeles, California);  Adeel A. Bajwa (Los Angeles, California);  Arpan Dasgupta (Los Angeles, California);  Arsalan Alam (Los Angeles, California)
ABSTRACT A system is provided for interconnecting multiple functional dies on a single substrate, including: (1) multiple global links in the substrate; (2) multiple local links in the substrate; and (3) multiple utility dies on the substrate, wherein each of the utility dies is connected to at least one of the global links, the utility dies are configured to communicate with one another through the global links, each of the utility dies is connected to at least one of the local links and is configured to communicate with at least one of the functional dies through the at least one of the local links. In some embodiments, an antenna is integrated into the substrate.
FILED Friday, September 04, 2020
APPL NO 17/013166
ART UNIT 2845 — Electrical Circuits and Systems
CURRENT CPC
Antennas, i.e Radio Aerials
H01Q 1/2283 (20130101) Original (OR) Class
H01Q 9/0407 (20130101)
H01Q 23/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239548 Merulla
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Secretary of the Army (SECARMY)
APPLICANT(S) The Government of the United States, as represented by the Secretary of the Army (Washington, District of Columbia)
ASSIGNEE(S) The Government of the United States, as represented by the Secretary of the Army (Washington, District of Columbia)
INVENTOR(S) Emanuel Merulla (Bel Air, Maryland)
ABSTRACT Various embodiments are described that relate to an antenna. In one embodiment, the antenna can be a low profile, multi-band (e.g., dual band), emulated GPS constellation antenna. In one embodiment, the antenna can form a cube with two open sides and four circuit board sides. The four circuit boards can include a first hardware portion that allows functioning in a higher frequency band and a second hardware portion that allows functioning in a lower frequency band.
FILED Monday, June 22, 2020
APPL NO 16/907392
ART UNIT 2845 — Electrical Circuits and Systems
CURRENT CPC
Antennas, i.e Radio Aerials
H01Q 1/38 (20130101) Original (OR) Class
H01Q 5/335 (20150115)
H01Q 9/27 (20130101)
H01Q 21/205 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239555 Behdad et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
ASSIGNEE(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
INVENTOR(S) Nader Behdad (Oregon, Wisconsin);  John H. Booske (McFarland, Wisconsin);  Hung Thanh Luyen (Madison, Wisconsin)
ABSTRACT A phase shift element includes a first dielectric layer, a conductive layer, a second dielectric layer, a conducting pattern layer, switches, and vertical interconnect accesses (vias). Each conductor of a plurality of conductors of the conducting pattern layer is orthogonal to two other conductors. Each switch is switchable between a conducting position and a non-conducting position. Each via is connected to a single conductor. The first conductive material reflects an electromagnetic wave incident on the conducting pattern layer and on the second dielectric layer. When a switch is in the conducting position, the switch electrically connects two conductors to each other through their respective vias. A plurality of different switch configurations of the switches provide a 2-bit phase quantization on the reflected electromagnetic wave relative to the electromagnetic wave incident on the conducting pattern layer when the electromagnetic wave is incident on the conducting pattern layer.
FILED Tuesday, October 08, 2019
APPL NO 16/595961
ART UNIT 2845 — Electrical Circuits and Systems
CURRENT CPC
Antennas, i.e Radio Aerials
H01Q 3/38 (20130101) Original (OR) Class
H01Q 3/247 (20130101)
H01Q 15/002 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239569 Dufilie
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
U.S. Air Force
MIT Lincoln Laboratory (MITLL)
Under Secretary of Defense for Research and Engineering (USDR&E)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Pierre A. Dufilie (Marlborough, Massachusetts)
ABSTRACT Described is a stacked patch antenna array scan-capable to 55 degrees and operable over an octave or greater frequency bandwidth.
FILED Friday, February 28, 2020
APPL NO 16/804814
ART UNIT 2845 — Electrical Circuits and Systems
CURRENT CPC
Antennas, i.e Radio Aerials
H01Q 5/307 (20150115)
H01Q 9/0414 (20130101)
H01Q 21/065 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239634 Osinski et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) STC.UNM (Albuquerque, New Mexico)
ASSIGNEE(S) UNM Rainforest Innovations (Albuquerque, New Mexico)
INVENTOR(S) Marek Osinski (Albuquerque, New Mexico);  Gennady A. Smolyakov (Albuquerque, New Mexico)
ABSTRACT The present invention provides one or more injection-lockable whistle-geometry semiconductor ring lasers, which may be cascaded, that are integrated on a common silicon-on-insulator (SOI) substrate with a single-frequency semiconductor master laser, wherein the light output from the semiconductor master laser is used to injection-lock the first of the semiconductor ring lasers. The ring lasers can be operated in strongly injection-locked mode, while at least one of them is subjected to direct injection current modulation.
FILED Tuesday, February 28, 2017
APPL NO 16/081028
ART UNIT 2828 — Semiconductors/Memory
CURRENT CPC
Devices Using the Process of Light Amplification by Stimulated Emission of Radiation [LASER] to Amplify or Generate Light; Devices Using Stimulated Emission of Electromagnetic Radiation in Wave Ranges Other Than Optical
H01S 5/12 (20130101)
H01S 5/021 (20130101)
H01S 5/22 (20130101)
H01S 5/026 (20130101)
H01S 5/042 (20130101)
H01S 5/125 (20130101)
H01S 5/0218 (20130101)
H01S 5/0225 (20210101)
H01S 5/1032 (20130101) Original (OR) Class
H01S 5/1071 (20130101)
H01S 5/1075 (20130101)
H01S 5/2205 (20130101)
H01S 5/3013 (20130101)
H01S 5/4006 (20130101)
H01S 5/04257 (20190801)
H01S 5/34306 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239736 Miesner
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Secretary of the Navy (SECNAV)
APPLICANT(S) The Government of the United States of America (Arlington, Virginia)
ASSIGNEE(S) The Government of the United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) John E Miesner (Fairfax, Virginia)
ABSTRACT An electromagnetic inertial force generator provides a linear output with improved compactness and reliability because it has no radial gaps and only one pair of axial gaps. Radial permanent magnet rings are directly in contact with inner and outer flux cylinders to provide magnetic bias. The magnetic bias flux flows across two axial air gaps to a supporting flux return structure. A current conducting coil drives magnetic flux across the same axial air gaps. The magnetic bias flux is in opposite directions across the two air gaps, while the coil flux across the two gaps is in the same direction. The combination of bias flux and coil flux cancels in one gap and adds in the other gap, producing a net force on an inertial mass and an equal and opposite force on the supporting structure. The resulting force is linear with current through the drive coil.
FILED Thursday, October 01, 2020
APPL NO 17/060236
ART UNIT 2832 — Electrical Circuits and Systems
CURRENT CPC
Dynamo-electric Machines
H02K 33/06 (20130101) Original (OR) Class
H02K 33/16 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239853 Dai et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S) Digital Analog Integration, Inc. (Auburn, Alabama)
ASSIGNEE(S) Digital Analog Integration, Inc. (Auburn, Alabama)
INVENTOR(S) Fa Dai (Auburn, Alabama);  Haoyi Zhao (Auburn, Alabama);  John David Irwin (Auburn, Alabama)
ABSTRACT An analog-to-digital converter includes a first converter stage, a second converter stage coupled to the first converter stage to quantize a residue signal of the first converter stage, and an inter-stage converter disposed between the first and second converter stages. The inter-stage converter is configured to convert between a first domain and a second domain. The inter-stage converter is configured to process the residue signal of the first converter stage such that a range of the residue signal matches a full scale of the second converter stage.
FILED Wednesday, October 28, 2020
APPL NO 17/082481
ART UNIT 2845 — Electrical Circuits and Systems
CURRENT CPC
Time-interval Measuring
G04F 10/005 (20130101)

Coding; Decoding; Code Conversion in General
H03M 1/50 (20130101)
H03M 1/145 (20130101)
H03M 1/164 (20130101)
H03M 1/1009 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11240078 White
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Naval Information Warfare Center (NIWC)
United States Navy (USN)
APPLICANT(S) HRL Laboratories, LLC (Malibu, California)
ASSIGNEE(S) HRL Laboratories, LLC (Malibu, California)
INVENTOR(S) Carson White (Agoura Hills, California)
ABSTRACT A Continuous Phase Frequency Shift Keying modulator provided to receive a series of binary symbols having a predetermined repetition period, and generate a series of sinusoidal signals comprising in sequence: a first sinusoidal signal with a first frequency in response to each received binary symbol having a first binary value; and a second sinusoidal signal with a second frequency in response to a received binary symbol having a second binary value, where the lowest of the first and second frequencies is larger than or equal to a third of the symbol rate; wherein the sinusoidal signals are shortened or lengthened with respect to the binary symbol they respond to, such that each first sinusoidal signal comprises an integer number of half periods of said first frequency and each second sinusoidal signal comprises an integer number of half periods of said second frequency.
FILED Thursday, December 31, 2020
APPL NO 17/139916
ART UNIT 2632 — Digital Communications
CURRENT CPC
Transmission of Digital Information, e.g Telegraphic Communication
H04L 5/0039 (20130101)
H04L 27/12 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11240137 Melodia et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) Northeastern University (Boston, Massachusetts)
ASSIGNEE(S) Northeastern University (Boston, Massachusetts)
INVENTOR(S) Tommaso Melodia (Newton, Massachusetts);  Zhangyu Guan (Chestnut Hill, Massachusetts)
ABSTRACT A wireless network operating system for communication between a plurality of nodes of a network is provided. The operating system can enable an operator to define a centralized network control problem at a high level, decompose automatically the network control problem into a set of distributed subproblems, each subproblem characterizing a local behavior of a single session or a subset of sessions or a single node or a subset of nodes or a single protocol layer or a subset of protocol layers, to generate in an automated manner a set of solution algorithms, and send the set of solution algorithms to each node for execution at an associated node controller to optimize the parameters of a programmable protocol stack based on local state information at each node. A network device for use at a node in a wireless network, a method of wirelessly communicating between a plurality of nodes in a network, and a method of providing a wireless network operating system are also provided.
FILED Thursday, November 29, 2018
APPL NO 16/764229
ART UNIT 2469 — Multiplex and VoIP
CURRENT CPC
Transmission
H04B 17/309 (20150115)
H04B 17/373 (20150115)
H04B 17/3912 (20150115)

Transmission of Digital Information, e.g Telegraphic Communication
H04L 43/14 (20130101) Original (OR) Class
H04L 43/0805 (20130101)
H04L 43/0823 (20130101)
H04L 43/0876 (20130101)

Wireless Communication Networks
H04W 16/18 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

National Science Foundation (NSF) 

US 11235067 Xu
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Trustees of Tufts College (Medford, Massachusetts)
ASSIGNEE(S) Trustees of Tufts College (Medford, Massachusetts)
INVENTOR(S) Qiaobing Xu (Lexington, Massachusetts)
ABSTRACT A nanocomplex, 50 to 1000 nm in size, containing a lipid-like nanoparticle formed of a cationic lipid-based compound and a modified protein formed of a protein and an anionic polymer that includes a plurality of polar groups, the lipid-like nanoparticle and the modified protein being non-covalently bonded to each other. Also disclosed are a method of preparing the above-described nanocomplex and use thereof for treating a medical condition. Further disclosed is a pharmaceutical composition containing a nanocomplex.
FILED Tuesday, January 23, 2018
APPL NO 16/479344
ART UNIT 1612 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/45 (20130101)
A61K 45/06 (20130101)
A61K 47/61 (20170801)
A61K 47/543 (20170801)
A61K 47/6907 (20170801)
A61K 47/6939 (20170801) Original (OR) Class

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 5/00 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235278 Adkins et al.
FUNDED BY
National Science Foundation (NSF)
Directorate of Geosciences (GEO)
Division of Ocean Sciences (OCE)
APPLICANT(S) California Institute of Technology (Pasadena, California);  University of Southern California (Los Angeles, California)
ASSIGNEE(S) California Institute of Technology (Pasadena, California);  University of Southern California (Los Angeles, California)
INVENTOR(S) Jess Firey Adkins (Altadena, California);  William Max Berelson (Los Angeles, California);  David B. Rogers (Pasadena, California)
ABSTRACT Systems and methods for sequestering emissions from marine vessels are provided. Emissions (either flue gas from exhaust or CO2 carried on the ship under pressure in gas cylinders or CO2 obtained during the ships travel via capture) are mixed in a reactor with sea water (e.g., via gas exchange through head-space equilibration or bubbling through a diffuser) until a pH of 5.5 to 6.5 is obtained. Systems and reactors pump seawater through a reactor vessel containing a reaction medium (e.g., carbonates and silicates). The reactor produces an effluent that can be expelled into the ocean. The effluent produced from the result of a reaction according to embodiments has approximately twice the concentration of Dissolved Inorganic Carbon (DIC) and Alkalinity (Alk) as the incoming sea water and has an increased Ca+2 concentration above sea water.
FILED Tuesday, May 26, 2020
APPL NO 16/883637
ART UNIT 1736 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Separation
B01D 53/92 (20130101)
B01D 53/346 (20130101)
B01D 53/1412 (20130101)
B01D 53/1475 (20130101) Original (OR) Class
B01D 53/1481 (20130101)
B01D 53/1493 (20130101)
B01D 2252/1035 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235286 Kumar et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
APPLICANT(S) THE PENN STATE RESEARCH FOUNDATION (University Park, Pennsylvania)
ASSIGNEE(S) The Penn State Research Foundation (University Park, Pennsylvania)
INVENTOR(S) Manish Kumar (State College, Pennsylvania);  Tingwei Ren (State College, Pennsylvania);  Woochul Song (State College, Pennsylvania);  Yu-Ming Tu (State College, Pennsylvania)
ABSTRACT The present disclosure describes compositions and methods for preparing membrane protein nanosheets and two-dimensional crystals. In particular, the methods employ a solvent. A mixture of a polymer and a membrane protein is solubilized in the solvent, applied to a substrate, and subsequently dried to form the nanosheet or two-dimensional crystal. Applicants have surprisingly found that the membrane proteins maintain their structure when exposed to solvents during the short processing time utilized.
FILED Thursday, May 16, 2019
APPL NO 16/414517
ART UNIT 1715 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Separation
B01D 67/0009 (20130101) Original (OR) Class
B01D 71/24 (20130101)
B01D 71/52 (20130101)
B01D 71/56 (20130101)
B01D 71/80 (20130101)

Processes for Applying Fluent Materials to Surfaces, in General
B05D 1/02 (20130101)
B05D 1/005 (20130101)
B05D 1/40 (20130101)
B05D 1/265 (20130101)
B05D 3/007 (20130101)
B05D 3/0254 (20130101)

Peptides
C07K 14/31 (20130101)
C07K 14/47 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235290 Hsiao et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (Albany, New York)
ASSIGNEE(S) The Research Foundation for the State University of New York (Albany, New York)
INVENTOR(S) Benjamin S. Hsiao (Setauket, New York);  Hongyang Ma (East Setauket, New York)
ABSTRACT Membranes are provided for use in reverse osmosis applications. Such membranes include a nanofibrous scaffold in combination with a barrier layer. The barrier layer is formed of a polymeric matrix having functionalized cellulose nanofibers incorporated therein. The membranes may, in embodiments, also include a substrate.
FILED Wednesday, February 14, 2018
APPL NO 16/485510
ART UNIT 1777 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Separation
B01D 61/025 (20130101)
B01D 69/12 (20130101) Original (OR) Class
B01D 71/10 (20130101)
B01D 2323/39 (20130101)

Treatment of Water, Waste Water, Sewage, or Sludge
C02F 1/441 (20130101)
C02F 2103/08 (20130101)
C02F 2305/08 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235307 Chang et al.
FUNDED BY
National Science Foundation (NSF)
Directorate of Geosciences (GEO)
Integrative and Collaborative Education and Research (ICER)
Department of Transportation (USDOT)
U.S. State Government
State of Florida
Florida Department of Transportation (FDOT)
APPLICANT(S) University of Central Florida Research Foundation, Inc. (Orlando, Florida)
ASSIGNEE(S) University of Central Florida Research Foundation, Inc. (Orlando, Florida)
INVENTOR(S) Ni-Bin Chang (Orlando, Florida);  Martin P. Wanielista (Orlando, Florida)
ABSTRACT A synergistic composition can be used to treat water containing nitrogen compounds and phosphorus compounds. The synergistic composition includes iron filings, clay particles, aluminum particles, and sand particles. The iron filings, clay particles, and aluminum particles act synergistically to remove nitrogen compounds and phosphorus compounds from water. Specifically, the clay particles attract the nitrogen compounds and the phosphorus compounds to be absorbed onto a surface of the iron filings and the clay particles. The aluminum particles react with the nitrogen compounds via an oxidation reaction to form ammonia compounds, and react with the phosphorus compounds to produce aluminum phosphate. As such, the synergistic relationship between the iron filings, clay particles, and aluminum particles remove nitrogen and phosphorus compounds from water and recover the compounds in usable forms, namely, ammonia and aluminum phosphate.
FILED Friday, May 14, 2021
APPL NO 17/302895
ART UNIT 1773 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 20/12 (20130101)
B01J 20/103 (20130101)
B01J 20/0229 (20130101)
B01J 20/0248 (20130101)
B01J 20/261 (20130101)
B01J 20/28016 (20130101) Original (OR) Class

Treatment of Water, Waste Water, Sewage, or Sludge
C02F 1/72 (20130101)
C02F 1/281 (20130101)
C02F 1/285 (20130101)
C02F 1/288 (20130101)
C02F 1/705 (20130101)
C02F 1/5245 (20130101)
C02F 2101/16 (20130101)
C02F 2101/105 (20130101)
C02F 2101/163 (20130101)
C02F 2103/001 (20130101)
C02F 2103/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235330 Hansen et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Biological Sciences (BIO)
Division of Molecular and Cellular Biosciences (MCB)
APPLICANT(S) Kansas State University Research Foundation (Manhattan, Kansas)
ASSIGNEE(S) Kansas State University Research Foundation (Manhattan, Kansas)
INVENTOR(S) Ryan R. Hansen (Manhattan, Kansas);  Thomas G. Platt (Manhattan, Kansas);  Andre Jacobus van der Vlies (Manhattan, Kansas)
ABSTRACT Polymer hydrogels and methods for selective retrieval of microbial targets from microwells and other cell culture devices. The methods use semi-permeable, photodegradable hydrogel membranes that permit exchange of nutrients and waste products but seals motile bacteria and other microbes within microwells. Light exposure can be used to degrade the hydrogel membrane in a targeted manner and release the microbes from targeted microwells for further study.
FILED Friday, October 05, 2018
APPL NO 16/753598
ART UNIT 1799 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Separation
B01D 63/088 (20130101)
B01D 67/0006 (20130101)
B01D 71/52 (20130101)
B01D 2323/30 (20130101)
B01D 2323/36 (20130101)
B01D 2325/36 (20130101)
B01D 2325/44 (20130101)

Chemical or Physical Laboratory Apparatus for General Use
B01L 3/50853 (20130101) Original (OR) Class
B01L 2300/044 (20130101)
B01L 2300/0819 (20130101)

Apparatus for Enzymology or Microbiology;
C12M 23/12 (20130101)
C12M 23/20 (20130101)
C12M 37/04 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235361 Quigley et al.
FUNDED BY
National Science Foundation (NSF)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Loci Controls, Inc. (Wareham, Massachusetts)
ASSIGNEE(S) Loci Controls, Inc. (Wareham, Massachusetts)
INVENTOR(S) Peter Quigley (Duxbury, Massachusetts);  Ian Martin (Sharon, Massachusetts);  Nicole Neff (Colorado Springs, Colorado);  Jack Rowbottom (Swansea, Massachusetts)
ABSTRACT Described herein are embodiments of a control system that automatically (1) determines whether a gas extraction system is in a state in which landfill gas is being released into the atmosphere, and (2) automatically controls landfill gas flow to mitigate, prevent and/or stop the release of landfill gas. The control system may control a valve to control flow of landfill gas through well piping of the gas extraction system. The pressure of landfill gas in the well piping at a location upstream of the valve may indicate whether there is a risk of landfill gas being released into the atmosphere. The control system may adjust a position of the valve in response to determining that the pressure at the location upstream of the valve indicates that there is a risk of landfill gas being released into the atmosphere.
FILED Monday, November 02, 2020
APPL NO 17/086987
ART UNIT 3672 — Wells, Earth Boring/Moving/Working, Excavating, Mining, Harvesters, Bridges, Roads, Petroleum, Closures, Connections, and Hardware
CURRENT CPC
Disposal of Solid Waste
B09B 1/006 (20130101) Original (OR) Class

Earth Drilling, e.g Deep Drilling; Obtaining Oil, Gas, Water, Soluble or Meltable Materials or a Slurry of Minerals From Wells
E21B 34/02 (20130101)

Climate Change Mitigation Technologies Related to Wastewater Treatment or Waste Management
Y02W 30/30 (20150501)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235466 Gupta et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) UNIVERSITY OF SOUTHERN CALIFORNIA (Los Angeles, California)
ASSIGNEE(S) UNIVERSITY OF SOUTHERN CALIFORNIA (Los Angeles, California)
INVENTOR(S) Satyandra Gupta (Los Angeles, California);  Ariyan Kabir (Los Angeles, California);  Brual Shah (Los Angeles, California)
ABSTRACT Methods, systems, and platforms for automatic setup planning for a robot. The method includes sampling multiple poses in multiple dimensions within a robotic workspace. The method includes generating one or more candidate configurations based on the multiple poses. The method includes determining a score for each candidate configuration of the one or more candidate configurations. The score represents area coverage of a region of interest and at least one of an amount of setup time of the candidate configuration or an amount of energy used. The method includes determining a set of candidate configurations that has an overall area coverage that covers the region of interest based on the score for each candidate configuration. The method includes controlling a position and an orientation of the object based on the set of candidate configurations.
FILED Tuesday, April 23, 2019
APPL NO 16/391676
ART UNIT 3664 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems
CURRENT CPC
Manipulators; Chambers Provided With Manipulation Devices
B25J 9/163 (20130101)
B25J 9/1664 (20130101)
B25J 9/1666 (20130101) Original (OR) Class
B25J 9/1669 (20130101)
B25J 9/1692 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235467 Gupta et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) UNIVERSITY OF SOUTHERN CALIFORNIA (Los Angeles, California)
ASSIGNEE(S) UNIVERSITY OF SOUTHERN CALIFORNIA (Los Angeles, California)
INVENTOR(S) Satyandra Gupta (Los Angeles, California);  Ariyan Kabir (Los Angeles, California);  Brual Shah (Los Angeles, California)
ABSTRACT Methods, systems, and apparatus for automatically moving a tool attached to a robotic manipulator from a start position to a goal position. The method includes determining, using a processor, a plurality of next possible positions from the start position. The method includes selecting a second position from the plurality of next possible positions based on respective costs associated with moving the tool from the start position to each of the possible positions in the plurality of next possible positions. The method includes moving, using a plurality of actuators, the tool to the second position. The method includes determining an updated plurality of next possible positions, selecting a next position, and moving the tool to the next position until the goal position is reached.
FILED Tuesday, April 23, 2019
APPL NO 16/391920
ART UNIT 3664 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems
CURRENT CPC
Manipulators; Chambers Provided With Manipulation Devices
B25J 9/163 (20130101)
B25J 9/1664 (20130101)
B25J 9/1666 (20130101) Original (OR) Class
B25J 9/1669 (20130101)
B25J 9/1692 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235972 Gopalkrishnan et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Science Foundation (NSF)
APPLICANT(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts)
INVENTOR(S) Nikhil Gopalkrishnan (Jamaica Plain, Massachusetts);  Thomas E. Schaus (Arlington, Massachusetts);  Peng Yin (Brookline, Massachusetts)
ABSTRACT The present disclosure provides, in some aspects, methods and compositions for producing nucleic acid nanostructures having little to no kinetic barriers to self-assembly.
FILED Tuesday, April 11, 2017
APPL NO 16/092802
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Nanostructures Formed by Manipulation of Individual Atoms, Molecules, or Limited Collections of Atoms or Molecules as Discrete Units; Manufacture or Treatment Thereof
B82B 3/0042 (20130101) Original (OR) Class

Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 40/00 (20130101)

Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids
C07H 21/04 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/10 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6811 (20130101)
C12Q 1/6811 (20130101)
C12Q 2563/155 (20130101)
C12Q 2563/155 (20130101)
C12Q 2563/157 (20130101)
C12Q 2563/157 (20130101)
C12Q 2565/133 (20130101)
C12Q 2565/133 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235977 Tse et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Army Research Office (CCDC ARO)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Chemical, Bioengineering, Environmental and Transport Systems (CBET)
APPLICANT(S) Rutgers, The State University of New Jersey (New Brunswick, New Jersey)
ASSIGNEE(S) RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (New Brunswick, New Jersey)
INVENTOR(S) Stephen D. Tse (Warren, New Jersey);  Hua Hong (Weehawken, New Jersey);  Bernard H. Kear (Whitehouse Station, New Jersey)
ABSTRACT Methods for the production of carbon-based and other nanostructures are provided.
FILED Friday, December 21, 2018
APPL NO 16/229055
ART UNIT 1736 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 40/00 (20130101)

Non-metallic Elements; Compounds Thereof;
C01B 32/184 (20170801) Original (OR) Class

Indexing Scheme Relating to Structural and Physical Aspects of Solid Inorganic Compounds
C01P 2002/52 (20130101)
C01P 2002/82 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236130 Ly et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) Carnegie Mellon University (Pittsburgh, Pennsylvania)
ASSIGNEE(S) Carnegie Mellon University (Pittsburgh, Pennsylvania)
INVENTOR(S) Danith H. Ly (Pittsburgh, Pennsylvania);  Suresh Kumar Gopalsamy (Tamilnadu, India);  Arunava Manna (Pittsburgh, Pennsylvania)
ABSTRACT Described herein are novel divalent nucleobases that each bind two nucleic acid strands, matched or mismatched when incorporated into a nucleic acid or nucleic acid analog backbone (a genetic recognition reagent, or genetic recognition reagent). In one embodiment, the genetic recognition reagent is a peptide nucleic acid (PNA) or gamma PNA (γPNA) oligomer. Uses of the divalent nucleobases and monomers and genetic recognition reagents containing the divalent nucleobases also are provided.
FILED Wednesday, June 19, 2019
APPL NO 16/445427
ART UNIT 1637 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 239/47 (20130101)
C07D 239/54 (20130101)
C07D 251/16 (20130101)
C07D 471/04 (20130101)
C07D 475/08 (20130101)
C07D 487/04 (20130101)
C07D 487/16 (20130101)

Sugars; Derivatives Thereof; Nucleosides; Nucleotides; Nucleic Acids
C07H 1/06 (20130101)
C07H 21/04 (20130101)

Peptides
C07K 14/003 (20130101) Original (OR) Class

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6809 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 33/5308 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236370 Lynch et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
Office of Naval Research (ONR)
National Science Foundation (NSF)
APPLICANT(S) DUKE UNIVERSITY (Durham, North Carolina)
ASSIGNEE(S) DUKE UNIVERSITY (Durham, North Carolina)
INVENTOR(S) Michael David Lynch (Durham, North Carolina);  Zhixia Ye (Raleigh, North Carolina)
ABSTRACT The present disclosure provides compositions and methods for rapid production of chemicals in genetically engineered microorganisms in a large scale. Also provided herein is a high-throughput metabolic engineering platform enabling the rapid optimization of microbial production strains. The platform, which bridges a gap between current in vivo and in vitro bio-production approaches, relies on dynamic minimization of the active metabolic network.
FILED Wednesday, October 23, 2019
APPL NO 16/661010
ART UNIT 1652 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/001 (20130101)
C12N 9/0006 (20130101)
C12N 9/0008 (20130101)
C12N 9/0016 (20130101)
C12N 9/0051 (20130101)
C12N 9/1025 (20130101)
C12N 15/746 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 7/42 (20130101) Original (OR) Class
C12P 13/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236382 Connolly et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Research, Development and Engineering Command (RDECOM)
U.S. Army Medical Research and Materiel Command (USAMRMC)
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Design, Manufacture, and Industrial Innovation (DMII)
Division of Industrial Innovation and Partnerships (IIP)
APPLICANT(S) Integrated Nano-Technologies, Inc. (Henrietta, New York)
ASSIGNEE(S) Integrated Nano-Technologies, LLC (Henrietta, New York)
INVENTOR(S) Dennis M. Connolly (Rochester, New York);  Tara Holz (Henrietta, New York);  Vera Tannous (Penfield, New York);  Christopher Kilcoin (Boulder Creek, California);  Konstantin Aptekarev (Santa Cruz, California);  David B. Bailey (Webster, New York);  Richard S. Murante (Henrietta, New York);  Nathaniel E. Wescott (West Henrietta, New York)
ABSTRACT A method for preparing a sample by utilizing a shearing force in the presence of a size stabilizer to break apart the sample to obtain nucleic acid molecules in a usable size range. Once nucleic acid molecules are obtained, magnetic nanoparticles are used to concentrate and clean the nucleic acid molecules for further testing.
FILED Friday, June 28, 2019
APPL NO 16/457602
ART UNIT 1798 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Chemical or Physical Laboratory Apparatus for General Use
B01L 3/502 (20130101)
B01L 2200/0631 (20130101)
B01L 2300/0681 (20130101)

Apparatus for Enzymology or Microbiology;
C12M 47/06 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 1/066 (20130101)
C12N 15/10 (20130101)
C12N 15/1013 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/02 (20130101)
C12Q 1/6806 (20130101)
C12Q 1/6825 (20130101) Original (OR) Class
C12Q 2531/113 (20130101)
C12Q 2563/107 (20130101)
C12Q 2563/143 (20130101)
C12Q 2565/629 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 1/286 (20130101)
G01N 2001/2866 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236404 Cibula et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) KW Associates LLC (Albany, Oregon)
ASSIGNEE(S) KW ASSOCIATES LLC (Albany, Oregon)
INVENTOR(S) Matthew A. Cibula (Salem, Oregon);  Joshua R. Motley (Corvallis, Oregon);  C. Rigel Woodside (Corvallis, Oregon);  Paul E. King (Albany, Oregon)
ABSTRACT Sensors measure magnetic field components, and the measured fields are used to calculate and estimated transverse position of a longitudinal electric current flowing as an electric discharge across a discharge gap. Based on the estimated position, and according to a selected transverse trajectory or distribution of the estimated discharge position, magnetic fields are applied transversely across the discharge gap so as to control or alter the estimated discharge position. Inventive apparatus and methods can be employed, inter alia, during operation of a vacuum arc furnace.
FILED Monday, July 27, 2020
APPL NO 16/939060
ART UNIT 2867 — Printing/Measuring and Testing
CURRENT CPC
Processing of Pig-iron, e.g Refining, Manufacture of Wrought-iron or Steel; Treatment in Molten State of Ferrous Alloys
C21C 5/5211 (20130101) Original (OR) Class
C21C 2005/5288 (20130101)

Furnaces, Kilns, Ovens, or Retorts in General; Open Sintering or Like Apparatus
F27B 3/28 (20130101)
F27B 3/085 (20130101)

Details or Accessories of Furnaces, Kilns, Ovens, or Retorts, in so Far as They Are of Kinds Occurring in More Than One Kind of Furnace
F27D 7/06 (20130101)
F27D 11/10 (20130101)
F27D 2007/066 (20130101)

Measuring Electric Variables; Measuring Magnetic Variables
G01R 15/20 (20130101)
G01R 33/06 (20130101)
G01R 35/005 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236426 Hamers et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
ASSIGNEE(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
INVENTOR(S) Robert John Hamers (Madison, Wisconsin);  Shuo Li (Madison, Wisconsin)
ABSTRACT Methods of forming plasmonic diamond films are provided. In an embodiment, such a method comprises forming a first layer of diamond on a substrate; depositing a layer of a metal on a surface of the first layer of diamond to form an as-deposited layer of metal; exposing the as-deposited layer of metal to a plasma treatment to convert the as-deposited layer of metal to a plurality of discrete regions of the metal on the surface of the first layer of diamond; and forming a second layer of diamond on the plurality of discrete regions of metal to form the plasmonic diamond film comprising a plurality of plasmonic nanoparticles.
FILED Friday, August 17, 2018
APPL NO 16/104460
ART UNIT 1715 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 23/50 (20130101)
B01J 35/004 (20130101)
B01J 35/0013 (20130101)

Coating Metallic Material; Coating Material With Metallic Material; Surface Treatment of Metallic Material by Diffusion into the Surface, by Chemical Conversion or Substitution; Coating by Vacuum Evaporation, by Sputtering, by Ion Implantation or by Chemical Vapour Deposition, in General
C23C 14/18 (20130101)
C23C 16/06 (20130101)
C23C 16/27 (20130101)
C23C 16/30 (20130101)
C23C 16/56 (20130101) Original (OR) Class
C23C 16/274 (20130101)
C23C 16/0281 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236935 Goldfarbmuren et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Rebound Technologies, Inc. (Commerce City, Colorado)
ASSIGNEE(S) Rebound Technologies, Inc. (Commerce City, Colorado)
INVENTOR(S) Russell Goldfarbmuren (Denver, Colorado);  Luke Erickson (Denver, Colorado);  Josh Nelson (Bennett, Colorado);  John Darrah (Winter Park, Florida);  Mauricio Sanchez (Denver, Colorado);  Chance Lord (Denver, Colorado)
ABSTRACT Methods, systems, and device for solidification and/or solid production, such as ice production, are provided. For example, a method of solid production includes contacting a first fluid with a second fluid to facilitate solidifying the second fluid; the first fluid and the second fluid are immiscible with respect to each other. The method includes solidifying the second fluid. A solid production system includes a first fluid and a second fluid; the first fluid and the second fluid are immiscible with respect to each other. The system includes one or more surfaces configured to contact the first fluid and the second fluid with each other and to form one or more solids from the second fluid.
FILED Thursday, January 23, 2020
APPL NO 16/750170
ART UNIT 3763 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Producing, Working or Handling Ice
F25C 1/00 (20130101)
F25C 1/12 (20130101) Original (OR) Class
F25C 1/147 (20130101)
F25C 2300/00 (20130101)
F25C 2301/002 (20130101)

Refrigerators; Cold Rooms; Ice-boxes; Cooling or Freezing Apparatus Not Otherwise Provided for
F25D 3/005 (20130101)
F25D 17/02 (20130101)
F25D 2303/084 (20130101)
F25D 2303/085 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237104 Pate
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) University of Virginia Patent Foundation (Charlottesville, Virginia)
ASSIGNEE(S) University of Virginia Patent Foundation (Charlottesville, Virginia)
INVENTOR(S) Brooks Hart Pate (Charlottesville, Virginia)
ABSTRACT A chiral molecule can be defined as a molecule that has a non-superimposable mirror image. These mirror images can be referred to as enantiomers. The enantiomers generally have the same set of bond lengths and bond angles in their three-dimensional geometry. Apparatus and techniques described herein can be used to perform analysis of chiral molecules using cavity-enhanced molecular rotational spectroscopy. A sample cell can define a resonant cavity, and a sample introduction port can provide pulse jet injection of an analyte molecule and a chiral tag to allow analysis of a complex comprising the analyte and chiral tag.
FILED Wednesday, October 25, 2017
APPL NO 16/344688
ART UNIT 2884 — Optics
CURRENT CPC
Measurement of Intensity, Velocity, Spectral Content, Polarisation, Phase or Pulse Characteristics of Infra-Red, Visible or Ultra-violet Light; Colorimetry; Radiation Pyrometry
G01J 1/16 (20130101)
G01J 3/30 (20130101)
G01J 3/447 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/3586 (20130101) Original (OR) Class
G01N 22/00 (20130101)

Electric Discharge Tubes or Discharge Lamps
H01J 23/20 (20130101)
H01J 23/207 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237369 Weida et al.
FUNDED BY
National Science Foundation (NSF)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) DAYLIGHT SOLUTIONS, INC. (San Diego, California)
ASSIGNEE(S) DAYLIGHT SOLUTIONS, INC. (San Diego, California)
INVENTOR(S) Miles James Weida (Poway, California);  Timothy Day (Poway, California)
ABSTRACT An imaging microscope (12) for generating an image of a sample (10) comprises a beam source (14) that emits a temporally coherent illumination beam (20), the illumination beam (20) including a plurality of rays that are directed at the sample (10); an image sensor (18) that converts an optical image into an array of electronic signals; and an imaging lens assembly (16) that receives rays from the beam source (14) that are transmitted through the sample (10) and forms an image on the image sensor (18). The imaging lens assembly (16) can further receive rays from the beam source (14) that are reflected off of the sample (10) and form a second image on the image sensor (18). The imaging lens assembly (16) receives the rays from the sample (10) and forms the image on the image sensor (18) without splitting and recombining the rays.
FILED Friday, March 20, 2020
APPL NO 16/825916
ART UNIT 2487 — Recording and Compression
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 21/00 (20130101)
G02B 21/0056 (20130101) Original (OR) Class
G02B 21/0088 (20130101)
G02B 21/088 (20130101)
G02B 21/365 (20130101)

Pictorial Communication, e.g Television
H04N 5/33 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237370 Han et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
National Science Foundation (NSF)
APPLICANT(S) University of Central Florida Research Foundation, Inc. (Orlando, Florida)
ASSIGNEE(S) UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (Orlando, Florida)
INVENTOR(S) Kyu Young Han (Orlando, Florida);  Jialei Tang (Oviedo, Florida)
ABSTRACT A dual inclined beam line-scanning confocal microscope apparatus, associated method, and applications thereof. An embodied dual-inclined beam line-scanning confocal microscope (2iLS) utilizes dual, parallel excitation beams each having a focused line shape that are scanned over a fluorescent sample. The emitted fluorescence from the sample is spatially filtered and detected by an array detector. 2iLS microscopy provides high resolution, ultrasensitivity, and deep optical sectioning capability. A reduced excitation intensity lowers photobleaching and photodamage.
FILED Tuesday, April 30, 2019
APPL NO 16/398630
ART UNIT 2884 — Optics
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/6458 (20130101)

Optical Elements, Systems, or Apparatus
G02B 21/02 (20130101)
G02B 21/008 (20130101)
G02B 21/0032 (20130101)
G02B 21/0036 (20130101)
G02B 21/36 (20130101)
G02B 21/0048 (20130101)
G02B 21/0076 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239320 Zhu et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Electrical, Communications and Cyber Systems (ECCS)
APPLICANT(S) The Board of Trustees of the University of Illinois (Urbana, Illinois)
ASSIGNEE(S) The Board of Trustees of the University of Illinois (Urbana, Illinois)
INVENTOR(S) Wenjuan Zhu (Champaign, Illinois);  Jialun Liu (Urbana, Illinois);  Hojoon Ryu (Urbana, Illinois)
ABSTRACT A classifier circuit includes an array of dual gate graphene transistors, each of the transistors having a source, a top gate receiving one of an input voltage to be evaluated or a reference voltage, a bottom or embedded gate receiving the other of the input voltage or reference voltage and a drain, the source and drain contacting a graphene channel One of the source and the drain is connected to a voltage source. A common output combines output current of a plurality of the dual gate graphene transistors, which current varies in response to the difference between the input voltage and the reference voltage. A method for forming a classifier transistor with high remanent polarization forms dielectric with ferroelectric capability on a low resistivity substrate. A non-ferroelectric oxide layer is formed on the dielectric. A window is opened, and a graphene channel is formed in the window.
FILED Friday, December 06, 2019
APPL NO 16/706004
ART UNIT 2896 — Semiconductors/Memory
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 29/516 (20130101)
H01L 29/1606 (20130101) Original (OR) Class
H01L 29/66045 (20130101)
H01L 29/78391 (20140902)
H01L 29/78603 (20130101)
H01L 29/78618 (20130101)
H01L 29/78648 (20130101)
H01L 29/78684 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239429 Yu et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
U.S. Air Force
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Electrical, Communications and Cyber Systems (ECCS)
APPLICANT(S) The Florida State University Research Foundation, Inc. (Tallahassee, Florida)
ASSIGNEE(S) THE FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (Tallahassee, Florida)
INVENTOR(S) Zhibin Yu (Tallahassee, Florida);  Junqiang Li (Tallahassee, Florida);  Xin Shan (Tallahassee, Florida)
ABSTRACT An emissive perovskite ternary composite thin film comprising a perovskite material, an ionic-conducting polymer and an ionic-insulating polymer is provided. Additionally, a single-layer LEDs is described using a composite thin film of organometal halide perovskite (Pero), an ionic-conducting polymer (ICP) and an ionic-insulating polymer (IIP). The LEDs with Pero-ICP-IIP composite thin films exhibit a low turn-on voltage of about 1.9V (defined at 1 cd m−2 luminance) and a luminance of about 600,000 cd m−2.
FILED Monday, June 19, 2017
APPL NO 15/626759
ART UNIT 1786 — Miscellaneous Articles, Stock Material
CURRENT CPC
Semiconductor Devices; Electric Solid State Devices Not Otherwise Provided for
H01L 51/004 (20130101)
H01L 51/0026 (20130101)
H01L 51/56 (20130101)
H01L 51/0077 (20130101) Original (OR) Class
H01L 51/5032 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239717 Islam et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) North Carolina State University (Raleigh, North Carolina)
ASSIGNEE(S) North Carolina State University (Raleigh, North Carolina)
INVENTOR(S) Md Sariful Islam (Raleigh, North Carolina);  Md Ashfanoor Kabir (Raleigh, North Carolina);  Iqbal Husain (Raleigh, North Carolina)
ABSTRACT Various examples related to shifted fractional pitch wye-delta multilayer windings and their use in AC machines. In one example, a winding includes a first wye-delta winding with first wye and delta windings for each phase and a second wye-delta winding with second wye and delta windings for each phase. The first and second wye windings for each phase are connected in series and the first and second delta windings are connected in series, and formed wye and delta windings are connected in a wye-delta configuration thereby providing an electrical phase shift between the two windings. The windings are interdigitated to provide a physical shift between the first and second wye windings and the first and second delta windings. Such windings can be used in, e.g., permanent magnet synchronous machines, synchronous machines, reluctance machines, and induction machines.
FILED Tuesday, June 11, 2019
APPL NO 16/438237
ART UNIT 2834 — Electrical Circuits and Systems
CURRENT CPC
Dynamo-electric Machines
H02K 1/16 (20130101)
H02K 3/12 (20130101) Original (OR) Class
H02K 3/48 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239877 Chopra et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Electrical, Communications and Cyber Systems (ECCS)
APPLICANT(S) AT and T Intellectual Property I, L.P. (Atlanta, Georgia);  University of Notre Dame du Lac (South Bend, Indiana)
ASSIGNEE(S) AT and T INTELLECTUAL PROPERTY I, L.P. (Atlanta, Georgia);  UNIVERSITY OF NOTRE DAME DU LAC (South Bend, Indiana)
INVENTOR(S) Aditya Chopra (Austin, Texas);  Ralf Bendlin (Cedar Park, Texas);  Nicholas Joseph Estes (South Bend, Indiana);  Kang Gao (San Diego, California);  Bertrand Martyn Hochwald (South Bend, Indiana);  Jonathan David Chisum (South Bend, Indiana)
ABSTRACT Aspects of the subject disclosure may include, for example, generating multiple digital reference pulses synchronously to a master oscillator, selectively switching the multiple digital reference pulses, and providing the switched pulses to multiple radio modules operating within a millimeter wave spectrum. For each radio module, counting cycles of an adjustable LO output signal occurring between consecutive pulses of the switched digital reference pulses, determining a difference between the count value and a reference value, and adjusting the adjustable LO according to the difference. A resulting corrected LO signal is synchronized to the master oscillator. Other embodiments are disclosed.
FILED Tuesday, November 24, 2020
APPL NO 17/102666
ART UNIT 2632 — Digital Communications
CURRENT CPC
Transmission
H04B 1/0003 (20130101)
H04B 1/50 (20130101) Original (OR) Class
H04B 1/0082 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239963 Melodia et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Computer and Network Systems (CNS)
APPLICANT(S) Northeastern University (Boston, Massachusetts)
ASSIGNEE(S) Northeastern University (Boston, Massachusetts)
INVENTOR(S) Tommaso Melodia (Newton, Massachusetts);  Giuseppe Enrico Santagati (Cambridge, Massachusetts)
ABSTRACT A system and method for transmitting data ultrasonically through biological tissue employs a network of a plurality of nodes, at least a portion of the nodes implantable within the biological tissue. At least one implanted node includes a transmitter having an orthogonal frequency division multiplex signal generator to encode an ultrasonic signal for transmission through the biological tissue to an ultrasonic receiver at another node.
FILED Monday, September 28, 2020
APPL NO 17/034217
ART UNIT 2631 — Digital Communications
CURRENT CPC
Transmission
H04B 11/00 (20130101)
H04B 13/005 (20130101)

Transmission of Digital Information, e.g Telegraphic Communication
H04L 1/0003 (20130101)
H04L 1/0009 (20130101)
H04L 1/0057 (20130101)
H04L 5/0012 (20130101) Original (OR) Class
H04L 27/0008 (20130101)
H04L 27/362 (20130101)
H04L 27/2053 (20130101)
H04L 27/2602 (20130101)
H04L 27/2626 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239998 Atallah et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Civil, Mechanical and Manufacturing Innovation (CMMI)
APPLICANT(S) Purdue Research Foundation (West Lafayette, Indiana)
ASSIGNEE(S) Purdue Research Foundation (West Lafayette, Indiana)
INVENTOR(S) Mikhail J Atallah (West Lafayette, Indiana);  Siva Chaitanya Chaduvula (Lafayette, Indiana);  Adam Dachowicz (West Lafayette, Indiana);  Jitesh H Panchal (West Lafayette, Indiana);  Mohammad S Rahman (West Lafayette, Indiana)
ABSTRACT A method of performing ordered statistics between at least two parties is disclosed which includes identifying a first dataset (xA) by a first node (A), identifying a second dataset (xB) by a second node (B), wherein xB is unknown to A and xA is unknown to B, and wherein A is in communication with B, and wherein A and B are in communication with a server (S), A and B each additively splitting each member of their respective datasets into corresponding shares, sharing the corresponding shares with one another, arranging the corresponding shares according to a mutually agreed predetermined order into corresponding ordered shares, shuffling the ordered shares into shuffled shares, re-splitting the shuffled shares into re-split shuffled shares, and performing an ordered statistical operation on the re-split shuffled shares, wherein the steps of shuffle and re-split is based on additions, subtractions but not multiplication and division.
FILED Friday, August 16, 2019
APPL NO 16/543495
ART UNIT 2437 — Cryptography and Security
CURRENT CPC
Electric Digital Data Processing
G06F 17/18 (20130101)

Transmission of Digital Information, e.g Telegraphic Communication
H04L 9/0631 (20130101) Original (OR) Class
H04L 2209/46 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11240752 Kassa et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Morgan State University (Baltimore, Maryland)
ASSIGNEE(S) Morgan State University (Baltimore, Maryland)
INVENTOR(S) Hailu Kassa (Nottingham, Maryland);  Kevin Kornegay (Towson, Maryland)
ABSTRACT Methods and systems are provided for managing a smart antenna system to maximize energy efficiency while maintaining spectral efficiency and signal integrity. In accordance with certain aspects of a particularly preferred embodiment, antenna beamforming may be optimized at a base station by combining a recursive least squares beamforming technique with Kaiser windowing functions to enable side lobe cancellation in the emitted beam, thus enhancing the capacity and service quality of smart antenna systems. With respect to further aspects of a particularly preferred embodiment, processing methods may be implemented at the base station of a cellular network to cluster mobile stations in a way that improves overall energy efficiency of a base station in the cellular network. More particularly, mobile stations or users may be clustered using a linear radius clustering method and a last user sector based clustering method to direct the beam emitted from the base station antenna to those sectors determined to contain the users having the greatest signal resource need.
FILED Tuesday, February 04, 2020
APPL NO 16/781480
ART UNIT 2412 — Multiplex and VoIP
CURRENT CPC
Electric Digital Data Processing
G06F 9/30036 (20130101)

Wireless Communication Networks
H04W 52/46 (20130101)
H04W 52/0206 (20130101)
H04W 52/0212 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Energy (DOE) 

US 11234678 Huang et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Congressionally Directed Medical Research Programs (CDMRP)
Department of Energy (DOE)
Los Alamos National Laboratory (LANL)
Los Alamos National Security, LLC (LANS)
National Nuclear Security Administration (NNSA)
Triad National Security, LLC (Triad)
APPLICANT(S) Los Alamos National Security, LLC (Los Alamos, New Mexico)
ASSIGNEE(S) TRIAD NATIONAL SECURITY, LLC (Los Alamos, New Mexico)
INVENTOR(S) Lianjie Huang (Los Alamos, New Mexico);  Zhigang Zhang (Los Alamos, New Mexico)
ABSTRACT Ultrasound tomography imaging methods for imaging a tissue medium with one or more ultrasound transducer arrays comprising a plurality of transducers, wherein said transducers comprise source transducers, receiving transducers. The methods include assigning a phase value or time delay to source transducers, exciting the transducers and calculating a search direction based on data relating to the excited transducers.
FILED Wednesday, July 25, 2018
APPL NO 16/045279
ART UNIT 3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Diagnosis; Surgery; Identification
A61B 5/0073 (20130101)
A61B 5/7275 (20130101)
A61B 8/13 (20130101)
A61B 8/14 (20130101)
A61B 8/15 (20130101)
A61B 8/085 (20130101)
A61B 8/145 (20130101)
A61B 8/406 (20130101)
A61B 8/483 (20130101)
A61B 8/0825 (20130101)
A61B 8/4477 (20130101)
A61B 8/4488 (20130101)
A61B 8/4494 (20130101)
A61B 8/5207 (20130101) Original (OR) Class

Radio Direction-finding; Radio Navigation; Determining Distance or Velocity by Use of Radio Waves; Locating or Presence-detecting by Use of the Reflection or Reradiation of Radio Waves; Analogous Arrangements Using Other Waves
G01S 15/8915 (20130101)
G01S 15/8929 (20130101)
G01S 15/8997 (20130101)

Image Data Processing or Generation, in General
G06T 5/001 (20130101)
G06T 11/005 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235055 Korber et al.
FUNDED BY
Department of Energy (DOE)
Los Alamos National Laboratory (LANL)
Los Alamos National Security, LLC (LANS)
National Nuclear Security Administration (NNSA)
Triad National Security, LLC (Triad)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Los Alamos National Security, LLC (Los Alamos, New Mexico);  Oxford University Innovation Limited (Oxford, United Kingdom)
ASSIGNEE(S) Triad National Security, LLC (Los Alamos, New Mexico);  Isis Innovation Limited (Oxford, United Kingdom)
INVENTOR(S) Bette T. M. Korber (Los Alamos, New Mexico);  Tomas Hanke (Oxford, United Kingdom);  Andrew McMichael (Oxford, United Kingdom)
ABSTRACT Disclosed herein are mosaic conserved region HIV polypeptides and immunogenic polypeptides including one or more of the mosaic conserved region polypeptides. In some embodiments, the immunogenic polypeptides are included in an immunogenic composition, such as a polyvalent immunogenic composition. Also disclosed herein are methods for treating or inhibiting HIV in a subject including administering one or more of the disclosed immunogenic polypeptides or compositions to a subject having or at risk of HIV infection. In some embodiments, the methods include inducing an immune response in a subject comprising administering to the subject at least one of the disclosed immunogenic polypeptides or a nucleic acid encoding at least one of the immunogenic polypeptides.
FILED Friday, June 29, 2018
APPL NO 16/023871
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/12 (20130101)
A61K 39/21 (20130101) Original (OR) Class

Peptides
C07K 14/005 (20130101)
C07K 14/161 (20130101)
C07K 14/162 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 2740/16034 (20130101)
C12N 2740/16122 (20130101)
C12N 2740/16222 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235076 Strong et al.
FUNDED BY
Department of Energy (DOE)
Lawrence Berkeley National Laboratory (LBNL)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Fred Hutchinson Cancer Research Center (Seattle, Washington);  The Regents of the University of California (Oakland, California)
ASSIGNEE(S) Fred Hutchinson Cancer Research Center (Seattle, Washington);  The Regents of the Universitv of California (Oakland, California)
INVENTOR(S) Roland K. Strong (Seattle, Washington);  Peter Rupert (Seattle, Washington);  Rebecca J. Abergel (Berkeley, California);  Ilya Captain (Moraga, California);  Gauthier J P Deblonde (Berkeley, California)
ABSTRACT Siderocalin-metal chelator combinations that bind metallic radioisotopes used in nuclear medicine with high affinity are described. The high affinity siderocalin-metal chelator combinations include a number of chelator backbone arrangements with functional groups that coordinate with metals. The siderocalin-metal chelator combinations can be used to deliver radionuclides for imaging and therapeutic purposes.
FILED Monday, August 28, 2017
APPL NO 16/329178
ART UNIT 1618 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 51/0478 (20130101)
A61K 51/0482 (20130101) Original (OR) Class

Separation
B01D 15/34 (20130101)
B01D 15/3804 (20130101)

Peptides
C07K 14/47 (20130101)

Production and Refining of Metals; Pretreatment of Raw Materials
C22B 60/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236057 Krumm et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
APPLICANT(S) REGENTS OF THE UNIVERSITY OF MINNESOTA (Minneapolis, Minnesota)
ASSIGNEE(S) REGENTS OF THE UNIVERSITY OF MINNESOTA (Minneapolis, Minnesota)
INVENTOR(S) Christoph Krumm (Saint Paul, Minnesota);  Kristeen Joseph (Minneapolis, Minnesota);  Dae Sung Park (Minneapolis, Minnesota);  Mahesh Mahanthappa (Minneapolis, Minnesota);  Paul J. Dauenhauer (Sunderland, Massachusetts)
ABSTRACT Disclosed are compounds of the Formula 1 wherein A is an aromatic moiety; H is a hydrophobic group comprising a main alkyl chain having from about 3 to about 26 carbon atoms and comprising a C2 or greater alkyl chain branched from the main alkyl chain; and K is a hydrophilic group.
FILED Monday, November 07, 2016
APPL NO 15/773991
ART UNIT 1699 — Organic Chemistry
CURRENT CPC
Heterocyclic Compounds
C07D 207/333 (20130101)
C07D 207/337 (20130101)
C07D 213/30 (20130101)
C07D 213/50 (20130101)
C07D 307/20 (20130101)
C07D 307/36 (20130101)
C07D 307/40 (20130101)
C07D 307/42 (20130101)
C07D 307/46 (20130101) Original (OR) Class
C07D 307/64 (20130101)
C07D 333/16 (20130101)
C07D 333/32 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236134 Kong et al.
FUNDED BY
Department of Energy (DOE)
Argonne National Laboratory (ANL)
UChicago Argonne, LLC (UCHICAGO)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) The Scripps Research Institute (La Jolla, California)
ASSIGNEE(S) The Scripps Research Institute (La Jolla, California)
INVENTOR(S) Leopold Kong (Bethesda, Maryland);  Ian A. Wilson (La Jolla, California);  Natalia De Val (San Diego, California);  Andrew B. Ward (San Diego, California);  Dennis Burton (La Jolla, California);  Linling He (San Diego, California);  Jiang Zhu (San Diego, California)
ABSTRACT The present invention provides HIV-1 vaccine immunogens. Some of the immunogens contain a soluble gp140-derived protein that harbors a modified N-terminus of the HR1 region in gp41. Some of the immunogens contain an HIV-1 Env-derived trimer protein that is presented on a nanoparticle platform. The invention also provides methods of using the HIV-1 vaccine immunogens for eliciting an immune response or treating HIV infections.
FILED Monday, February 03, 2020
APPL NO 16/780495
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 39/12 (20130101)
A61K 39/21 (20130101)
A61K 47/64 (20170801)
A61K 47/6929 (20170801)
A61K 2039/645 (20130101)
A61K 2039/5258 (20130101)
A61K 2039/6031 (20130101)

Peptides
C07K 14/005 (20130101)
C07K 14/162 (20130101) Original (OR) Class

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 2740/16122 (20130101)
C12N 2740/16134 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236196 Bae et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
APPLICANT(S) Rensselaer Polytechnic Institute (Troy, New York)
ASSIGNEE(S) Rensselaer Polytechnic Institute (Troy, New York)
INVENTOR(S) Chulsung Bae (Cohoes, New York);  Woo-Hyung Lee (Siheung-Si, South Korea)
ABSTRACT Embodiments of the invention relate to a novel class of polymers with superior mechanical properties and chemical stability, as compared to known polymers. These polymers are particularly well suited for use in anion exchange membranes (AEMs), including those employed in fuel cells. Novel methods for the manufacture of these polymers are also described.
FILED Wednesday, February 12, 2020
APPL NO 16/788506
ART UNIT 1766 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Preservation of Bodies of Humans or Animals or Plants or Parts Thereof; Biocides, e.g as Disinfectants, as Pesticides or as Herbicides; Pest Repellants or Attractants; Plant Growth Regulators
A01N 29/00 (20130101)

Macromolecular Compounds Obtained Otherwise Than by Reactions Only Involving Unsaturated Carbon-to-carbon Bonds
C08G 10/00 (20130101)
C08G 61/02 (20130101) Original (OR) Class
C08G 2261/20 (20130101)
C08G 2261/45 (20130101)
C08G 2261/124 (20130101)
C08G 2261/146 (20130101)
C08G 2261/312 (20130101)
C08G 2261/332 (20130101)

Coating Compositions, e.g Paints, Varnishes or Lacquers; Filling Pastes; Chemical Paint or Ink Removers; Inks; Correcting Fluids; Woodstains; Pastes or Solids for Colouring or Printing; Use of Materials Therefor
C09D 5/14 (20130101)
C09D 165/00 (20130101)

Electrolytic or Electrophoretic Processes for the Production of Compounds or Non-metals; Apparatus Therefor
C25B 13/08 (20130101)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 8/1004 (20130101)
H01M 8/1039 (20130101)
H01M 8/1072 (20130101)

Climate Change Mitigation Technologies in the Production or Processing of Goods
Y02P 70/50 (20151101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236429 Voskian et al.
FUNDED BY
Department of Energy (DOE)
Pacific Northwest National Laboratory (PNNL)
APPLICANT(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Sahag Voskian (Cambridge, Massachusetts);  Alexander Murray (Canterbury, United Kingdom);  Trevor Alan Hatton (Sudbury, Massachusetts);  Yogesh Surendranath (Cambridge, Massachusetts)
ABSTRACT Systems and methods for electrochemically producing chemical products are provided. In certain cases, the systems and methods described herein are capable of producing chemical products such as hydrogen peroxide in solutions with relatively low concentrations of electrolyte or other dissolved species at high efficiencies and/or low energetic cost. In some cases, redox mediators are used to temporally decouple direct electrochemical processes from the production of the chemical product.
FILED Monday, June 24, 2019
APPL NO 16/450859
ART UNIT 1796 — Coating, Etching, Cleaning, Single Crystal Growth
CURRENT CPC
Electrolytic or Electrophoretic Processes for the Production of Compounds or Non-metals; Apparatus Therefor
C25B 1/30 (20130101)
C25B 9/19 (20210101)
C25B 9/23 (20210101)
C25B 15/08 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236863 Ruiz-Rodriguez et al.
FUNDED BY
Department of Energy (DOE)
UT-Battelle, LLC (UT-BATTELLE)
Oak Ridge National Laboratory (ORNL)
APPLICANT(S) UT-Battelle, LLC (Oak Ridge, Tennessee)
ASSIGNEE(S) UT-BATTELLE, LLC (Oak Ridge, Tennessee)
INVENTOR(S) Mariano M Ruiz-Rodriguez (Knoxville, Tennessee);  Saad R Elorfi (Lafollette, Tennessee);  Christopher M Redmon (Rockwood, Tennessee);  Ryan J Morgan (Lancing, Tennessee)
ABSTRACT An improved system and method for the automated refilling of cryogenic helium is provided. In one embodiment, the system includes a dewar in fluid communication with a liquid helium cryostat through a cryogen transfer line. A controller regulates operation of a three-way valve to pre-cool the transfer line and to cause gaseous helium to flow to the dewar and force liquid helium through the transfer line into the cryostat. The controller is coupled to the output of a cryogenic level sensor, such that the controller regulates the helium liquid level within the cryostat. During filling cycles, the dewar liquid level is also monitored by the cryogenic level sensor and an alarm sounds if the dewar liquid level is undesirably low. Between filling cycles, the controller is operable to ventilate the dewar through a solenoid vent valve in fixed time intervals to ensure the dewar pressure is sufficiently low so as to not bleed liquid helium into the cryostat.
FILED Wednesday, December 19, 2018
APPL NO 16/225396
ART UNIT 3763 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Vessels for Containing or Storing Compressed, Liquefied or Solidified Gases; Fixed-capacity Gas-holders; Filling Vessels With, or Discharging From Vessels, Compressed, Liquefied, or Solidified Gases
F17C 5/06 (20130101) Original (OR) Class
F17C 13/025 (20130101)
F17C 2221/017 (20130101)
F17C 2223/033 (20130101)
F17C 2223/0161 (20130101)
F17C 2225/0123 (20130101)
F17C 2250/043 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236953 de Bock et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
APPLICANT(S) General Electric Company (Schenectady, New York)
ASSIGNEE(S) GENERAL ELECTRIC COMPANY (Schenectady, New York);  U.S. DEPARTMENT OF ENERGY (Washington, District of Columbia)
INVENTOR(S) Hendrik Pieter Jacobus de Bock (Clifton Park, New York);  William Dwight Gerstler (Niskayuna, New York);  Daniel J. Erno (Clifton Park, New York);  John C. Glessner (Kings Mills, Ohio);  Neil R. Garrigan (Niskayuna, New York);  Jeffrey Rambo (Mason, Ohio)
ABSTRACT An inverted heat exchanger device includes an exterior conduit elongated and extending around a center axis between a first end and second end. The exterior conduit including a body having an exterior surface, an interior surface, a center core elongated along the center axis, and plural walls extending between the center core and the interior surface. A first conduit is disposed inside the exterior conduit that includes an inlet, plural core passages, an outlet, and internal manifolds. A first fluid is configured to flow along the first conduit. A second conduit is also disposed inside the exterior conduit. The second conduit includes an inlet, plural core passages, an outlet, and internal manifolds. A second fluid is configured to flow along the second conduit. The plural walls are configured to define the first conduit and the second conduit within the body of the exterior conduit.
FILED Friday, November 22, 2019
APPL NO 16/692728
ART UNIT 3763 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Additive Manufacturing, i.e Manufacturing of Three-dimensional [3-D] Objects by Additive Deposition, Additive Agglomeration or Additive Layering, e.g by 3-d Printing, Stereolithography or Selective Laser Sintering
B33Y 80/00 (20141201)

Details of Heat-exchange and Heat-transfer Apparatus, of General Application
F28F 1/42 (20130101) Original (OR) Class
F28F 7/02 (20130101)
F28F 13/08 (20130101)
F28F 2250/104 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11238013 Oganezov et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) INTEL CORPORATION (Santa Clara, California)
ASSIGNEE(S) INTEL CORPORATION (Santa Clara, California)
INVENTOR(S) Alexander Oganezov (Portland, Oregon);  Jeffrey V. Olivier (Longmont, Colorado);  Christopher Holguin (Denver, Colorado)
ABSTRACT Logic may pre-populate cache of compute nodes allocated to a user's session. Logic may access an image file of a global filesystem, the image file to comprise a first set of one or more files associated with a user session and a second set of one or more files upon which execution of the first set will depend. Logic may store the image file in local data storage of each compute node of a spanning tree of compute nodes allocated for the user session. Logic may unpack the image file based on the data. Logic may configure the local environment of each compute node in the spanning tree to identify a location in local memory of each of the files. And logic may initiate execution of a local filesystem service in each of the compute nodes of the spanning tree.
FILED Wednesday, June 27, 2018
APPL NO 16/020906
ART UNIT 2165 — Data Bases & File Management
CURRENT CPC
Electric Digital Data Processing
G06F 9/4416 (20130101)
G06F 16/51 (20190101)
G06F 16/176 (20190101) Original (OR) Class
G06F 16/9027 (20190101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11238999 Piefer et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin);  SHINE Medical Technologies, Inc. (Janesville, Wisconsin)
ASSIGNEE(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin);  SHINE Medical Technologies, Inc. (Madison, Wisconsin)
INVENTOR(S) Gregory Richard Piefer (Middleton, Wisconsin);  Thad Alexander Heltemes (Waunakee, Wisconsin);  Eric Nicholas Van Abel (Oregon, Wisconsin);  Ross Francis Radel (Madison, Wisconsin)
ABSTRACT An apparatus for generating medical isotopes provides an annular fissile solution vessel surrounding a neutron generator. The annular fissile solution vessel provides for good capture of the emitted neutrons and a geometry that provides enhanced stability in an aqueous reactor. A neutron multiplier and/or a neutron moderator may be used to improve the efficiency and control the criticality of the reaction in the annular fissile solution vessel.
FILED Friday, June 07, 2019
APPL NO 16/434324
ART UNIT 3646 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Conversion of Chemical Elements; Radioactive Sources
G21G 1/06 (20130101)
G21G 1/08 (20130101) Original (OR) Class
G21G 1/10 (20130101)
G21G 4/02 (20130101)
G21G 2001/0036 (20130101)
G21G 2001/0042 (20130101)
G21G 2001/0063 (20130101)
G21G 2001/0068 (20130101)

Techniques for Handling Particles or Ionising Radiation Not Otherwise Provided For; Irradiation Devices; Gamma Ray or X-ray Microscopes
G21K 5/08 (20130101)

Plasma Technique; Production of Accelerated Electrically-charged Particles or of Neutrons; Production or Acceleration of Neutral Molecular or Atomic Beams
H05H 3/06 (20130101)
H05H 6/00 (20130101)
H05H 2277/116 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239495 Visco et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
APPLICANT(S) PolyPlus Battery Company (Berkeley, California)
ASSIGNEE(S) PolyPlus Battery Company (Berkeley, California)
INVENTOR(S) Steven J. Visco (Berkeley, California);  Vitaliy Nimon (San Francisco, California);  Yevgeniy S. Nimon (Danville, California);  Bruce D. Katz (Moraga, California)
ABSTRACT Nanofilm-encapsulated sulfide glass solid electrolyte structures and methods for making the encapsulated glass structures involve a lithium ion conducting sulfide glass sheet encapsulated on its opposing major surfaces by a continuous and conformal nanofilm made by atomic layer deposition (ALD). During manufacture, the reactive surfaces of the sulfide glass sheet are protected from deleterious reaction with ambient moisture, and the nanofilm can be configured to provide additional performance advantages, including enhanced mechanical strength and improved chemical resistance.
FILED Tuesday, February 04, 2020
APPL NO 16/781713
ART UNIT 1729 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Specific Uses or Applications of Nanostructures; Measurement or Analysis of Nanostructures; Manufacture or Treatment of Nanostructures
B82Y 30/00 (20130101)

Coating Metallic Material; Coating Material With Metallic Material; Surface Treatment of Metallic Material by Diffusion into the Surface, by Chemical Conversion or Substitution; Coating by Vacuum Evaporation, by Sputtering, by Ion Implantation or by Chemical Vapour Deposition, in General
C23C 16/40 (20130101)
C23C 16/345 (20130101)
C23C 16/45536 (20130101)

Processes or Means, e.g Batteries, for the Direct Conversion of Chemical Energy into Electrical Energy
H01M 4/382 (20130101)
H01M 4/0421 (20130101)
H01M 10/0525 (20130101)
H01M 10/0562 (20130101) Original (OR) Class
H01M 2300/0068 (20130101)
H01M 2300/0071 (20130101)
H01M 2300/0094 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239631 Barwicz et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
APPLICANT(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Tymon Barwicz (Yorktown Heights, New York);  Yves C. Martin (Ossining, New York);  Jason S. Orcutt (Katonah, New York)
ABSTRACT A method of forming a laser including device is provided that in one embodiment includes providing a laser chip including at least one ridge structure that provides an alignment features. The method further includes bonding a type IV photonics chip to the laser chip, wherein a vertical alignment feature from the type IV photonics chip is inserted in a recess relative to the at least one ridge structure that provides the alignment features of the laser structure.
FILED Thursday, September 26, 2019
APPL NO 16/584218
ART UNIT 2828 — Semiconductors/Memory
CURRENT CPC
Devices Using the Process of Light Amplification by Stimulated Emission of Radiation [LASER] to Amplify or Generate Light; Devices Using Stimulated Emission of Electromagnetic Radiation in Wave Ranges Other Than Optical
H01S 5/22 (20130101)
H01S 5/0234 (20210101)
H01S 5/0237 (20210101)
H01S 5/02326 (20210101)
H01S 5/02375 (20210101) Original (OR) Class
H01S 5/04252 (20190801)
H01S 2301/176 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239732 Hagen et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
ASSIGNEE(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
INVENTOR(S) Skyler S. Hagen (Markesan, Wisconsin);  Daniel Colin Ludois (Middleton, Wisconsin)
ABSTRACT An electrical rotating machine, such as a generator or motor, communicates power from a stationary location to the rotating rotor of the rotating machine via opposed pairs of capacitor plates, one plate of each pair rotating with the rotor and one plate of each pair fixed not to rotate. Larger plate gaps suitable for mechanically rigid plates are possible through high-voltage and high-frequency AC signals managed by using a dielectric support design for the capacitor plates minimizing dielectric loss and/or impedance matching on the rotor.
FILED Wednesday, August 07, 2019
APPL NO 16/534735
ART UNIT 2832 — Electrical Circuits and Systems
CURRENT CPC
Electrically-conductive Connections; Structural Associations of a Plurality of Mutually-insulated Electrical Connecting Elements; Coupling Devices; Current Collectors
H01R 39/02 (20130101)

Dynamo-electric Machines
H02K 13/003 (20130101) Original (OR) Class
H02K 13/14 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11240433 Dayton et al.
FUNDED BY
Department of Energy (DOE)
Lawrence Livermore National Laboratory (LLNL)
Lawrence Livermore National Security LLC (LLNS)
APPLICANT(S) Lawrence Livermore National Security, LLC (Livermore, California)
ASSIGNEE(S) Lawrence Livermore National Security, LLC (Livermore, California)
INVENTOR(S) Matthew S. Dayton (Hayward, California);  John E. Field (Dorrington, California)
ABSTRACT The present disclosure is directed to a snapshot multiframe imager having an aperture element having at least one aperture, an adjacently positioned random mask, an imaging element and a computer. The random mask has a plurality of micron scale apertures and receives light passing through the aperture element, which represents the spatial information from the scene being imaged, and generates a plurality of image frames encoded in a spatial domain. The imaging element may operate in a drift-scan mode receives the encoded image frames and generates a streaked pattern of electrons representing a plurality of images of the scene at a plurality of different times. The computer analyzes the streaked pattern of electrons and mathematically reconstructs the plurality of images.
FILED Friday, April 24, 2020
APPL NO 16/857913
ART UNIT 2696 — Selective Visual Display Systems
CURRENT CPC
Pictorial Communication, e.g Television
H04N 5/32 (20130101)
H04N 5/372 (20130101)
H04N 5/23277 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11240935 Chainer et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Timothy J. Chainer (Putnam Valley, New York);  Pritish R. Parida (Fishkill, New York)
ABSTRACT A data center cooling system is operated in a first mode, has an indoor portion wherein heat is absorbed from components in the data center by a heat transfer fluid, and has an outdoor heat exchanger portion and a geothermal heat exchanger portion. The first mode includes ambient air cooling of the heat transfer fluid in the outdoor heat exchanger portion and/or geothermal cooling of the heat transfer fluid in the geothermal heat exchanger portion. Based on an appropriate metric, a determination is made that a switch should be made from the first mode to a second, different, mode; and, responsive thereto, the data center cooling system is switched to the second mode. The second mode includes at least another of ambient air cooling of the heat transfer fluid in the outdoor heat exchanger portion and geothermal cooling of the heat transfer fluid in the geothermal heat exchanger portion.
FILED Saturday, July 11, 2020
APPL NO 16/926663
ART UNIT 3763 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Electric Digital Data Processing
G06F 1/20 (20130101)
G06F 2200/201 (20130101)

Printed Circuits; Casings or Constructional Details of Electric Apparatus; Manufacture of Assemblages of Electrical Components
H05K 7/2079 (20130101)
H05K 7/20654 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

National Aeronautics and Space Administration (NASA) 

US 11236764 Phui et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
Marshall Space Flight Center (MSFC)
APPLICANT(S) Aerojet Rocketdyne, Inc. (Sacramento, California)
ASSIGNEE(S) Aerojet Rocketdyne, Inc. (Canoga Park, California)
INVENTOR(S) Khin Phui (Cucamonga, California);  Sen Meng (Reseda, California)
ABSTRACT A pump includes an axial inducer. The axial inducer includes a housing that has an internal surface that defines an axial fluid passage. A rotor is disposed about a central axis in the fluid passage. The rotor includes at least one blade that defines at least one blade tip. The internal surface of the housing defines a plurality of grooves adjacent the at least one blade tip. The grooves are elongated in a circumferential direction.
FILED Friday, October 12, 2018
APPL NO 16/767820
ART UNIT 3746 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Non-positive-displacement Pumps
F04D 29/52 (20130101) Original (OR) Class
F04D 29/688 (20130101)
F04D 29/4293 (20130101)

Indexing Scheme for Aspects Relating to Non-positive-displacement Machines or Engines, Gas-turbines or Jet-propulsion Plants
F05D 2250/50 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237056 Hosseini
FUNDED BY
National Aeronautics and Space Administration (NASA)
Jet Propulsion Laboratory (JPL)
APPLICANT(S) California Institute of Technology (Pasadena, California)
ASSIGNEE(S) California Institute of Technology (Pasadena, California)
INVENTOR(S) Seyedeh Sona Hosseini (Pasadena, California)
ABSTRACT Novel monolithic cyclical reflective spatial heterodyne spectrometers (CRSHS) are presented. Monolithic CRSHS in accordance with the invention have a single frame wherein a flat mirror, roof mirror, and symmetric grating are affixed. The invention contains only fixed parts; the flat mirror, roof mirror, and symmetric grating do not move in relation to the frame. Compared to conventional CRSHS known in the art, the present invention enables much smaller and lighter CRSHS, requires less time and skill for maintenance, and is a better economic option. The disclosed invention may include fixed field-widening optical elements or a fiber-fed assembly.
FILED Tuesday, November 07, 2017
APPL NO 15/806305
ART UNIT 2886 — Optics
CURRENT CPC
Measurement of Intensity, Velocity, Spectral Content, Polarisation, Phase or Pulse Characteristics of Infra-Red, Visible or Ultra-violet Light; Colorimetry; Radiation Pyrometry
G01J 3/18 (20130101)
G01J 3/0202 (20130101)
G01J 3/0205 (20130101)
G01J 3/0218 (20130101)
G01J 3/0259 (20130101)
G01J 3/453 (20130101) Original (OR) Class
G01J 3/1804 (20130101)
G01J 3/4531 (20130101)
G01J 3/4532 (20130101)
G01J 2003/1204 (20130101)
G01J 2003/1208 (20130101)
G01J 2003/1861 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11238196 Bolander et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
United States Army (USA)
Department of the Navy (DON)
Naval Air Systems Command (NAVAIR)
United States Navy (USN)
National Aeronautics and Space Administration (NASA)
NASA Shared Services Center (NSSC)
APPLICANT(S) Sentient Science Corporation (Buffalo, New York)
ASSIGNEE(S) Sentient Science Corporation (Buffalo, New York)
INVENTOR(S) Nathan Bolander (Idaho Falls, Idaho);  Rajasekhar V. Pulikollu (Nashville, Tennessee);  Behrooz Jalalahmadi (Idaho Falls, Idaho)
ABSTRACT A system and method for determining surface contact fatigue life may use a finite element method to determine when components, such as a power transmission component, may fail in operation. The method may generate a finite element model based on the material parameters related to a power transmission component, generate a surface pressure time history for a loading event based on one or more loading parameters, determine, based on the surface pressure time history for a loading event, a finite element solution that describes stress in the grain structure, calculate damage in the finite element solution using a damage model, and determine whether a damage threshold is exceeded.
FILED Tuesday, November 12, 2019
APPL NO 16/680728
ART UNIT 2863 — Printing/Measuring and Testing
CURRENT CPC
Gearing
F16H 2057/0087 (20130101)

Testing Static or Dynamic Balance of Machines or Structures; Testing of Structures or Apparatus, Not Otherwise Provided for
G01M 13/022 (20130101)

Electric Digital Data Processing
G06F 17/18 (20130101)
G06F 30/23 (20200101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239567 Freebury et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
NASA Shared Services Center (NSSC)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) TENDEG LLC (Louisville, Colorado)
ASSIGNEE(S) TENDEG LLC (Louisville, Colorado)
INVENTOR(S) Gregg E. Freebury (Louisville, Colorado);  Matthew Phillip Mitchell (Colorado Springs, Colorado)
ABSTRACT An antenna having a reflector mounted on a rigid boom uses a line feed or phased array feed to operate in the Ka band with frequencies up to 36 gigahertz while maintaining the ability to operate at frequencies down to L-Band of 1-2 GHz.
FILED Thursday, May 07, 2020
APPL NO 16/869420
ART UNIT 2844 — Electrical Circuits and Systems
CURRENT CPC
Antennas, i.e Radio Aerials
H01Q 15/14 (20130101) Original (OR) Class
H01Q 15/141 (20130101)
H01Q 15/147 (20130101)
H01Q 15/161 (20130101)
H01Q 15/162 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239745 Hesterman
FUNDED BY
National Aeronautics and Space Administration (NASA)
Glenn Research Center (GLENN)
APPLICANT(S) Aerojet Rocketdyne, Inc. (Sacramento, California)
ASSIGNEE(S) AEROJET ROCKETDYNE, INC (Redmond, Washington)
INVENTOR(S) Bryce L. Hesterman (Redmond, Washington)
ABSTRACT A power converter includes a first rectifier circuit having a pair of first rectifier circuit output terminals and a second rectifier circuit having a pair of second rectifier circuit output terminals, a snubber circuit comprising a first diode and a first capacitor connected to each other at a first node and connecting the pair of first rectifier circuit output terminals, a second diode and a second capacitor connected to each other at a second node and connecting the pair of second rectifier circuit output terminals, a third diode connecting the first node to one of the pair of second rectifier output terminals, and a fourth diode connecting the second node to one of the pair of first rectifier output terminals.
FILED Wednesday, April 11, 2018
APPL NO 17/045607
ART UNIT 2838 — Electrical Circuits and Systems
CURRENT CPC
Apparatus for Conversion Between AC and AC, Between AC and DC, or Between DC and DC, and for Use With Mains or Similar Power Supply Systems; Conversion of DC or AC Input Power into Surge Output Power; Control or Regulation Thereof
H02M 1/34 (20130101) Original (OR) Class
H02M 1/0048 (20210501)
H02M 1/0077 (20210501)
H02M 1/346 (20210501)
H02M 7/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Small Business Administration (SBA) 

US 11235141 Lucke et al.
FUNDED BY
Department of Health and Human Services (HHS)
U.S. Public Health Service (USPHS)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Minnetronix, Inc. (St. Paul, Minnesota)
ASSIGNEE(S) Minnetronix, Inc. (St. Paul, Minnesota)
INVENTOR(S) Lori Lucke (Rosemount, Minnesota);  Vlad Bluvshtein (Plymouth, Minnesota);  James Kurkowski (Roseville, Minnesota);  William Weiss (Mechanicsburg, Pennsylvania)
ABSTRACT Disclosed are systems and methods for use of an inductive link for a communication channel in a transcutaneous energy transfer system. An example system may include a resonant circuit associated with an external primary, a power transistor connected to the resonant circuit and configured to drive the resonant circuit with a first time-varying electrical signal having a frequency, and a power driver connected to the power transistor that is configured to set the frequency of the first time-varying electrical signal to a resonant frequency to enable power transfer from the external primary to an implanted secondary. The example system may further include a communication driver operatively connected to the power transistor and configured to encode the first time-varying electrical signal with a data signal by modulating an attribute of the time-varying electrical signal as electrical power is transferred from the external primary to the implanted secondary.
FILED Monday, September 09, 2019
APPL NO 16/564210
ART UNIT 3792 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
CURRENT CPC
Devices for Introducing Media Into, or Onto, the Body; Devices for Transducing Body Media or for Taking Media From the Body; Devices for Producing or Ending Sleep or Stupor
A61M 60/148 (20210101)
A61M 60/205 (20210101)
A61M 60/871 (20210101) Original (OR) Class

Electrotherapy; Magnetotherapy; Radiation Therapy; Ultrasound Therapy
A61N 1/3727 (20130101)
A61N 1/3787 (20130101)
A61N 1/37223 (20130101)

Transmission
H04B 3/54 (20130101)
H04B 3/548 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11235361 Quigley et al.
FUNDED BY
National Science Foundation (NSF)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Loci Controls, Inc. (Wareham, Massachusetts)
ASSIGNEE(S) Loci Controls, Inc. (Wareham, Massachusetts)
INVENTOR(S) Peter Quigley (Duxbury, Massachusetts);  Ian Martin (Sharon, Massachusetts);  Nicole Neff (Colorado Springs, Colorado);  Jack Rowbottom (Swansea, Massachusetts)
ABSTRACT Described herein are embodiments of a control system that automatically (1) determines whether a gas extraction system is in a state in which landfill gas is being released into the atmosphere, and (2) automatically controls landfill gas flow to mitigate, prevent and/or stop the release of landfill gas. The control system may control a valve to control flow of landfill gas through well piping of the gas extraction system. The pressure of landfill gas in the well piping at a location upstream of the valve may indicate whether there is a risk of landfill gas being released into the atmosphere. The control system may adjust a position of the valve in response to determining that the pressure at the location upstream of the valve indicates that there is a risk of landfill gas being released into the atmosphere.
FILED Monday, November 02, 2020
APPL NO 17/086987
ART UNIT 3672 — Wells, Earth Boring/Moving/Working, Excavating, Mining, Harvesters, Bridges, Roads, Petroleum, Closures, Connections, and Hardware
CURRENT CPC
Disposal of Solid Waste
B09B 1/006 (20130101) Original (OR) Class

Earth Drilling, e.g Deep Drilling; Obtaining Oil, Gas, Water, Soluble or Meltable Materials or a Slurry of Minerals From Wells
E21B 34/02 (20130101)

Climate Change Mitigation Technologies Related to Wastewater Treatment or Waste Management
Y02W 30/30 (20150501)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237369 Weida et al.
FUNDED BY
National Science Foundation (NSF)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) DAYLIGHT SOLUTIONS, INC. (San Diego, California)
ASSIGNEE(S) DAYLIGHT SOLUTIONS, INC. (San Diego, California)
INVENTOR(S) Miles James Weida (Poway, California);  Timothy Day (Poway, California)
ABSTRACT An imaging microscope (12) for generating an image of a sample (10) comprises a beam source (14) that emits a temporally coherent illumination beam (20), the illumination beam (20) including a plurality of rays that are directed at the sample (10); an image sensor (18) that converts an optical image into an array of electronic signals; and an imaging lens assembly (16) that receives rays from the beam source (14) that are transmitted through the sample (10) and forms an image on the image sensor (18). The imaging lens assembly (16) can further receive rays from the beam source (14) that are reflected off of the sample (10) and form a second image on the image sensor (18). The imaging lens assembly (16) receives the rays from the sample (10) and forms the image on the image sensor (18) without splitting and recombining the rays.
FILED Friday, March 20, 2020
APPL NO 16/825916
ART UNIT 2487 — Recording and Compression
CURRENT CPC
Optical Elements, Systems, or Apparatus
G02B 21/00 (20130101)
G02B 21/0056 (20130101) Original (OR) Class
G02B 21/0088 (20130101)
G02B 21/088 (20130101)
G02B 21/365 (20130101)

Pictorial Communication, e.g Television
H04N 5/33 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239567 Freebury et al.
FUNDED BY
National Aeronautics and Space Administration (NASA)
NASA Shared Services Center (NSSC)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) TENDEG LLC (Louisville, Colorado)
ASSIGNEE(S) TENDEG LLC (Louisville, Colorado)
INVENTOR(S) Gregg E. Freebury (Louisville, Colorado);  Matthew Phillip Mitchell (Colorado Springs, Colorado)
ABSTRACT An antenna having a reflector mounted on a rigid boom uses a line feed or phased array feed to operate in the Ka band with frequencies up to 36 gigahertz while maintaining the ability to operate at frequencies down to L-Band of 1-2 GHz.
FILED Thursday, May 07, 2020
APPL NO 16/869420
ART UNIT 2844 — Electrical Circuits and Systems
CURRENT CPC
Antennas, i.e Radio Aerials
H01Q 15/14 (20130101) Original (OR) Class
H01Q 15/141 (20130101)
H01Q 15/147 (20130101)
H01Q 15/161 (20130101)
H01Q 15/162 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Agriculture (USDA) 

US 11236315 Donovan et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) The United States of America, as Represented by the Secretary of Agriculture (Washington, District of Columbia);  University of Maryland (College Park, Maryland)
ASSIGNEE(S) The United States of America, as represented by the Secretary of Agriculture (Washington, District of Columbia);  University of Maryland (College Park, Maryland)
INVENTOR(S) David M. Donovan (Essex, Maryland);  Steven M. Swift (Bethesda, Maryland)
ABSTRACT The disclosure relates to chimeric recombinant lysins comprising at least one thermophile endolysin catalytic domain and at least one cell wall binding domain. Also disclosed are polynucleotides encoding the chimeric recombinant lysins, host cells expressing the chimeric recombinant lysins, and use of such chimeric recombinant lysins.
FILED Thursday, April 04, 2019
APPL NO 16/375287
ART UNIT 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Fodder
A23K 20/147 (20160501)

Preparations for Medical, Dental, or Toilet Purposes
A61K 38/00 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 31/04 (20180101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/2462 (20130101) Original (OR) Class

Enzymes
C12Y 302/01017 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236355 Staskawicz et al.
FUNDED BY
Department of Agriculture (USDA)
National Institute of Food and Agriculture (NIFA)
Institute of Youth, Family, and Community (IYFC)
APPLICANT(S) The Regents of the University of California (Oakland, California)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California)
INVENTOR(S) Brian J. Staskawicz (Berkeley, California);  Alexander Christiaan Schultink (Berkeley, California)
ABSTRACT Provided herein is a non-Nicotiana transgenic plant comprising an exogenous polynucleotide encoding Nicotiana benthamiana Roq1 or a variant thereof. These plants have enhanced resistance to at least one species of Xanthomonas, Pseudomonas, Ralstonia, and/or another pathogen containing a homolog of XopQ whose recognition is mediated by Roq1.
FILED Tuesday, August 21, 2018
APPL NO 16/639379
ART UNIT 1662 — Plants
CURRENT CPC
Peptides
C07K 14/415 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/8281 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236368 Steele et al.
FUNDED BY
Department of Agriculture (USDA)
National Institute of Food and Agriculture (NIFA)
APPLICANT(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
ASSIGNEE(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
INVENTOR(S) James L. Steele (Madison, Wisconsin);  Jeffrey Broadbent (Logan, Utah);  Ekkarat Phrommao (Madison, Wisconsin)
ABSTRACT An ethanologen for producing biofuel from one or more carbohydrates and reducing lactate and acetate production in a biofuel manufacturing process. The ethanologen is made by introducing into the ethanologen one or more exogenous genes required for production of a bacteriocin. The resulting ethanologen reduces lactate and acetate production by contaminant lactic acid bacteria by expression of the bacteriocin during the biofuel manufacturing process. Certain resulting ethanologens ferment sugars not naturally or not preferentially utilized by Saccharomyces cerevisiae during the manufacturing process.
FILED Thursday, July 13, 2017
APPL NO 15/648872
ART UNIT 1652 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Peptides
C07K 14/195 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 1/16 (20130101)
C12N 1/20 (20130101)
C12N 1/38 (20130101)
C12N 9/88 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 7/06 (20130101)
C12P 7/10 (20130101)
C12P 7/065 (20130101) Original (OR) Class
C12P 7/649 (20130101)
C12P 21/02 (20130101)

Enzymes
C12Y 101/01001 (20130101)
C12Y 401/01001 (20130101)

Reduction of Greenhouse Gas [GHG] Emissions, Related to Energy Generation, Transmission or Distribution
Y02E 50/10 (20130101)
Y02E 50/30 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Homeland Security (DHS) 

US 11235181 Daeffler et al.
FUNDED BY
Department of Homeland Security (DHS)
APPLICANT(S) The Government of the United States of America, as represented by the Secretary of Homeland Security (Washington, District of Columbia)
ASSIGNEE(S) The Government of the United States of America, as represented by the Secretary of Homeland Security (Washington, District of Columbia)
INVENTOR(S) Michael Daeffler (Salem, Connecticut);  Michael Plumley (New London, Connecticut);  Ronald Adrezin (East Lyme, Connecticut)
ABSTRACT In an example, a respirator includes a respirator body having a distal portion and a proximal portion, the distal portion including a filter housing wall and an open distal end. The proximal portion includes a facial interface which is compliant and deformable from an undeformed state to a deformed state to conform to a facial contour of an individual. One or more filter frames are inserted into the distal portion and supported by the filter housing wall to separate filter media on opposite sides of at least one of the one or more filter frames. A filter cover is releasably attached to the open distal end to enclose the one or more filter frames and filter media, forming a filter housing. The one or more filter frames are removable from the distal portion and replaced into the distal portion to allow replacement of the filter media.
FILED Thursday, November 12, 2020
APPL NO 17/096561
ART UNIT 3785 — Body Treatment, Kinestherapy, and Exercising
CURRENT CPC
Devices, Apparatus or Methods for Life-saving
A62B 7/10 (20130101) Original (OR) Class
A62B 9/06 (20130101)
A62B 18/025 (20130101)
A62B 18/084 (20130101)
A62B 23/02 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237083 Cho
FUNDED BY
Department of Homeland Security (DHS)
APPLICANT(S) The Government of the United States of America, as represented by the Secretary of Homeland Security (Washington, District of Columbia)
ASSIGNEE(S) The Government of the United States of America, as represented by the Secretary of Homeland Security (Washington, District of Columbia)
INVENTOR(S) Inho Cho (Egg Harbor Township, New Jersey)
ABSTRACT In an example, a thermal extraction apparatus includes: a housing having a gas inlet and a gas outlet to receive a gas flow through the housing from the gas inlet to the gas outlet, and a side opening to receive a sample collector, having a sample collector adsorbent containing a vapor sample, into a sample collector location; a pump to generate the gas flow; a heater to heat the sample collector adsorbent of the sample collector to a temperature sufficient to release the vapor sample; a thermal desorption (TD) tube connected with the gas outlet of the housing to receive the gas flow downstream of the sample collector and collect the vapor sample released from the sample collector adsorbent of the sample collector; and a cooling member in heat exchange with the TD tube to cool the TD tube.
FILED Friday, January 29, 2021
APPL NO 17/162984
ART UNIT 2856 — Printing/Measuring and Testing
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 1/44 (20130101)
G01N 1/2214 (20130101) Original (OR) Class
G01N 1/2247 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237143 Gregory et al.
FUNDED BY
Department of Homeland Security (DHS)
Science and Technology Directorate (DHS-S&T)
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Materiel Command (AFMC)
Air Force Office of Scientific Research (AFOSR)
MIT Lincoln Laboratory (MITLL)
Under Secretary of Defense for Research and Engineering (USDR&E)
APPLICANT(S) Massachusetts Institute Of Technology (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute Of Technology (Cambridge, Massachusetts)
INVENTOR(S) Kerin E. Gregory (Bolton, Massachusetts);  Roderick R. Kunz (Acton, Massachusetts);  Michael Sworin (Marlboro, Massachusetts)
ABSTRACT Reagents and methods are disclosed for detection of oxidizers and inorganic salts and other analytes of interest. The reagents can interact with their target analytes, especially oxidizer compositions or oxidizer-based explosives, to selectively enhance their ionization yield, interacting by chemical reaction or by forming an associative adduct which facilitates their detection. For example, the reagents can adduct with the counter-ion of the intended analyte for improved direct detection and/or react chemically via acid-base reactions to produce a new product for detection. In another aspect of the invention, reactive reagents and methods are also disclosed that facilitate indirect detection of the analyte at lower temperatures based on reduction-oxidation (redox) chemistry. These reagents are particularly useful in detecting oxidizer analytes.
FILED Friday, February 17, 2017
APPL NO 15/435733
ART UNIT 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 27/622 (20130101)
G01N 31/227 (20130101)
G01N 33/227 (20130101) Original (OR) Class
G01N 2001/028 (20130101)

Technical Subjects Covered by Former US Classification
Y10T 436/19 (20150115)
Y10T 436/24 (20150115)
Y10T 436/141111 (20150115)
Y10T 436/143333 (20150115)
Y10T 436/173076 (20150115)
Y10T 436/206664 (20150115)
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Veterans Affairs (DVA) 

US 11236139 Dubinett et al.
FUNDED BY
Department of Veterans Affairs (DVA)
APPLICANT(S) The Regents of the University of California (Oakland, California);  United States Government represented by the Department of Veterans Affairs (Washington, District of Columbia)
ASSIGNEE(S) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, California);  UNITED STATES GOVERNMENT REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (Washington, District of Columbia)
INVENTOR(S) Steven M. Dubinett (Los Angeles, California);  Sherven Sharma (Culver City, California);  Jay M. Lee (Los Angeles, California)
ABSTRACT The invention is based on the disclosure provided herein that secondary lymphoid organ chemokine (SLC) inhibits the growth of syngeneic tumors in vivo. Thus, the invention provides a method of treating cancer in a mammal subject by administering a therapeutically effective amount of an SLC to the mammal in combination with a checkpoint inhibitor, including monoclonal antibodies and small molecule inhibitors. Exemplary checkpoint molecules include CTLA-4, a CTLA-4 receptor, PD-1, PD1-L1, PD1-L2, 4-1BB, OX40, LAG-3, TIM-3 or a combination thereof. SLCs useful in the methods of the invention include SLC polypeptides, variants and fragments and related nucleic acids.
FILED Thursday, November 05, 2015
APPL NO 15/524740
ART UNIT 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 9/0019 (20130101)
A61K 38/195 (20130101)
A61K 38/195 (20130101)
A61K 39/0011 (20130101)
A61K 39/3955 (20130101)
A61K 39/3955 (20130101)
A61K 39/39558 (20130101)
A61K 45/06 (20130101)
A61K 48/00 (20130101)
A61K 2039/54 (20130101)
A61K 2039/545 (20130101)
A61K 2039/5154 (20130101)
A61K 2039/5256 (20130101)
A61K 2300/00 (20130101)
A61K 2300/00 (20130101)

Specific Therapeutic Activity of Chemical Compounds or Medicinal Preparations
A61P 35/00 (20180101)

Peptides
C07K 14/521 (20130101) Original (OR) Class
C07K 16/24 (20130101)
C07K 16/249 (20130101)
C07K 16/2818 (20130101)
C07K 2317/76 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 7/00 (20130101)
C12N 2710/10041 (20130101)
C12N 2710/10043 (20130101)
C12N 2710/10071 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236340 Wyss-Coray et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Aging (NIA)
NIH Office of the Director (NIHOD)
APPLICANT(S) THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford, California);  THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (Washington, District of Columbia)
ASSIGNEE(S) THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (Stanford, California);  THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (Washington, District of Columbia)
INVENTOR(S) Anton Wyss-Coray (Palo Alto, California);  Thomas A. Rando (Stanford, California);  Markus Britschgi (Allscwil, Switzerland);  Kaspar Rufibach (Basel, Switzerland);  Saul A. Villeda (Lancaster, California)
ABSTRACT Methods of treating an adult mammal for an aging-associated impairment are provided. Aspects of the methods include modulating CCR3, e.g., by modulating eotaxin-1/CCR3 interaction, in the mammal in a manner sufficient to treat the mammal for the aging-associated impairment. A variety of aging-associated impairments may be treated by practice of the methods, which impairments include cognitive impairments.
FILED Tuesday, April 07, 2020
APPL NO 16/842054
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 31/00 (20130101)
A61K 31/7088 (20130101)
A61K 38/19 (20130101)
A61K 38/45 (20130101)
A61K 2039/505 (20130101)

Peptides
C07K 16/24 (20130101)
C07K 16/28 (20130101)
C07K 2317/76 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 15/1138 (20130101) Original (OR) Class
C12N 2310/14 (20130101)
C12N 2799/06 (20130101)
C12N 2799/022 (20130101)

Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6883 (20130101)
C12Q 2600/136 (20130101)
C12Q 2600/158 (20130101)

Enzymes
C12Y 207/10001 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236398 Glazko et al.
FUNDED BY
Department of Veterans Affairs (DVA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) BioVentures, LLC (Little Rock, Arkansas);  The United States As Represented By The Department of Veterans Affairs (Washington, District of Columbia)
ASSIGNEE(S) BioVentures, LLC (Little Rock, Arkansas);  The United States As Represented By The Department of Veterans Affairs (Washington, District of Columbia)
INVENTOR(S) Galina Glazko (Little Rock, Arkansas);  Curt H. Hagedorn (Little Rock, Arkansas);  Yasir Rahmatallah (Little Rock, Arkansas)
ABSTRACT The disclosure provides a method to detect sessile serrated adenomas/polyps (SSA/Ps) and to differentiate SSA/Ps from hyperplastic polyps (HPs). The method uses a molecular signature that is platform-independent and could be used with multiple platforms such as microarray, RNA-seq or real-time quantitative platforms.
FILED Thursday, March 01, 2018
APPL NO 16/489604
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Measuring or Testing Processes Involving Enzymes, Nucleic Acids or Microorganisms; Compositions or Test Papers Therefor; Processes of Preparing Such Compositions; Condition-responsive Control in Microbiological or Enzymological Processes
C12Q 1/6886 (20130101) Original (OR) Class
C12Q 2600/112 (20130101)
C12Q 2600/118 (20130101)

Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 2800/7028 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

United States Postal Service (USPS) 

US 11235903 Lee, Sr.
FUNDED BY
United States Postal Service (USPS)
APPLICANT(S) United States Postal Service (Washington, District of Columbia)
ASSIGNEE(S) United States Postal Service (Washington, District of Columbia)
INVENTOR(S) James Edward Lee, Sr. (St. Leonard, Maryland)
ABSTRACT Embodiments of a reusable stackable shipping box are provided herein. The reusable stackable shipping box may be reused and cleaned without causing harm to the integrity of the box. In addition, the box is slightly tapered in shape such that the box may be stacked upon and within other boxes for ease in shipping and organization.
FILED Wednesday, April 22, 2020
APPL NO 16/855392
ART UNIT 3734 — Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
CURRENT CPC
Containers for Storage or Transport of Articles or Materials, e.g Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding Containers; Accessories, Closures, or Fittings Therefor; Packaging Elements; Packages
B65D 5/001 (20130101) Original (OR) Class
B65D 5/10 (20130101)
B65D 5/14 (20130101)
B65D 5/0245 (20130101)
B65D 5/0281 (20130101)
B65D 5/4266 (20130101)
B65D 5/4608 (20130101)
B65D 5/48024 (20130101)

Climate Change Mitigation Technologies Related to Wastewater Treatment or Waste Management
Y02W 30/80 (20150501)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11238298 Schimmel
FUNDED BY
United States Postal Service (USPS)
APPLICANT(S) United States Postal Service (Washington, District of Columbia)
ASSIGNEE(S) United States Postal Service (Washington, District of Columbia)
INVENTOR(S) Todd M. Schimmel (Annandale, Virginia)
ABSTRACT Systems, devices, and methods for monitoring items in a defined physical area can include a primary camera configured to detect a region of interest within a defined physical area and the coordinates of the region of interest in the defined physical area. A plurality of secondary cameras can positioned throughout a defined physical area. One of the secondary cameras can be selected to capture an image of a region of interest based on the coordinates of the region of interest.
FILED Tuesday, March 17, 2020
APPL NO 16/821714
ART UNIT 2665 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Recognition of Data; Presentation of Data; Record Carriers; Handling Record Carriers
G06K 9/00744 (20130101)
G06K 9/00771 (20130101)
G06K 9/3233 (20130101) Original (OR) Class

Data Processing Systems or Methods, Specially Adapted for Administrative, Commercial, Financial, Managerial, Supervisory or Forecasting Purposes; Systems or Methods Specially Adapted for Administrative, Commercial, Financial, Managerial, Supervisory or Forecasting Purposes, Not Otherwise Provided for
G06Q 10/087 (20130101)
G06Q 10/0833 (20130101)

Image Data Processing or Generation, in General
G06T 7/11 (20170101)

Pictorial Communication, e.g Television
H04N 5/23203 (20130101)
H04N 5/23238 (20130101)
H04N 7/181 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11238399 Dixon et al.
FUNDED BY
United States Postal Service (USPS)
APPLICANT(S) United States Postal Service (Washington, District of Columbia)
ASSIGNEE(S) United States Postal Service (Washington, District of Columbia)
INVENTOR(S) Robert E. Dixon (Haymarket, Virginia);  Ryan Luckay (Vienna, Virginia)
ABSTRACT Methods and systems for on demand logistics management are disclosed. An on-demand logistics system includes an electronic hardware processor configured to receive an on-demand request, the request indicating an on-demand location for an on-demand transaction, determine locations of a plurality of vehicles on a plurality of delivery routes, determine whether the on-demand location is within a threshold distance of at least one of the plurality of delivery routes based on the vehicle locations and assign the on-demand transaction to a vehicle based on the determination.
FILED Monday, July 16, 2018
APPL NO 16/036829
ART UNIT 3662 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems
CURRENT CPC
Measuring Distances, Levels or Bearings; Surveying; Navigation; Gyroscopic Instruments; Photogrammetry or Videogrammetry
G01C 21/343 (20130101)
G01C 21/3415 (20130101)

Systems for Controlling or Regulating Non-electric Variables
G05D 1/0212 (20130101)
G05D 1/0287 (20130101)
G05D 2201/0212 (20130101)
G05D 2201/0213 (20130101)

Data Processing Systems or Methods, Specially Adapted for Administrative, Commercial, Financial, Managerial, Supervisory or Forecasting Purposes; Systems or Methods Specially Adapted for Administrative, Commercial, Financial, Managerial, Supervisory or Forecasting Purposes, Not Otherwise Provided for
G06Q 10/0834 (20130101)
G06Q 10/06315 (20130101)
G06Q 10/08355 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Transportation (USDOT) 

US 11235307 Chang et al.
FUNDED BY
National Science Foundation (NSF)
Directorate of Geosciences (GEO)
Integrative and Collaborative Education and Research (ICER)
Department of Transportation (USDOT)
U.S. State Government
State of Florida
Florida Department of Transportation (FDOT)
APPLICANT(S) University of Central Florida Research Foundation, Inc. (Orlando, Florida)
ASSIGNEE(S) University of Central Florida Research Foundation, Inc. (Orlando, Florida)
INVENTOR(S) Ni-Bin Chang (Orlando, Florida);  Martin P. Wanielista (Orlando, Florida)
ABSTRACT A synergistic composition can be used to treat water containing nitrogen compounds and phosphorus compounds. The synergistic composition includes iron filings, clay particles, aluminum particles, and sand particles. The iron filings, clay particles, and aluminum particles act synergistically to remove nitrogen compounds and phosphorus compounds from water. Specifically, the clay particles attract the nitrogen compounds and the phosphorus compounds to be absorbed onto a surface of the iron filings and the clay particles. The aluminum particles react with the nitrogen compounds via an oxidation reaction to form ammonia compounds, and react with the phosphorus compounds to produce aluminum phosphate. As such, the synergistic relationship between the iron filings, clay particles, and aluminum particles remove nitrogen and phosphorus compounds from water and recover the compounds in usable forms, namely, ammonia and aluminum phosphate.
FILED Friday, May 14, 2021
APPL NO 17/302895
ART UNIT 1773 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 20/12 (20130101)
B01J 20/103 (20130101)
B01J 20/0229 (20130101)
B01J 20/0248 (20130101)
B01J 20/261 (20130101)
B01J 20/28016 (20130101) Original (OR) Class

Treatment of Water, Waste Water, Sewage, or Sludge
C02F 1/72 (20130101)
C02F 1/281 (20130101)
C02F 1/285 (20130101)
C02F 1/288 (20130101)
C02F 1/705 (20130101)
C02F 1/5245 (20130101)
C02F 2101/16 (20130101)
C02F 2101/105 (20130101)
C02F 2101/163 (20130101)
C02F 2103/001 (20130101)
C02F 2103/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236322 Corgie et al.
FUNDED BY
Department of Transportation (USDOT)
APPLICANT(S) CORNELL UNIVERSITY (Ithaca, New York)
ASSIGNEE(S) CORNELL UNIVERSITY (Ithaca, New York)
INVENTOR(S) Stephane C. Corgie (Ithaca, New York);  Xiaonan Duan (Ithaca, New York);  Emmanuel Giannelis (Ithaca, New York);  Daniel Aneshansley (Ithaca, New York);  Larry P. Walker (Ithaca, New York)
ABSTRACT A hierarchical catalyst composition comprising a continuous or particulate macroporous scaffold in which is incorporated mesoporous aggregates of magnetic nanoparticles, wherein an enzyme is embedded in mesopores of the mesoporous aggregates of magnetic nanoparticles. Methods for synthesizing the hierarchical catalyst composition are also described. Also described are processes that use the recoverable hierarchical catalyst composition for depolymerizing lignin, remediation of water contaminated with aromatic substances, polymerizing monomers by a free-radical mechanism, epoxidation of alkenes, halogenation of phenols, inhibiting growth and function of microorganisms in a solution, and carbon dioxide conversion to methanol. Further described are methods for increasing the space time yield and/or total turnover number of a liquid-phase chemical reaction that includes magnetic particles to facilitate the chemical reaction, the method comprising subjecting the chemical reaction to a plurality of magnetic fields of selected magnetic strength, relative position in the chemical reaction, and relative motion.
FILED Friday, August 28, 2020
APPL NO 17/005962
ART UNIT 1655 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Chemical Means for Extinguishing Fires or for Combating or Protecting Against Harmful Chemical Agents; Chemical Materials for Use in Breathing Apparatus
A62D 3/02 (20130101)

Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 8/00 (20130101)
B01J 19/12 (20130101)
B01J 31/02 (20130101)
B01J 31/003 (20130101)
B01J 35/04 (20130101)
B01J 35/0033 (20130101)
B01J 35/1061 (20130101)
B01J 35/1066 (20130101)
B01J 37/02 (20130101)
B01J 2208/00805 (20130101)
B01J 2219/0854 (20130101)
B01J 2219/0862 (20130101)

Treatment of Water, Waste Water, Sewage, or Sludge
C02F 1/484 (20130101)
C02F 3/00 (20130101)
C02F 3/342 (20130101)
C02F 2101/327 (20130101)
C02F 2209/006 (20130101)
C02F 2303/04 (20130101)
C02F 2305/08 (20130101)

Acyclic or Carbocyclic Compounds
C07C 1/12 (20130101)

Heterocyclic Compounds
C07D 301/22 (20130101)

Compounds of Unknown Constitution
C07G 1/00 (20130101)

Macromolecular Compounds Obtained by Reactions Only Involving Carbon-to-carbon Unsaturated Bonds
C08F 14/00 (20130101)
C08F 18/00 (20130101)

Microorganisms or Enzymes; Compositions Thereof; Propagating, Preserving, or Maintaining Microorganisms; Mutation or Genetic Engineering; Culture Media
C12N 9/0004 (20130101)
C12N 9/0006 (20130101)
C12N 9/0061 (20130101)
C12N 9/0065 (20130101)
C12N 11/04 (20130101) Original (OR) Class
C12N 11/08 (20130101)
C12N 11/14 (20130101)
C12N 13/00 (20130101)

Fermentation or Enzyme-using Processes to Synthesise a Desired Chemical Compound or Composition or to Separate Optical Isomers From a Racemic Mixture
C12P 7/04 (20130101)
C12P 7/22 (20130101)
C12P 17/02 (20130101)

Enzymes
C12Y 101/03004 (20130101)
C12Y 111/01 (20130101)

Climate Change Mitigation Technologies in the Production or Processing of Goods
Y02P 20/50 (20151101)

Climate Change Mitigation Technologies Related to Wastewater Treatment or Waste Management
Y02W 10/40 (20150501)
VIEW PATENT @ USPTO:  Full Text   PDF 

Office of the Director of National Intelligence (ODNI) 

US 11238470 Stepp et al.
FUNDED BY
Office of the Director of National Intelligence (ODNI)
Intelligence Advanced Research Projects Activity (IARPA)
APPLICANT(S) HRL Laboratories, LLC (Malibu, California)
ASSIGNEE(S) HRL Laboratories, LLC (Malibu, California)
INVENTOR(S) Nigel D. Stepp (Santa Monica, California);  David J. Huber (Calabasas, California);  Tsai-Ching Lu (Thousand Oaks, California)
ABSTRACT A method for collecting and processing user input. In some embodiments the method includes presenting a first user with a prompt for eliciting a first response, the first response including a numerical portion including one or more numbers, and an explanatory portion; receiving, from the first user, the first response; receiving from each of a plurality of other users, a respective response of a plurality of other responses; and displaying, to the first user, an ordered list of other responses. Within the ordered list, a second response, of the plurality of other responses, may be earlier than a third response, of the plurality of other responses, the second response being, according to a measure of distance, more distant, than the third response, from the first response.
FILED Friday, December 20, 2019
APPL NO 16/724130
ART UNIT 3623 — Business Methods - Incentive Programs, Coupons; Operations Research; Electronic Shopping; Health Care; Point of Sale, Inventory, Accounting; Cost/ Price, Reservations, Shipping and Transportation; Business Processing
CURRENT CPC
Electric Digital Data Processing
G06F 17/16 (20130101)

Data Processing Systems or Methods, Specially Adapted for Administrative, Commercial, Financial, Managerial, Supervisory or Forecasting Purposes; Systems or Methods Specially Adapted for Administrative, Commercial, Financial, Managerial, Supervisory or Forecasting Purposes, Not Otherwise Provided for
G06Q 10/04 (20130101)
G06Q 30/0203 (20130101) Original (OR) Class
G06Q 30/0204 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11239996 Masters et al.
FUNDED BY
Office of the Director of National Intelligence (ODNI)
Intelligence Advanced Research Projects Activity (IARPA)
APPLICANT(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
ASSIGNEE(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
INVENTOR(S) Oliver Paul Masters (Birmingham, United Kingdom);  Hamish C Hunt (Ashford, United Kingdom);  Flavio A Bergamaschi (Southampton, United Kingdom);  Enrico Steffinlongo (Winchester, United Kingdom)
ABSTRACT Various embodiments are provided for performing weighted partial matching under homomorphic encryption in a computing environment. Selected data may be encoded and encrypted into an encrypted query for comparison using private set intersection (PSI) under homomorphic encryption (HE). An encrypted score may be determined according to data blocks of the selected data and a set of weights for each of the data blocks of the selected data to identify matches between the data and the encrypted query. The encrypted score may be decrypted and decoded to identify matches between the encrypted query with the selected data.
FILED Wednesday, December 18, 2019
APPL NO 16/719056
ART UNIT 2491 — Cryptography and Security
CURRENT CPC
Electric Digital Data Processing
G06F 16/245 (20190101)
G06F 21/602 (20130101)

Transmission of Digital Information, e.g Telegraphic Communication
H04L 9/008 (20130101) Original (OR) Class
H04L 9/3073 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

National Security Agency (NSA) 

US 11237933 Riabov et al.
FUNDED BY
Department of Defense (DOD)
National Security Agency (NSA)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) INTERNATIONAL BUSINESS MACHINES CORPORATION (Armonk, New York)
INVENTOR(S) Anton V. Riabov (Ann Arbor, Michigan);  Shirin Sohrabi Araghi (Port Chester, New York);  Octavian Udrea (Ossining, New York)
ABSTRACT Techniques for solving a multi-agent plan recognition problem are provided. In one example, a computer-implemented method comprises transforming, by a device operatively coupled to a processor, a problem model and an at least partially ordered sequence of observations into an artificial intelligence planning problem through a transform algorithm. The problem model can comprises a domain description from a plurality of agents and a durative action. Furthermore, at least one of the observations of the at least partially ordered sequence of observations can be a condition that changes over time. The computer-implemented method further comprises determining, by the device, plan information using an artificial intelligence planner on the artificial intelligence planning problem. The computer-implemented method further comprises translating, by the device, the plan information into information indicative of a solution to the artificial intelligence planning problem.
FILED Thursday, December 14, 2017
APPL NO 15/842449
ART UNIT 2488 — Recording and Compression
CURRENT CPC
Electric Digital Data Processing
G06F 9/4862 (20130101)
G06F 11/302 (20130101) Original (OR) Class
G06F 11/3006 (20130101)
G06F 11/3438 (20130101)
G06F 16/951 (20190101)

Computer Systems Based on Specific Computational Models
G06N 5/043 (20130101)
G06N 20/00 (20190101)
VIEW PATENT @ USPTO:  Full Text   PDF 

U.S. State Government 

US 11235307 Chang et al.
FUNDED BY
National Science Foundation (NSF)
Directorate of Geosciences (GEO)
Integrative and Collaborative Education and Research (ICER)
Department of Transportation (USDOT)
U.S. State Government
State of Florida
Florida Department of Transportation (FDOT)
APPLICANT(S) University of Central Florida Research Foundation, Inc. (Orlando, Florida)
ASSIGNEE(S) University of Central Florida Research Foundation, Inc. (Orlando, Florida)
INVENTOR(S) Ni-Bin Chang (Orlando, Florida);  Martin P. Wanielista (Orlando, Florida)
ABSTRACT A synergistic composition can be used to treat water containing nitrogen compounds and phosphorus compounds. The synergistic composition includes iron filings, clay particles, aluminum particles, and sand particles. The iron filings, clay particles, and aluminum particles act synergistically to remove nitrogen compounds and phosphorus compounds from water. Specifically, the clay particles attract the nitrogen compounds and the phosphorus compounds to be absorbed onto a surface of the iron filings and the clay particles. The aluminum particles react with the nitrogen compounds via an oxidation reaction to form ammonia compounds, and react with the phosphorus compounds to produce aluminum phosphate. As such, the synergistic relationship between the iron filings, clay particles, and aluminum particles remove nitrogen and phosphorus compounds from water and recover the compounds in usable forms, namely, ammonia and aluminum phosphate.
FILED Friday, May 14, 2021
APPL NO 17/302895
ART UNIT 1773 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Chemical or Physical Processes, e.g Catalysis or Colloid Chemistry; Their Relevant Apparatus
B01J 20/12 (20130101)
B01J 20/103 (20130101)
B01J 20/0229 (20130101)
B01J 20/0248 (20130101)
B01J 20/261 (20130101)
B01J 20/28016 (20130101) Original (OR) Class

Treatment of Water, Waste Water, Sewage, or Sludge
C02F 1/72 (20130101)
C02F 1/281 (20130101)
C02F 1/285 (20130101)
C02F 1/288 (20130101)
C02F 1/705 (20130101)
C02F 1/5245 (20130101)
C02F 2101/16 (20130101)
C02F 2101/105 (20130101)
C02F 2101/163 (20130101)
C02F 2103/001 (20130101)
C02F 2103/06 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

Government Rights Acknowledged 

US 11236637 Parnin et al.
FUNDED BY
APPLICANT(S) UNITED TECHNOLOGIES CORPORATION (Farmington, Connecticut)
ASSIGNEE(S) Raytheon Technologies Corporation (Farmington, Connecticut)
INVENTOR(S) Francis Parnin (Suffield, Connecticut);  Anthony Spagnoletti (Newington, Connecticut)
ABSTRACT A lubrication system is disclosed. In various embodiments, the lubrication system includes a storage tank configured to store a lubricant; a flow management valve configured to direct the lubricant to a starvation tolerant component and to a valve exit conduit; and a main pump configured to receive the lubricant from the storage tank and to pump the lubricant to the flow management valve and to a starvation intolerant component.
FILED Friday, December 21, 2018
APPL NO 16/230711
ART UNIT 3654 — Material and Article Handling
CURRENT CPC
Non-positive Displacement Machines or Engines, e.g Steam Turbines
F01D 25/20 (20130101) Original (OR) Class

Lubricating of Machines or Engines in General; Lubricating Internal Combustion Engines; Crankcase Ventilating
F01M 11/067 (20130101)

Gas-turbine Plants; Air Intakes for Jet-propulsion Plants; Controlling Fuel Supply in Air-breathing Jet-propulsion Plants
F02C 7/06 (20130101)

Indexing Scheme for Aspects Relating to Non-positive-displacement Machines or Engines, Gas-turbines or Jet-propulsion Plants
F05D 2260/98 (20130101)
F05D 2270/301 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11236677 Hough et al.
FUNDED BY
APPLICANT(S) UNITED TECHNOLOGIES CORPORATION (Farmington, Connecticut)
ASSIGNEE(S) Raytheon Technologies Corporation (Farmington, Connecticut)
INVENTOR(S) Matthew Andrew Hough (West Simsbury, Connecticut);  John S. Tu (Agawam, Massachusetts);  Stephen C. Harmon (East Hampton, Connecticut);  Paul F. Croteau (Columbia, Connecticut);  Russell B. Hanson (Jupiter, Florida);  Joshua C. Rathgeb (Glastonbury, Connecticut)
ABSTRACT A diffuser case support structure for a gas turbine engine includes a fairing disposed circumferentially about a longitudinal axis. The fairing defines a plurality of passages circumferentially spaced apart and forming at least a portion of a fluid path between a compressor and a combustor of the gas turbine engine. A diffuser frame includes a plurality of struts. Each of the plurality of struts is disposed between a pair of adjacent passages of the plurality of passages. The diffuser frame is configured to couple an inner diffuser case to an outer diffuser case. A sliding joint is formed between the fairing and the diffuser frame, the sliding joint comprising a fastener extending generally axially through an aperture disposed in the fairing.
FILED Wednesday, May 15, 2019
APPL NO 16/413347
ART UNIT 3745 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Gas-turbine Plants; Air Intakes for Jet-propulsion Plants; Controlling Fuel Supply in Air-breathing Jet-propulsion Plants
F02C 7/28 (20130101) Original (OR) Class
F02C 7/32 (20130101)

Indexing Scheme for Aspects Relating to Non-positive-displacement Machines or Engines, Gas-turbines or Jet-propulsion Plants
F05D 2220/32 (20130101)
F05D 2240/55 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 
US 11237117 Havener et al.
FUNDED BY
APPLICANT(S) BWXT Nuclear Operations Group, Inc. (Lynchburg, Virginia);  BWXT NOG Technologies, Inc. (Lynchburg, Virginia);  Aaron C. Havener (Pittsburgh, Pennsylvania)
ASSIGNEE(S) BWXT Nuclear Operations Group, Inc. (Lynchburg, Virginia);  BWXT NOG Technologies, Inc. (Lynchburg, Virginia)
INVENTOR(S) Aaron C. Havener (Pittsburgh, Pennsylvania);  James D. Jogerst (Forest, Virginia);  Thomas C. Mohr (Forest, Virginia);  Keith B. Rider (Prospect, Virginia)
ABSTRACT Methods of and apparatus for inspecting composite layers of a first material formed on a second material are provided including providing an illumination source, illuminating at least a portion of the composite at the layer, receiving light reflected from the sample, determining a spectral response from the received light, and comparing the received spectral response to an expected spectral response.
FILED Monday, August 31, 2020
APPL NO 17/008103
ART UNIT 2882 — Optics
CURRENT CPC
Investigating or Analysing Materials by Determining Their Chemical or Physical Properties
G01N 21/94 (20130101)
G01N 21/8806 (20130101) Original (OR) Class
G01N 2021/8812 (20130101)
G01N 2021/8835 (20130101)
VIEW PATENT @ USPTO:  Full Text   PDF 

How To Use This Page 

THE FEDINVENT PATENT DETAILS PAGE

Each week, FedInvent analyzes newly granted patents and published patent applications whose origins lead back to funding by the US Federal Government. The FedInvent Patent Details page is a companion to the weekly FedInvents Patents Report.

This week's information is published in the FedInvent Patents report for Tuesday, February 01, 2022.

The FedInvent Weekly Patent Details Page contains a subset of patent information to provide a deeper dive into the week’s taxpayer-funded patents to help the reader better understand where a patent fits in the federal innovation ecosphere.

HOW IS THE INFORMATION ORGANIZED?

Patents are organized by the funding agency. Within each group, the patents are organized in numeric order. A patent funded by more than one agency will appear in the section of each of the agencies that funded the research and development that resulted in the invention. This approach gives the reader a complete view of the department or agency activity for the week.

WHAT INFORMATION WILL I FIND?

THE PANEL
There is a panel for each patent that contains the patent number and the title of the patent. When you click the panel, it opens to reveal the following information:

FUNDED BY
The agencies that funded the grants, contracts, or other research agreements that resulted in the patent. FedInvent includes as much information on the source of the funding as possible. The information is presented in a hierarchy going from the Federal Department down to the agencies, subagencies, and offices that funded the work. Here are two examples:

Department of Health and Human Services (HHS)
     National Institutes of Health (NIH)
         National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Department of Defense (DOD)
     Defense Advanced Research Projects Agency (DARPA)
         Army Research Office (ARO)

We do our best to provide detailed information about the funding. In some cases, the patent only reports limited information on the origins of the funding. FedInvents presents what it can confirm. We add the patents without the information required by the Bayh-Dole Act to our list of patents worthy of further investigation.

APPLICANT(S) and ASSIGNEES
FedInvent includes both the Applicants and the Assignees because having both provides more information about where the inventive work was done and by what organizations. Many organizations — universities, corporations, and federal agencies — standardize the Assignee/Owner information by the time a patent is granted. In the case of federal patents, many of the patents use the agency headquarters information for patent assignment.

Showing just the headquarters address would make Washington, DC the epicenter of all taxpayer-funded research and development. Providing both the applicant information and the assignee information provides a more accurate picture of where important taxpayer funded innovation is happening in America. Here are two examples from two different patents:

APPLICANT: U.S. Army Research Laboratory, Adelphi, MD
ASSIGNEE: The United States of America as represented by the Secretary of the Army Washington, DC

APPLICANT: Optech Ventures, LLC (Torrance, California)
ASSIGNEE(S): The Regents of the University of California (Oakland, California); Optech Ventures, LLC (Torrance, California)

INVENTOR(S)
The inventors appear in the same order as they appear on the patent. FedInvents presents the names in first name/last name order because they are easier to read than the last name/first name order of the names on the USPTO patent documents.

ABSTRACT
The abstract as it appears on the patent.

FILED
The date of the patent application including the day of the week.

APPL NO
This is the patent application serial number. If you’d like to learn more about how application serial numbers work you can go to the Lists Page.

ART UNIT
Patent data includes the Art Unit where a patent was examined. (The Art Unit isn’t available for published patent applications.) The Art Unit provides insight into what group of patent examiners prosecuted the patent application and the subject matter that the examiners work on. For example:

3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices

You can learn more about ART UNITS on the FedInvent Patents Weekly panel called About Tech Center or you can find information on the FedInvent Lists Page.

CURRENT CPC
Current CPC provides a list of the Cooperative Patent Classification symbols assigned to the patent. These are the CPC symbols assigned at the time the patent was granted.

The FedInvent Project is a patent classification maximalist endeavor or put another way, we believe that more you understand about patent classification the more you'll learn about the nature of the invention and the types of work that the federal government is funding.

The symbol presented in BOLD is the symbol identified as the "first" classification which is the most relevant classification on the patent. The date that follows the symbol is the date of the most recent revision to the art classed there.

  • A61B 1/149 (20130101)
  • A61B 1/71 (20130101)
  • A61B 1/105 (20130101)

The CPC symbols match the classifications found on the PDF version of the patent. Over time, the classifications on the full-text version of the patent change to reflect how USPTO organizes patent art to support its examiners. The two sets of CPCs don’t always match.

VIEW PATENT
As of June 2021, we include two ways to view a patent at USPTO. FedInvent provides a link to the Full-Text Version of the patent and a link to the PDF version of the patent.

HOW DO I FIND A SPECIFIC PATENT ON A PAGE?

You can use the Command F or Control F to find a specific patent you are interested in.

HOW DO I GET HERE?

You navigate to the details of a patent by clicking the information icon that follows a patent on the FedInvent Patents Weekly Report.

You can also reach this page using the weekly page link that looks like this:

https://wayfinder.digital/fedinvent/patents-2022/details-patents-20220201.html

Just update the date portion of the URL. Tuesdays for patents. Thursdays for pre-grant publication of patent applications.

Download a copy of the How To Use This Page

HAVE MORE QUESTIONS?

info@wayfinder.digital